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Abstract 
Plant pathogens constitute a major threat to global food security. The use of naturally 
resistant crop varieties can limit crop losses, however new races of pathogen can arise that 
are able to overcome these defences. Plant breeding for race-specific resistance typically 
relies on disease-resistance genes, which generally encode proteins with nucleotide-binding 
and leucine-rich repeat domains (NB-LRRs). NB-LRRs are a large of proteins found in both 
plants and animals, with plant NB-LRRs further classified by the presence of N-terminal 
coiled-coil or toll-interleukin receptor domains. 
Although qualitative models exist to describe R-protein regulation and activation, these are 
predominantly based on genetic and molecular studies. Biochemical investigations into R-
protein function have been hampered by difficulties obtaining sufficient yields of material. 
When suitable material has been identified, biochemical studies have been used to 
complement well-established in planta assays to validate numerous hypotheses. 
This work describes the screening processes undertaken to obtain R-protein domains 
suitable for downstream experiments. Using E. coli for high-throughput screening of 
constructs from a single R-protein, traditional construct design to investigate multiple R-
protein domains and expanding our expression hosts to eukaryotic systems we successfully 
purified four coiled-coil domains and a single NBARC domain for use in downstream 
experiments. 
Characterisation of this NBARC domain by circular dichroism and small-angle X-ray 
scattering indicates that the protein is well-folded and stable in solution, allowing in vitro 
investigations. In testing models for R-protein regulation we were able to confirm previous 
findings, such as low levels of ATPase activity, however we were unable to find evidence for 
a commonly cited method of signal repression.  A preliminary crystal structure of the NBARC 
domain shows significant similarity to Apaf-1, and highlights the importance of conserved 
motifs in NBARC architecture. 
The tools presented here should prove a valuable resource to complement existing models 
to better understand the structure, biochemistry, and ultimately regulation of plant R-
proteins. 
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HMFM Hogness modified freezing media 
HR Hypersensitive response (cell death) 
IMAC Immobilised metal ion affinity chromatography 
IP Immunoprecipitation 
IPTG isopropyl β-D-1-thiogalactopyranoside  
LB Lysogeny broth 
LRR Leucine rich repeat domain 
LysM Lysine-rich motif (chitin binding) 
MAMP Microbe-associated molecular pattern 
MAPK Mitogen-activated protein kinase 
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MBP Maltose binding protein 
MES 2-(N-morpholino)ethanesulfonic acid 
MMT MES, malic acid, Tris buffer 
MS Mass spectrometry 
MW Molecular weight 
NBARC 
Nucleotide binding with similarty to Apaf-1, R-proteins and Ced-
4 
NB-LRR Nucleotide binding Leucine-rich-repeat protein 
NBT Nitro blue tetrazolium chloride  
Ni2+-NTA Nickel- nitrilotriacetic acid column 
NLR NOD-like receptor/NBARC-LRR receptor 
OD600 Optical density at 600nm 
OPPF Oxford protein production facility 
ORF Open reading frame 
PAMP Pathogen-associated molecular pattern 
PB Power broth 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PEG Polyethylene glycol 
PFAM Protein family database 
PK/LDH Pyruvate kinase/lactate dehydrogenase 
PRR Pattern recognition receptor 
PTI PAMP-triggered immunity 
R-gene Disease resistance gene 
R-protein Disease resistance protein  
Rx Resistance to potato virus x protein 
SAD Single wavelength anomalous dispersion 
SAXS Small-angle X-ray scattering 
SC-LY Synthetic complement media lacking leu and trp 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate- polyacrylamide gel electrophoresis 
SUMO Small ubiquitin-like modifier 
T3SS Type 3 secretion system 
TB Terrific broth 
TBS Tris buffered saline 
TCEP 3,3′,3′′-Phosphanetriyltripropanoic acid 
TIR Toll-interleukin receptor 
TNL Toll-interleukin receptor NBARC Leucine-rich-repeat protein 
Tris 2-Amino-2-hydroxymethyl-propane-1,3-diol 
Y2H Yeast 2-hybrid 
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When faced with infection by invading microbes, animals use a complex series of 
immune responses arising from both the adaptive and innate immune systems to 
prevent colonisation and disease progression. The adaptive immune response 
relies on specialised circulatory cells (T- and B- lymphocytes), which are able to 
detect self and non-self-derived molecules (antigens). This immune response is 
responsive to new threats, with the ability to “remember” past pathogens, and forms 
the basis of modern immunizations. Plants on the other hand, lack specialised 
circulatory immune cells. In order to respond to invasion by a pathogen, plants rely 
on genetically determined innate immunity to detect foreign bodies and respond 
appropriately. Although passive defences exist in the form of structural polymers 
and constitutively expressed defensive proteins, plants are also able to actively 
detect and, for the most part, rebuff potential invaders. Without specialised cells to 
monitor for foreign bodies, individual plant cells are capable of mounting an 
appropriate response to invaders, and to do so use a complex series of intracellular 
and extracellular receptors.  
The focus of this project has been to understand the structural and biochemical 
properties of plant disease-resistance proteins (R-proteins). R-proteins reside in the 
plant cytoplasm are capable of mounting rapid and effective immune responses to 
microbial pathogens in a race-cultivar dependent manner. In order to understand 
the significance of results generated, and rationale for the approaches taken in this 
project, it is necessary to have a sound understanding of plant immunity. The 
purpose of this chapter is to give a broad introduction to the key concepts in plant 
immunity, with emphasis on prior work done with R-proteins.  
 
1.1 Plant immunity 
Pre-harvest losses caused by plant diseases are a major constraint to achieving 
food security. These losses have wide-reaching effects, ranging from globalised 
price increases, to more localised and dramatic effects for subsistence and small-
scale farmers who are more susceptible to price fluctuations and losses in 
productivity.  
Such losses can be reduced through a variety of techniques. Crop rotation relies on 
the fact that many pathogens typically have limited host ranges. Replacing a 
susceptible crop with a non-susceptible one for a number of growing seasons 
ideally results in the population of the disease-causing pathogen falling to a point 
whereby the original crop can be replanted at this site. This method can be effective 
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for reducing crop losses and therefore boost per-acre yields. However there are 
limitations to the efficacy of this method. Some pathogens have large host ranges, 
such as Phytophthora ramorum, making rotation to a non-host crop more difficult. 
Alternatively, pathogens such as Phytophthora infestans are able to produce long-
lived structures, such as oospores, which may persist in the soil for several years3.  
Practices like crop rotation can be supplemented with chemical controls, such as 
the application of pesticides and fungicides. Excessive use of chemical agents is 
undesirable for multiple reasons: many pesticides may have off-targets, causing 
harm to ecologically important organisms, exposure to such chemicals can be 
potentially harmful to humans, and organisms can evolve resistance to such 
chemicals over time. 
Alternatively, the spread of a disease may be reduced by the use of specific 
cultivars which are resistant to colonisation by the pathogen. This resistance is 
genetically determined, and dependent on both the genotype of the host and the 
genotype of the pathogen4, 5. The resulting resistance can be narrow- if either host 
or pathogen does not express the correct proteins the result for the plant will be 
disease susceptibility. Effector-triggered immunity (Section 1.4) is an example of 
such gene-for-gene resistance. In ETI, a pathogenic protein termed an effector, is 
recognised by a host disease-resistance protein, R-protein (encoded by an R-gene), 
which typically results in a rapid and localised cell death response. As biotrophic 
and hemi-biotrophic pathogens require living cells to survive, this cell death 
response is an effective way to prevent colonisation and disease progression. 
Historically, the genes responsible for these resistance phenotypes have been 
introgressed from a related non-crop species into the target crop over the course of 
several years. The gene can then be crossed into an elite variety, with several 
rounds of backcrossing, to add the new resistance phenotype to varieties with 
desirable properties, such as high yield or similar consumer-desired traits.  
With new technologies it is possible to transfer the genes responsible for resistance 
phenotypes, once they have been identified and cloned, directly into certain crops. 
Although this certainly reduces the time required to produce new resistant crop 
varieties, this approach has the same limitations as traditional breeding techniques. 
If a new variety is successful and becomes widely used, it places a selective 
pressure on the pathogen to overcome this new resistance. The end result being 
that in some instances new resistance genes are rapidly overcome (or “broken”) in 
the field. 
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There are a number of key methods that may overcome this shortcoming. Elite 
varieties are genetically homogenous, meaning that large areas of farmland can be 
susceptible to infection by a single virulent pathogen. Using more genetically 
diverse crop varieties may reduce susceptibility to such infections, however this may 
lead to decreased crop yields in the short-term as elite varieties are produced 
specifically for their favourable characteristics. A second approach would be to 
“stack” multiple resistance genes in a single variety, or into several high-yielding 
varieties. Rather than relying on a single resistance gene to give resistance, using 
multiple R-genes, which recognise multiple pathogenic effector proteins, decreases 
the chances of the pathogen evolving to overcome these combined resistances 
simultaneously. Without a good understanding of the signalling pathways used by 
these proteins however, stacking R-proteins may have limited success if similar 
signal transduction machinery is used. Furthermore certain combinations of R-
genes are incompatible, leading to inviable embryos or aberrant developmental 
phenotypes6, which may restrict the repertoires of resistance genes that can be 
deploy in parallel.  
Our increasing understanding of how R-proteins work is opening new avenues into 
producing synthetic resistance proteins. The aim of such work is to mutate a single 
R-protein to allow it to respond to a broader range of effectors, giving resistance to 
multiple pathogen races. So far work with the Solanum tuberosum resistance 
protein R3a has demonstrated that such approaches show merit with work by 
Segretin et al and Chapman et al producing mutant variants of R3a that are able to 
respond to both their normal targets, and to effectors that would normally be 
undetected7, 8. Further work by Harris et al with the resistance protein Rx 
demonstrates that it is possible to produce mutants that not only respond to a 
broader range of pathogenic proteins, but are able to translate this recognition to 
disease resistance9. The methods used to generate these synthetic proteins are 
time consuming and labour-intensive, typically relying on random mutagenesis 
followed by phenotyping many hundreds of individuals. In the case of Rx a second 
round of labour-intensive screening was required to obtain a desirable phenotype. 
To understand the importance of R-proteins and the key concepts surrounding their 
function, it is important to put these specific immune receptors in the broader 
context of plant immunity.  
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1.2 PAMPs/MAMPs and PTI 
Plants mount responses against attempted infection by detecting highly conserved 
“molecular patterns”. Depending on the context these patterns are referred to as 
microbe-associate molecular patterns, MAMPs, PAMPs with respect to pathogens, 
or when referring to general damage often associated with invasion, DAMPs. These 
“molecular patterns” may be proteins, such as bacterial Ef-Tu and bacterial flagellin, 
carbohydrates, such as fungal chitin, or host-derived molecules released from 
neighbouring cells10-13. One thing that these microbially-derived patterns have in 
common is that they each show a high level of conservation throughout diverse 
species, both with regards to sequence and prevalence. Significant modifications to 
these molecules is suggested to lead to decreased fitness, and so these patterns 
provide a reliable platform for microbial detection. Interestingly the mammalian 
immune system, despite significant differences from the plant immune system, also 
targets these infection-related molecules to aid immunity14.  
Plant proteins responsible for detecting PAMPs are known as pattern-recognition 
receptors (PRRs) and the resulting immune response termed PAMP-triggered 
immunity (PTI). PRRs are transmembrane proteins with apoplastic leucine-rich 
repeat regions (LRRs), and can be divided into sub-classes on the basis of their 
cytoplasmic domains: receptor-like kinases have a cytoplasmic kinase domain that 
allows signal transduction when activated. On the other hand, receptor-like proteins 
(RLPs) lack a predicted kinase domain, and so presumably require additional 
components to activate a signalling cascade.  
One of the best studied PRRs is FLS2 (Flagellin-sensing 2), the transmembrane 
receptor from Arabidopsis thaliana required to detect a conserved region of bacterial 
flagellin, known as flg2215. FLS2 is an apoplastic LRR with a cytoplasmic 
serine/threonine protein kinase domain, and its activation requires the co-receptor 
BAK116. Investigations of FLS2 have helped our understanding not only of the 
specific recognition of an important MAMP, but has also revealed common themes 
in PAMP-triggered immunity (PTI). For example investigations into other PRRs 
suggest that BAK1 is required for not only FLS2 function, but also responses to 
elf18 (an N-terminal region of EF-Tu) and pep1, an A. thaliana DAMP17. Many of the 
functional readouts for FLS2 activation have been used to screen for activity of 
other PRRs. Upon flg22 detection, cells produce a burst of reactive oxygen species 
(ROS), increase the concentration of cytoplasmic calcium, deposit the structural 
polymer callose, and undergo transcriptional changes leading to upregulation of a 
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number of defence-related proteins such as PR118. These broad responses are also 
seen upon perception of elf18 and chitin, and can be used to screen for novel 
elicitors. Together these responses are capable of preventing poorly adapted 
phytopathogens from colonising plants and causing disease symptoms. 
Alongside these defensive readouts, studies into FLS2 may also be revealing 
common themes for PRR behaviour post-activation. When an active FLS2-BAK1 
complex forms it undergoes endocytosis19, which is emerging as a potential 
common behaviour of many PRRs20. 
Of particular interest to this project, the crystal structure of the FLS2 ectodomain 
was recently solved, revealing a corkscrew-like arrangement of LRR units and 
highlighting the mechanistic basis for activation by flg22 and BAK1 dimerisation21. 
Binding of flg22 occurs by binding along a major groove in the protein’s surface, 
forming an extensive interaction from LRR 3 to LRR 16, and forming a partially 
shared interface with BAK1. This binding interface is consistent with previous work 
indicating that LRRs 7-10 are important for high-affinity binding22. Interestingly, Sun 
et al suggest that ligand binding does not seem to require or lead to significant 
conformational changes in this receptor. Structural similarities between FLS2 and 
BRI1 (a plant hormone receptor) leads to the possibility that other apoplastic LRRs 
may share the same general global fold and thus have common activation 
mechanisms. 
Given that plants appear to have a repertoire of PRRs capable of detecting 
essential microbial features and mounting effective defences, the question arises of 
how plant diseases can occur. As PAMPs cannot be lost or significantly modified 
without fitness cost to the microbe, selective pressures result in the evolution of 
populations of microbe with proteins capable of subverting PRR recognition and 
responses. These proteins are collectively referred to as effectors.  
 
1.3 Effectors and ETS 
The nomenclature used to describe the proteins produced by pathogens to enhance 
virulence has changed over the years. Many of these proteins are termed avirulence 
proteins, or AVRs, as they were initially identified by their effect of limiting the range 
of cultivars a given pathogen could infect. Avirulence proteins are typically only 
detrimental to a pathogen in specific contexts, i.e. in the presence of a resistance 
protein capable of detecting the AVR. For example the effector AVR3a from P. 
infestans was originally identified by the inability of P. infestans race 3 to grow on 
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plants harbouring the R3 locus. In this context Avr3a is an avirulence protein, 
however in the absence of the R3 locus (specifically the R3a gene) Avr3a boosts 
the virulence of P. infestans by disrupting basal immunity. Effectors, or effector 
proteins, is a more broad term used to denote proteins produced by pathogens 
during the course of infection to enhance pathogen success. This term 
encompasses proteins that are known to be recognised (AVRs), and those for which 
this response has not been identified. Therefore “effector” will be used to discuss 
both AVR and non AVR-proteins.  
Effector recognition leads to an immune response, decreasing the fitness of the 
pathogen. Despite this, many effectors are maintained in natural populations, 
suggesting that in the absence of cultivar-specific R-genes, effectors bestow an 
advantage to the pathogen. With access to cheaper and faster sequencing 
technology, improvements to map-based cloning, and bioinformatics tools the 
number of identified and cloned effectors has increased hugely in the past two 
decades. With increased examples of effectors to work with researchers have been 
able to dissect the activities of multiple effectors to determine how these proteins 
can be beneficial to pathogens. A key theme in research into the function of 
effectors has been the identification of proteins capable of subverting plant 
immunity. This subversion can act at multiple levels of plant immunity, and can 
occur in two distinct compartments: the apoplast, or the host cytoplasm. 
1.3.1 Apoplastic effectors 
When filamentous pathogens invade prospective hosts they form intimate 
associations with cells using specialised feeding structures called haustoria. This 
host-pathogen interface is one of the first sites for both potential detection and 
defence, making it an ideal place for effectors to act to subvert immunity.  
In order to protect against fungal pathogens plants produce a number of chitinases 
capable of degrading fungal cell walls. These proteins are able to reduce pathogen 
fitness by directly attacking the microbe, but can also act to trigger further induced 
responses by releasing chitin monomers to be detected by PRRs. To combat this 
fungal pathogens produce chitinase inhibitors to protect against attack, and chitin-
binding proteins to reduce PAMP-triggered responses, presumably by preventing 
chitin detection by PRRs. Diverse fungal pathogens from Magnaporthe oryzae to 
Cladosporium fulvum have evolved similar molecular machinery to sequester chitin 
oligomers, producing the lysine-motif (LsyM domain)- containing proteins SLP1 and 
Ecp6 respectively23-25 
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Plants produce not only chitinases, but also a suite of proteases that aid defence 
against filamentous pathogens. In the same way that the selective pressure of 
chitinase production leads to the evolution of chitinase inhibitors, filamentous 
pathogens secrete a number of serine, aspartate and cysteine protease inhibitors to 
boost pathogenicity and facilitate growth in the apoplast. Whilst fungal pathogens 
have evolved LsyM-containing proteins to bind self-derived chitin oligomers, 
protease inhibitors have evolved not only to target diverse proteases, but have also 
convergently evolved in distinct kingdoms (fungi and oomycetes) to target the same 
host protease26. Such points of functional convergence are interesting as they may 
highlight important immune proteins and guide future work into improving disease 
resistance. 
Apoplastic effectors play an important role in determining the outcome of many 
plant-pathogen interactions, however they are not the only tool at the microbe’s 
disposal. Many microbes supplement their apoplastic arsenals with effectors that act 
in the host cytoplasm. 
1.3.2 Translocated effectors 
Getting an effector into the apoplast is relatively straightforward to conceptualise, 
after all it is in the microbe’s interest to be able to deliver these proteins, and so 
transportation and secretion can be actively supported. Plant cells on the other hand 
have an incentive not to take up foreign proteins during infection that could subvert 
normal functions. How then can pathogenic proteins enter and become cytoplasmic, 
rather than apoplastic effectors? For bacteria this issue can be addressed directly. 
The type 3 secretion system (T3SS) can act like a molecular syringe. It spans from 
the microbial cytoplasm, through the apoplast until it reaches and penetrates the 
host’s plasma membrane. This needle-like structure can then be used to inject a 
number of bacterial effectors directly into the host cytoplasm (Figure 1.3.1). 
Fungi and oomycetes lack an analogous T3SS. A large number of oomycete 
effectors are characterised by an N-terminal RXLR (arginine, any amino acid, 
leucine, arginine) motif27, 28. This motif occurs downstream of canonical secretion 
signals, indicating that the protein is first secreted out of the pathogen, and does not 
appear to be required for effector activity within the cytoplasm. Mutations to the 
RXLR motif of AVR3a results in non-uptake of the protein into plant cells, 
highlighting the role of this motif in translocation28. However the exact function of 
this motif remains controversial. Contradicting reports about whether the RXLR 
motif alone is capable of mediating pathogen-independent protein uptake29-31, and 
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disputes over the potential for this motif to bind to cell membranes32, 33 to facilitate 
entry into host cells make it difficult to draw meaningful conclusions about exactly 
how the RXLR motif functions. 
Host 
cytoplasm
PM
Cell Wall
Apoplast
SP
Oomycete pathogen Bacterial pathogen
 
Figure 1.3.1 Delivery of pathogenic proteins into plant cells 
 
Regardless of the exact mechanism of entry, once inside the host cytoplasm 
effectors are able to carry out a wide range of activities. This project has focussed 
on their role in both subverting and triggering immune responses, but this is not the 
extent of effector function. Manipulation of the host encompasses not only immune-
related activities, but also influences cell growth and metabolism to facilitate 
pathogenicity. Subversion of immune responses can act at many levels- from 
preventing signal initiation by a PRR to preventing transcriptional changes with 
multiple points for interference between. 
If an effector is able to stop a PRR from initiating a signalling cascade in response 
to a PAMP the plant can be rendered effectively blind, analogous to apoplastic chitin 
binding proteins sequestering chitooligosaccharides to prevent PRR activation. 
Pseudomonas syringae for example has evolved the 18kDa cytoplasmic effector 
AvrPto that is capable of interacting with FLS2, and other defence-related kinase 
domains, and suppresses PTI by interfering with kinase activity34, 35. This inhibitory 
activity is not general to all kinases and the effector is itself the target of additional 
host kinases to promote virulence36, part of an emerging theme of effector “helpers”. 
Bacterial pathogens (right) are able to use the type 3 secretion system (T3SS) to directly 
transfer proteins into the host’s cytoplasm. Oomycete pathogens (left) secrete effectors 
with N-terminal RXLR effectors into the host cytoplasm. The most likely site for this 
delivery is the haustorium, a specialised feeding structure that forms intimate 
associations with the host plasma membrane. Once in the apoplast, these RXLR 
effectors then translocate into the host cell through some unknown mechanism.  
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In addition to trying to prevent immune signalling at the source, effectors can target 
downstream components of the signalling cascade to prevent resistance. In the 
case of P. syringae, inhibition of FLS2 function by AvrPto can be supplemented or 
replaced by the activity of an additional effector, HopA1. This translocated effector 
has been shown to interact with two mitogen-activated protein kinases (MAPKs), 
and prevents flg22-induced oxidative bursts and full immunity through its 
phospholyase activity37, an activity that seems to be conserved in bacteria infecting 
both plants and animals38, 39.  
Just as diverse pathogens have produced apoplastic effectors to target the same 
classes of defensive hydrolytic enzymes, targeting of related signalling pathways, 
namely MAPKs, is a common theme in cytoplasmic host manipulation. PexRD2 is a 
121 amino acid protein produced by P. infestans comprising an N-terminal secretion 
signal, an RXLR motif and a C-terminal effector domain of approximately 64 
residues forming a WY-fold. The effector domain of this protein alone is sufficient for 
virulence and avirulence functions, and acts as a dimer in vivo and in vitro40, 41. 
Once in the plant cell, this homodimer interacts with MAPKs (specifically S. 
tuberosum MAPKKKε) and interferes with cell death by preventing activities of the 
protein41, analogous to P. syringae HopA1 activity. 
Effectors are not only able to interfere with the signalling events leading to immunity, 
but can play a more direct role in preventing appropriate responses. The bacterial 
pathogen Xanthomonas campestris is able to use the T3SS to translocate the 
effector AVRBs3 into host cells, where it then uses host machinery to accumulate in 
nucleus42, 43. Once in the nucleus AVRBs3 is able to manipulate defence-related 
transcription through its DNA binding and transcription-activation domains43, 44. This 
DNA-binding and transcriptional control is not limited to X. campestris, but can be 
found in a wide range of Xanthamonas species45, and so may be a general method 
to enhance pathogeneicity. 
Understanding how effectors function not only illuminates the specific activities of 
individual proteins, but gives a greater insight into host manipulation, important 
features of the immune system, pathogen evolution and limitations, and allows the 
development of new and useful tools. For example knowledge of the Phytophthora 
RXLR motif has allowed bioinformatic screening to identify new candidate effectors, 
opening new avenues for investigation46,47, and investigating X. campestris effectors 
has resulted in the development of new tools for DNA manipulation48. 
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Identification of the WY-domain has led to new ideas regarding effector evolution, 
and the relationship between sequence identity and structural similarity. WY-fold 
proteins are a significant subset of the large RXLR-class of oomycete effector 
proteins, of which there are over 500 predicted in the P. infestans genome27. 
Despite low sequence identity, these WY-fold effectors are predicted to share a 
similar core fold which appears to be adaptable to a variety of oligomeric states and 
repeat lengths 40, 49-51. Despite structural similarities, these proteins display a wide 
range of biochemical properties, leading to the hypothesis that this fold has evolved 
as a scaffold onto which new functions can be added. 
With multiple proteins seemingly capable of overcoming basal resistance 
mechanisms, plant disease should be rampant. Fortunately there is a fitness cost 
associated with effector expression in specific contexts. That fitness cost comes in 
the form of cultivar-specific plant disease-resistance proteins (R-proteins) that are 
capable of detecting the presence of certain effectors and triggering rapid immune 
responses.  
 
1.4 R-proteins and ETI 
Although the term R-protein refers to any plant protein capable of initiating a gene-
for-gene style immune response, the focus of this project has been typical NB-LRR 
(in particular CC-NB-LRR or CNL) proteins. These proteins share a conserved 
nucleotide-binding domain (NB or NBARC domain) and C-terminal leucine-rich 
repeat (LRR) domain, and may have N-terminal Toll-interleukin receptor-like (TIR) 
or coiled-coil (CC) domains (Section 1.6).  However the ability to trigger specific 
resistance is not restricted to this family of proteins52. 
A key function of an R-protein is to detect the presence of a pathogen effector. This 
typically results in a rapid cell death response (termed a hypersensitive response, or 
HR), which is particularly effective at stopping further infection by biotrophic or hemi-
biotrophic microbes. Just as pathogens use multiple methods to interfere with basal 
immunity, plants deploy R-proteins that use diverse methods to detect cytoplasmic 
effectors.  
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1.5 Models for AVR recognition 
1.5.1 Direct interactions (canonical NB-LRRs) 
The most straightforward model to describe how R-proteins are able to detect the 
presence of pathogenic effectors is that the effector directly interacts with the R-
protein, resulting in activation of the protein. This is the case for Flax (Linum 
usitatissimum) resistance proteins L5 and L6 which were found to interact directly 
with the corresponding AVRL567 alleles from flax rust (Melampsora lini). 
Recognition specificity is determined in this case by the ability to interact with the 
various alleles53. From mutagenesis and domain swap experiments it is possible to 
assign this interaction activity to the LRR domains of these proteins54. Where 
examples of direct interactions can be found between canonical NB-LRR proteins 
and effectors, binding appears to be mediated predominantly by LRR domains55, 56.  
Although direct interactions are able to explain the recognition of certain effectors, a 
lack of evidence for direct interactions in other pathosystems has led to hypotheses 
regarding indirect activation. Indirect activation covers a wide range of potential 
mechanisms, from recognition of host protein-effector complexes to recognition of 
modified host proteins. There are two main models for indirect R-protein activation 
depending on the effect that interactions with host proteins has on pathogen 
virulence in the absence of an R-protein: the guard hypothesis and the decoy 
model. 
1.5.2 Guard hypothesis 
In the guard hypothesis an effector targets a specific host protein to enhance 
virulence of the pathogen. In the presence of the cognate R-protein, interaction 
between the effector and host protein (or guardee) results in R-protein activation 
and HR57. In this instance silencing or removal of the host target will result in a loss 
of effector-dependent enhanced virulence. 
AvrPto is not only able to interact with the kinase domains of FLS2 and related PRR 
proteins, but also with a 321 amino-acid cytoplasmic kinase, Pto58 59. Pto forms 
large complexes with the NB-LRR, Prf, through multiple interactions with the poorly 
characterised N-terminal region of the R-protein60-62. When AvrPto interacts with 
Pto, it stimulates phosphorylation of Pto in a Prf-dependent manner, leading to HR 
and limiting infection63-65. In this example of guarding, it is the effector-dependent 
change in Pto that activates Prf, with the loss of either the R-protein (Prf) or the 
guardee (Pto) leading to a loss of immune response.  
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Similarly, the A. thaliana host protein Rin4 (RPM1-interacting protein 4) interacts 
with, and is required for, the activation of the NB-LRR, RPM166. Unlike Pto Rin4 is 
targeted by multiple pathogen effectors, however interaction with two (AvrRpm1 and 
AvrB) also leads to phosphorylation of the guardee and immune activation66. 
Interactions between RIN4 and a third effector AvrRpt2 leads to activation of a 
separate R-protein, RPS267. Although triggered by a similar guarding mechanism to 
RIN4-dependent RPM1 activation, RPS2 activation occurs instead by cleavage and 
degradation of RIN468, 69. 
One potential advantage for indirect activation of R-proteins is that it may make it 
more difficult for effectors to evolve to avoid recognition. In the case of direct 
interactions, provided that the R-protein recognition interface is distinct from the 
functional region of the effector, surface mutations may lead to escape of 
recognition without affecting fitness. If R-protein activation is based not on direct 
interactions, but the function of an effector then these simple surface mutations will 
not result in evasion by the effector- the only ways to prevent recognition would be 
to either prevent effector function, presumably with an associated fitness cost, or by 
evolving separate proteins capable of mitigating the effects of this active R-protein.  
Although this system of recognition may lead to more stable resistance for the plant, 
the unequal prevalence of guards and effectors in potential host and pathogen 
populations may result in an unstable situation for the host target, leading to 
additional hypotheses about the nature of effector targets in pathology.  
1.5.3 The decoy model 
At its most simple, the decoy model put forth by van der Hoorn and Kamoun states 
that plants will evolve host proteins that are able to mimic effector targets, but are 
only involved in effector perception70. The authors state that in the absence of an R-
protein capable of detecting effector-mediated modification, there will be a pressure 
for the host target to evolve to escape interactions that aid virulence. Conversely in 
the presence of a cognate R-protein, there will be a pressure for the host protein to 
evolve a higher affinity for the effector to facilitate recognition. The decoy model 
solves this unstable situation by the introduction of a second protein, which can 
evolve a high affinity for the effector to aid recognition in the presence of the 
cognate R-protein, but the manipulation of which does not lead to enhanced 
virulence.  
In this paper the authors cite a number of examples to back this idea. AvrBS3 
(introduced in Section 1.3.2) was identified through its avirulence function. 
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Alongside upregulating promoters that enhance pathogenicity, this protein also 
binds to the promoter of the resistance protein BS3 and induces expression. This in 
turn triggers an immune response to limit infection. A second example is the case of 
Pto (Section 1.5.2, Guard hypothesis). P. syringae expressing AvrPto have 
enhanced fitness on plants even in the absence of Pto, however this advantage is 
lost on plants that do not express FLS2, suggesting that FLS2 is the bona fide 
effector target, with Pto acting as a decoy which mimics this protein.  
More recently Wang et al demonstrated that a host protein PBL2 was a functional 
decoy for its paralog BIK1 to allow detection of the X. campestris effector AvrAC71. 
AvrAC interacts with, and modifies, BIK1 to prevent its activation via 
phosphorylation, and thus suppresses PTI72. AvrAC also triggers an immune 
response in plants that express the NLR ZAR1, and an additional host protein, 
RKS1. The key finding for this most recent publication was the discovery that 
although PBL2 was modified in the same way as BIK1, the loss of PBL2 did not 
affect AvrAC virulence73. 
Recently researchers have discovered novel NB-LRRs that appear to take the use 
of decoy molecules to a new level, directly linking effector activity to R-protein 
activation. 
 
1.5.4 Integrated decoys 
R-protein architecture shows some degrees of plasticity. Although most common 
are CNL or TNL proteins, there are R-proteins with additional domains, such as 
leucine-zipper-like domains or the N-terminal solanaceous domain. Recently 
research into predicted R-proteins in rice has led to the discovery of R-proteins with 
domains that directly tie effector function to R-protein activation.  
The atypical R-protein Pikp-1, which has a novel small heavy-metal associated 
domain (HMA domain) fused between the classical coiled-coil and NBARC 
domains, works in concert with the genetically linked canonical CNL Pikp-2 to 
mediate an immune response to Magnaporthe oryzae AVR-Pik proteins, via direct 
interactions with the effector74. Unlike the rice R-protein Pi-ta, which directly 
interacts with its cognate effector through its LRR domain, Pikp-1 interacts with 
AVR-Pik proteins through its HMA domain to mediate recognition75. Likewise, the 
rice R-protein pair RGA4 and RGA5 utilise a similar domain (this time fused to the 
C-terminus of RGA5) to detect the presence of M. oryzae effectors AVR-Pia and 
CO3976, 77. The inclusion of non-canonical domains into R-proteins is not restricted 
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to rice, but can also be seen in the model plant A. thaliana. The A. thaliana 
Resistance to Ralstonia solanacearum (RRS1) protein belongs to the TNL class of 
R-proteins, and works in conjunction with another TNL, genetically linked, called 
RPS4. Like RGA4 RRS1 also has a novel C-terminal fusion, however this fusion 
encodes a WRKY transcription factor domain78. This incorporated WRKY domain is 
essential to detect the P. syringae effectors AvrRPS4 and the acetyltransferase-like 
effector Pop2, which interact with multiple WRKY transcription factors79, 80. Together 
these examples have led to the formulation of an integrated decoy model. These 
fused domains act analogously to molecular decoys described in Section 1.5.3, 
however incorporation into R-proteins leads to a direct link between effector function 
and immune activation81. 
Host-microbe interactions and the behaviour of individual components can be 
complex. Figure 1.5.1 summarises how translocated effectors may aid or hinder 
pathogenicity depending on the genotype of the host. 
Pathogen genotype Host genotype Cytoplasmic interactions Disease phenotype
Effector targetEffector
Effector enhanced virulence
Guarding CNL
+
Resistance
Effector decoy 
No effector enhanced virulence
+
Resistance
Integrated decoy 
Resistance
 
Figure 1.5.1 Schematic of how host proteins influence disease outcomes 
 
When pathogens translocate effectors (red circles) into host cytoplasm, they can interact 
with effector targets, decoys, or intergrated decoy regions. Depending on whether the 
host produces a cognate resistance protein, these pathogenic effectors can either aid, or 
hinder infection. 
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The general outcome of microbe-plant interactions can be represented more simply 
by a zig-zag model describing how PAMPs, effectors, PRRs and R-proteins 
contribute to infection and resistance (Figure 1.5.2). 
 
PAMP presentation
PAMP detection 
by PRR
PTI
Immunity
Effector deployment
Defence suppression
ETI
Effector 
recognition
Negation of constitutive 
defences
Susceptibility
 
Figure 1.5.2 Zig-zag model of plant immunity 
 
1.6  R-protein structure 
The majority of R-proteins identified to date have shown very similar domain 
organisations- a central NBARC domain, a C-terminal LRR domain and most 
commonly either a Toll-interleukin receptor-like (TIR) domain or a coiled-coil (CC) 
domain at the N-terminus. The modular nature of R-proteins has led to hypotheses 
that the individual domains are responsible for different aspects of R-protein 
behaviour. For R-proteins to be useful in plant immunity they must carry out certain 
functions. They must be able to detect the presence of an effector (recognition), 
translate that detection to an appropriate response (signalling), and remain in a 
signalling-competent, inactive state prior to effector recognition (inhibition). 
Investigations into the behaviour of R-protein domains suggest that such functional 
division is possible. 
1.6.1 N-terminal TIR or CC domains and signalling 
The two largest families of R-proteins have either N-terminal TIR (Toll-interleukin 
receptor-like) domains or predicted coiled-coil (CC) domains, abbreviated to TNL or 
Whether or not a plant-pathogen interaction results in disease or resistance depends on 
the interactions of host-microbe proteins. Degradation of structural polymers such as 
cellulose, or the deployment of effectors reduce the plant’s ability to defend itself and 
leads to susceptibility. Detection of PAMPs, or effectors leads to recapitulation of 
immune responses and prevents disease progression. Adapted from Jones and Dangl2. 
 Page 35 of 232 
 
CNL (TIR/CC-NBARC-LRR) proteins. TIR domains have been implicated in signal 
transduction in animal immune receptors82 and overexpression of the TIR domains 
of the plant TNLs L6, RPS4 and RPP1A lead to effector-independent cell death83, 84. 
TIR domains have a 5-stranded parallel β-sheet surrounded by 5 α-helices82, with 
multiple homo- and hetero- dimerization interfaces that are important for signalling 
and regulation84, 85. Furthermore structural investigations into the role of homo- vs. 
hetero- dimers in the RPS4 RRS1 system highlighted that activation leads to a 
change in hetero- to homo- dimer formation to enable signalling, rather than 
depending solely on intra-molecular rearrangements85 (Section 1.7).  
Consistent with observations from TNLs, the overexpression of the coiled-coil 
domain of ML10 (flax) and Rp1-D (maize) alone are able to trigger a cell death 
response86, 87, as does the CC domain of A. thaliana RPS5 when fused to its 
NBARC domain. 
Although these data suggests that CNLs use their N-terminal domains to initiate 
cell-death signalling, the functions of coiled-coil domains are not limited to triggering 
HR. Overexpression of the CC of Rx for example does not lead to cell-death. 
Instead it appears to be involved in interactions with a host protein, either for 
localisation or as a guardee88, similar to the guarding of Pto by Prf, which is also 
mediated by the N-terminus of the NB-LRR61. Additionally the coiled-coil domain of 
a number of plant resistance proteins appear to be targets for post-translational 
modification and localisation89-91. 
Recently, the crystal structure of two unrelated R-protein coiled-coil domains have 
also been solved. Unlike the broad similarities seen between the TIR domains of 
RPS4, RRS1 and L6, these two coiled-coil domains show dramatically different 
topologies. MLA10 coiled-coil domain forms homodimers, as demonstrated for 
various TIR domains, and forms an elongated structure with two interlocking coiled-
coils resembling links in a chain86. The CC domain of Rx on the other hand shows a 
more globular fold overall, with a more typical stacked 4-helix bundle92. Whether 
these differences in structure reflect the functional differences of these proteins 
(MLA10 CC triggering cell death, and the CC of Rx interacting with RanGAP2), or 
whether CC domains as a whole will show diverse structures is yet to be 
demonstrated. 
1.6.2 LRR domains as protein-interaction and recognition interfaces 
R-proteins possess a leucine-rich repeat region (LRR) C-terminal to the highly-
conserved NBARC domain, which show high sequence diversity. LRRs have been 
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implicated in mediating protein-protein interactions, and have been suggested to 
facilitate protein recognition93. Confirmation of this idea comes from plant PRRs 
such as FLS2 using its LRR domain to recognise flg22, as well as direct interactions 
seen in flax rust and rice blast resistance to mediate recognition of pathogenic 
proteins. This leads to the hypothesis that molecular recognition is a generic 
function of R-protein LRRs.  
The LRR domains of plant R-proteins are predicted to not only detect the presence 
of cognate effectors, but are implicated in the autoinhibition of R-proteins in the 
absence of a pathogen. Expression of the CC-NBARC domain of RPS5 leads to 
effector-independent cell-death, which can be abolished by the inclusion of a short 
region of the LRR domain89. Similarly, step-wise truncations of Rx indicate that the 
LRR has repressive functions in this protein too94. Co-expression of the Rx CC-
NBARC domains with its LRR in trans results in a stable complex. This complex is 
disrupted by the expression of the potato virus X (PVX) coat protein, which normally 
triggers an Rx-mediated response95. Domain swaps between homologous proteins 
further support the role of the LRR as a signal inhibitor, with specific LRR and ARC 
combinations required to prevent autoactivity96, 97.  
Although no examples of cytoplasmic plant LRR structures are available, the 
functional similarities between cytoplasmic and the apoplastic LRR domains of 
PRRs allows homology modelling, and inference of mechanistic basis of R-protein 
LRR function. The crystal structure of the LRR domains of FLS2 and BRI1 have 
been solved, and despite detecting very different ligands (a microbe-derived peptide 
and a host-derived hormone respectively), the two protein domains show a high 
degree of structural similarity. This may suggest that their super-helical structure 
may be a common feature of apoplastic LRR domains. Whether this is true of their 
cytoplasmic counterparts remains to be demonstrated. Unlike PRR ectodomains, 
LRR domains of cytoplasmic R-proteins are suggested to have two functions (both 
detection and repression), which may not be supported by the same structural 
features shown by these apoplastic receptors, particularly given the suggested lack 
of conformational change in FLS2 in response to flg22 binding. Recently, the 
solution of the mouse NBARC-containing protein NLRC4 was solved to give greater 
insight into the inactivation of these proteins by extensive LRR-NBARC 
interactions98. Given that this represents a cytoplasmic, immune-based NBARC-
LRR protein, it would be interesting to see whether plant cytoplasmic LRRs favour a 
conformation similar to structures already seen within the plant kingdom, or whether 
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functional similarities from distantly related proteins will be reflected in their 
structures.    
 
1.6.3 The NBARC as a molecular switch 
Most R-proteins identified to date are predicted to have a central nucleotide binding 
domain with sequence similarity to that seen in the mammalian apoptotic protease 
activating factor 1 protein (Apaf-1) and C. elegans death protein 4 (Ced-4). In light 
of this predicted conservation, this domain is referred to as the NBARC (Nucleotide 
Binding domain found in Apaf-1 R-proteins and Ced-4), or sometimes the NBS 
(Nucleotide Binding Site), however to emphasise the putative functional differences 
in the sub-regions of this module, it will be referred to here as the NBARC domain. 
Sequence analysis of plant NBARC domains identifies a conserved Walker-A (or P-
loop) motif seen in many AAA proteins (ATPases associated with diverse cellular 
activities), which is known to be required for nucleotide binding, and also a 
conserved Walker-B (or kinase-2) motif- an essential feature for hydrolysis of 
nucleotide tri-phosphates to nucleotide di-phosphates (such as the conversion of 
ATP to ADP). 
If initiation of cell death signalling is performed by the CC domain, and the LRR is 
responsible for both signal repression and effector detection, what is the purpose of 
this additional, highly conserved domain? Initial suggestions regarding the function 
of this region comes from the similarity shared between this protein and the animal 
proteins Apaf-1 and CED-4. Both of these proteins are involved in programmed cell 
death, however the stimuli they respond to are very different. Apaf-1 is a modular 
protein that responds to cell stresses. Like CNLs it has an N-terminal helical 
domain, this time a helical bundle termed a CARD domain (Caspase activation and 
recruitment domain). C-terminal to this is the NBARC domain, followed by a region 
of WD40 repeats, which are implicated in mediating protein-protein interactions. 
Like Apaf-1, Ced-4 is modular and shares an N-terminal CARD domain and NBARC 
domain. Unlike Apaf-1 and R-proteins, this protein lacks C-terminal extensions 
typically associated with protein-ligand interactions. A potential explanation for this 
absence is that the Ced-4 protein does not respond to stress stimuli as Apaf-1 and 
R-proteins do, but is developmentally regulated, and therefore may be under 
different regulatory pressures. Despite responding to different stimuli, the function of 
activated Apaf-1 and Ced-4 are very similar- both proteins form large oligomeric 
complexes that interact with downstream procaspases to trigger caspase 
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maturation. These matured cysteine-aspartatc proteases go on to cleave a number 
of downstream targets resulting in apoptosis. 
How do these two proteins contribute to our ideas about R-protein regulation? Apaf-
1 is able to remain in an apparently auto-inactive state until required to trigger a 
response, much like R-proteins. The switch from inactive to an active state requires 
the binding of cytochrome-c99 (released from mitochondria under stress conditions), 
and dATP100. Although not requiring cytochrome-c release to activate cell death, 
Ced-4 also appears to require the ability to bind to dATP for activation101. Both Ced-
4 and Apaf-1 nucleotide binding is attributable to their NBARC domains, as 
highlighted by the presence of conserved ATP-binding motifs (P-loop or Walker-A 
motifs), which when perturbed prevent cell-death initiation. Given the presence of 
conserved Walker-A motifs in many R-proteins, their apparent ability to self-regulate 
and the sequence similarity between the NBARC domains of many R-proteins and 
these animal homologs (>30%) suggests that nucleotide binding is required for R-
protein function.  
Indeed, mutations in the Walker-A motif of several R-proteins has been linked to 
loss-of-function. Absence of canonical GTPase motifs in R-protein sequences led to 
early speculation that these proteins would be specific for ATP, with adenosine 
substrate specificity subsequently confirmed experimentally102. Furthermore, the N-
terminal domains of I-2 and Mi-1 refolded from inclusion bodies have both been 
shown to be catalytically active, capable of hydrolysing ATP to ADP, with reports 
that additional phosphatase activity may be possible to produce AMP102, 103. 
Additional reports of ATP binding and hydrolysis from the soluble expression of the 
tobacco mosaic virus (TMV) resistance protein N, point to this being a shared 
activity of both CNL and TNL NBARC domains104. 
Given that NBARC domains require nucleotide binding to function, and that distinct 
R-proteins are capable of hydrolysing ATP, hypotheses were put forth regarding the 
role of ATP in R-protein function. Two main possibilities are that the hydrolysis of 
ATP provides energy to drive conformational changes in the protein, giving rise to 
activation. Alternatively, the binding of ATP alone may be sufficient to lead to protein 
activation. Researchers used knowledge of related STAND proteins to target a 
second ATPase-related motif, the Walker-B motif (also known as the kinase-2 motif) 
for mutation and in planta investigations. Mutations in this motif allow nucleotide 
binding, however ATPase activity is significantly reduced by disrupting interactions 
with catalytic metal ions. When expressed in planta, R-proteins with reduced 
ATPase activity display effector-independent activation, suggesting that ATP 
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binding is sufficient for activation, and conversely that ATP hydrolysis is required for 
proper regulation105.  
A further common feature of Ced-4 and Apaf-1 is their ability to form large 
multimeric complexes (termed apoptosomes) once activated106. The NBARC 
domains of these proteins were originally called nucleotide-binding oligomerization 
domains (NOD) 107. These large, ring-like structures are seen in other cell-death 
initiating Ced-4 homologs, such as the Drosophila protein DARK, with inter-
molecular interactions mediated by the NBARC domain108. This leads the possibility 
that R-proteins may also form the large apoptosomes upon activation, however it 
may be that these structures are specific to caspase-interacting proteins.  
More recently, the crystal structure of NLRC4 from Mus musculus, another Apaf-1-
like protein, has been solved. This structure represents a more comprehensive view 
of the autoinhibitory activities of NBARC-containing proteins as the crystal structure 
entails not only the NBARC domain of NLRC4, but also the C-terminal LRR repeats. 
In this structure extensive interactions between the LRR domain and the NBARC 
domain suggests that this C-terminal extension acts to prevent nucleotide 
exchange.  
Homology modelling of R-proteins onto the structure of ADP-bound Apaf-1 and ATP 
bound Ced-4 suggests that nucleotide exchange may be associated with 
conformational changes in the NBARC domain109. These conformational changes 
are then predicted to drive larger conformational changes in the protein resulting in 
an active R-protein. Similar homology modelling combined with sequence 
alignments have suggested that R-protein NBARC domains structurally resemble 
Apaf-1, and point to an invariant histidine in the “MHD” motif of the NBARC playing 
a role in interacting with bound ADP110. 
 
1.7 Models for R-protein regulation 
These studies indicating functional divisions between R-protein domains and the 
roles of intramolecular interactions have led to the formation of models for R-protein 
regulation such as the one presented in Figure 1.7.1. 
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Figure 1.7.1 Schematic of R-protein regulation and changes upon effector detection 
Although models like this give a good conceptual framework to understand how R-
proteins function in general, there are a number of R-proteins whose behaviour 
cannot be predicted in this way. Overexpression of the NB domain of Rx, and not 
the CC domain leads to effector-independent cell death, and fusion of the CC 
domain of Rp1-D21 to its NBARC domain leads to repression of normal cell death 
responses. Likewise evidence suggests that the coiled-coil domain has a role in 
protein localisation89, 90 and is not simply an interaction interface for signal 
transduction. Although the idea of the LRR as an effector sensor and auto-inhibitory 
domain is well evidenced, exceptions such as the case of Rp1-D should be 
acknowledged and kept in mind when working with a novel R-protein.  
Furthermore these models are useful for qualitative rather than quantitative 
predictions. Given that much of the work underlying these models was performed in 
planta, biochemical and mechanistic details such as interaction affinities are lacking. 
Biochemical investigations into R-protein activity have been severely hampered by 
the lack of sufficient yields of suitable protein for sensitive investigations. Production 
of materials for such studies has been a central part of this project, to allow detailed 
investigations into R-protein regulation. 
In this model for R-protein regulation, the domains of the protein form extensive intra-
molecular interactions, with ADP bound at the centre of the NBARC domain. Upon 
effector detection the protein undergoes conformational changes to allow ADP release. 
The CNL then undergoes ATP binding and further conformational changes, such as the 
release of the CC domain, into an “on” state to trigger HR. Adapted from Takken and 
Goverse1.  
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1.8 Aims of this project 
This project has four key aims. Firstly to develop tools, in the form of solubly-
expressing proteins, that will be of interest to the field. Secondly to use these 
derived tools to investigate the biochemical basis for R-protein regulation and auto-
inhibition in the absence of an effector. Thirdly to improve our understanding of R-
proteins and their domains at the structural level, allowing comparison to other 
characterised systems, and furthering our mechanistic understanding of R-protein 
regulation. Finally this project will attempt to develop tools to further our knowledge 
of the inter- and intra- molecular interactions that are important for R-protein 
function. A fully descriptive model for R-protein regulation, with empirical data 
describing how biochemical and structural features influence regulation, the 
mechanistic basis for signal repression, and high-resolution data regarding 
important intramolecular interactions may allow us to fine-tune R-protein 
responsiveness. Combining this information with structural data regarding the 
specifics of effector detection may open up possibilities for rational design of R-
proteins with targeted responses to a wide variety of pathogen, and ultimately 
durable resistance in the field.  
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 Materials and methods 
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2.1 General chemicals and reagents  
2.1.1 Chemicals  
All chemicals were supplied by Sigma-Aldrich Ltd, ThermoFisher Scientific Inc. or 
VWR International, unless explicitly stated.  
2.1.2 Antibiotics 
Antibiotics were prepared by dissolving into de-ionised H2O and filter sterilised using 
0.3μm Minisart® filters before being stored at -20°C. Exceptions to this are 
Rifampicin, which was dissolved in 100% DMSO, and Chloramphenicol, which was 
dissolved in ethanol. 1000x stocks were used to supplement both liquid and solid 
media to the following concentrations: Carbenicillin 100μg/mL, Kanamycin 30μg/mL 
Rifampicin 50μg/mL, Spectinomycin 100μg/mL, Chloramphenicol 34μg/mL 
2.1.3 Bacterial media- LB 
Lysogeny broth (Lauria-Bertani) was purchased from Formedium and 2.5% w/v 
dissolved in de-ionised water before autoclaving. This broth (LB broth Millar) 
contains high salt concentrations (1.0% w/v tryptone, 0.5% w/v yeast extract, 1.0% 
w/v sodium chloride), and so for salt-sensitive antibiotics, namely spectinomycin, L 
broth (1.0% w/v tryptone, 0.5% yeast extract 0.5% w/v sodium chloride, 0.1% w/v 
glucose- Formedium) was used.     
For solid LB/L agar plates 1% w/v agar (Formedium) was added prior to 
autoclaving.  
2.1.4 Bacterial media- Power broth™ 
Power broth™ (Molecular dimensions) powder was purchased from molecular 
dimensions and prepared as per manufacturer’s recommendations. 5.2% w/v Power 
broth was dissolved in dH2O with 0.4% v/v glycerol, and autoclaved before use. 
2.1.5 Bacterial media- AIM 
Bacterial auto-induction media (not suitable for BL21AI protein expression) consisted 
of 1% w/v Yeast extract, 0.5% w/v Tryptone, 0.035% w/v auto induction medium 
micro element mix (Formedium), 0.33% w/v ammonium sulphate, 0.68% potassium 
dihydrogen phosphate, 0.71% w/v Disodium hydrogen phosphate, 0.05% w/v 
glucose, 0.2% w/v α-lactose, 0.015% w/v magnesium. Overnight cultures were 
centrifuged, re-suspended in an equal volume of AIM, and this stock used to 
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inoculate Litre-cultures so that OD520 = 0.05. Cultures were then allowed to grow at 
18-20°C for 16-24 hours.  
2.1.6 Yeast non-selective media- YPAD 
Untransformed MaV203 yeast were grown overnight in liquid YPAD (1% w/v yeast 
extract, 2% w/v bactopeptone, 2% w/v glucose, 0.003% w/v adenine hemisulphate, 
pH 6.0) prior to transformation. Untransformed yeast were propagated by streaking 
on solid YPAD agar plates (YPAD supplemented with 2% w/v agar). 
2.1.7 Yeast selective media 
Yeast co-transformants were selected for by plating transformed cells on double 
dropout synthetic-complement (SC) media plates lacking leucine and tryptophan 
(0.67% w/v Yeast nitrogen base without Amino Acids, 0.16% w/v yeast synthetic 
drop-out medium supplements, 0.0075% w/v histidine, 0.0075% w/v uracil made up 
in dH2O and pH to 5.6 prior to addition of 2% w/v agar. SC-LT was then autoclaved 
and 2% w/v glucose added when cooled <50°C.).  
Triple-dropout plates (SC-LTH) were produced as described above, with the 
exclusion of histidine from the medium. 
2.1.8 Protein purification buffers 
2.1.8.1 Buffers for extraction of protein from bacteria 
IMAC column equilibration buffer, referred to throughout as A1 buffer, consisted of 
50mM Tris-HCl pH 8.0, 500mM NaCl, 50mM glycine, 20mM imidazole, and 5% v/v 
glycerol. When used as a bacterial lysis buffer, 50mL A1 was supplemented with 1 
cOmplete™ EDTA-free protease inhibitor cocktail (Roche) tablet. IMAC column 
elution buffer was produced as A1, but with 500mM imidazole. Gel filtration 
equilibration and running buffer, referred to throughout as A4 buffer, consisted of 
20mM HEPES pH 7.5 and 150mM NaCl. 
2.1.8.2 Buffers for extraction of protein from insect cells 
For purification of proteins from Sf9 expression, IMAC column equilibration was 
performed with 50mM Tris-HCl pH 7.5, 500mM NaCl, 30mM imidazole (referred to 
as IC A1). Elution of proteins from Ni2+-NTA columns was performed using IC A1 
with 500mM imidazole. To make insect cell lysis buffer, IC A1 was supplemented 
with 0.2% v/v TWEEN 20 and 1 EDTA-free cOmplete™ protease inhibitor cocktail 
tablet per 50mL. Gel filtration was performed with a superdex™ S75 26/600 GL 
column pre-equilibrated with running buffer (20mM Tris pH 7.5, 200mM NaCl, 1mM 
TCEP, referred to as IC A4)  
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2.2 DNA techniques 
2.2.1 Plant and Bacterial expression vectors 
Vectors used for expression of proteins in N. benthamiana, E. coli and sf9 (insect 
cell) heterologous systems are listed in Table 2.2.1. 
Vector 
Expression 
system 
Features 
Cloning 
method 
Reference 
 
pOPIN-S3C 
Bacterial/ 
Insect 
N-terminal histidine-
tagged SUMO tag 
 
Infusion® 
 
OPPF 
 
pOPIN-F 
Bacterial/ 
Insect 
N-terminal histidine tag 
 
Infusion® 
 
Berrow 2007111 
 
pOPIN-M 
 
Bacterial 
N-terminal histidine-
tagged MBP tag 
 
Infusion® 
 
Berrow 2007111 
 
pESPRIT 
 
Bacterial 
N-terminal histidine tag, 
C-terminal biotin-acceptor 
peptide 
 
Restriction-
ligation 
 
Yumerefendi 
2010112 
 
pOPIN-
TRBO 
 
N. 
benthamiana 
CaMV35S promoter, 
pOPIN-F infusion 
cassette 
 
 
Infusion® 
 
Linbo 2007 
(modified by R. 
Hughes) 
 
pK7-FLAG 
(PVX 
derivative) 
 
N. 
benthamiana 
 
CaMV35S promoter, N-
terminal FLAG tag 
 
 
Gateway® 
 
Oh 2009113, 
Chapman 1992114 
(modified by M. 
Franceschetti) 
pCB302-3 
N. 
benthamiana 
CaMV35S promoter Gateway® Hamada 2004115 
Table 2.2.1 Vectors used for heterologous expression in this project 
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2.2.2 Cloning 
Cloning was performed using two ligation-independent techniques: Gateway® 
(Invitrogen) and Infusion® (Clontech) reactions.  
Cloning into gateway-compatible vectors was performed in a two-step process- 
firstly cloning purified PCR product into a DONR vector, and secondly cloning the 
target gene into a destination vector. 
DONR vectors were created by adding 100-150ng purified PCR product with 
flanking attB sites to 100ng purified vector, containing attP sites, and incubating for 
either 1 hour at room temperature or 16 hours at 4°C with 1μL of BP clonase ® mix 
II (Invitrogen)  in a total volume of 5μL. BP clonase® mix II contains both an 
integrase and integration host factor proteins to recognise the att sites and catalyse 
recombination. 1μL proteinase K was added to the mixture and incubated for 15 
minutes at 37°C. The plasmid mix was cooled on ice before being transformed into 
DH5α E. coli. 
Sequence-verified DONR vector was purified as described in Section 2.2.5. 100μL 
of purified vector with attL sites flanking the insert were added to 100μL purified 
destination vector, which carry attR sites, and 1μL LR clonase mix to a total volume 
of 5μL. Like the BP clonase mix, LR clonase mix also contains integrase and 
integration host factor proteins, but also includes exiscionase proteins to facilitate att 
site recognition and recombination between DONR and Destination vectors. 
Plasmid mix was incubated for either 1 hour at room temperature or overnight at 
4°C. Reaction mix was subjected to treatment with 1μL proteinase K for 15 minutes 
at 37°C before chilling on ice and transformation into DH5a.  
Infusion® cloning involves incubation of adaptor-sequence-flanked PCR product 
and linearised vector, resulting in partial 3’->5’ digestion by the proof-reading activity 
of proteins in the Infusion® cloning reaction mix to give complementary single-
strand overhangs. The overhangs between insert and linearised vector then anneal 
and are resistant to further exonuclease activity116. 15bp flanking sequences are 
introduced to target inserts by PCR, allowing this method of cloning to be essentially 
sequence independent.  
Infusion® vectors pOPIN-F, pOPIN-M and pOPIN-S3C were linearised by 
incubation with KpnI and HindIII. When exposed to 3’->5’ exonuclease activity, the 
KpnI overhang site is lost, whilst the HindIII overhangs are maintained. The resulting 
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fusion of adaptor-flanked insert into this linearised vector leads to the formation of a 
3C protease cleavage site upstream of the target protein.    
100ng of KpnI and HindIII linearised pOPIN vector was mixed with 50-100ng of 
purified PCR product (Section 2.2.3) and 1μL of Infusion® HD enzyme mix to a total 
volume of 5μL. Reactions were incubated at 42°C for 30-60 minutes before 
transforming into DH5α (Section 2.3.3). Transformants were plated on LB agar 
plates supplemented with carbenicillin, IPTG, and X-gal to allow blue-white 
selection.  
2.2.3 PCR 
Polymerase chain reactions (PCRs) were carried out for two purposes. Firstly to 
amplify target DNA sequences, and add adaptor sequences for downstream 
cloning. Secondly to confirm the presence of a target construct in bacterial colonies 
following transformation (colony PCR). 
Colony PCR was performed using MYTAQ™ (Bioline) following manufacturer’s 
recommendations. Typically reactions were performed using vector-specific forward 
primer and insert-specific reverse primers. Reactions consisted of 10μL MYTAQ 5x 
reaction buffer, 1.5U MYTAQ™ enzyme, 0.2μM of each dNTP, 0.4μM each primer, 
1μL saturated bacterial culture, and made up to 50μL with dH2O 
PCR for downstream cloning used Velocity DNA Polymerase (Bioline). Reaction 
mixtures were as described above, however using 5x Hi-Fi reaction buffer, 2.0U 
Velocity enzyme and 20-50ng purified DNA template. 
PCR reactions were performed in a T3000 Thermocycler (Biometra), with PCR 
programmes following the Polymerase manufacturers’ recommendations. 
2.2.4 DNA oligonucleotides 
DNA oligonucleotides were synthesised to order by Integrated DNA technologies 
using their custom DNA oligonucleotide synthesis service. Oligonucelotides were 
delivered lyophilised, and so were dissolved in dH2O to generate a stock solution of 
100μM, which was stored at -20°C. Working stocks were produced by dilution with 
dH2O to 20μM and also stored at -20°C. 
2.2.5 Plasmid purification 
Purification of plasmid DNA was performed using Bioline Isolate II plasmid mini kit, 
according to manufacturer's guidelines. Overnight cultures were pellet by 
centrifugation at 4,000g for 10 minutes and the supernatant removed. Pellets were 
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resuspended in 500μL resuspension buffer supplemented with RNAse and 
transferred to 2mL eppendorf tubes. 500μL alkaline lysis buffer was added and 
mixed by gentle inversion. Samples were left at room temperature for circa 5 
minutes before 600μL neutralising buffer added. Samples were mixed by several 
rounds of gentle inversion and cell debris pelleted by centrifugation at 13,300g for 
30 minutes. Supernatant was transferred to spin columns and centrifuged for 30 
seconds at 10,000g to bind DNA. Flow through was removed and membranes 
washed with both wash buffer 1 and wash buffer 2. Membranes were dried to 
remove residual wash buffer and ethanol by centrifugation at 10,000g for two 
minutes, with the spin columns then placed into fresh 1.5mL eppendorf tubes. 30-
50μL deionised water was spotted onto the centre of the membranes and incubated 
at room temperature for 5-10 minutes. DNA was then eluted by centrifugation at 
10,000g for 1 minute.  
2.2.6 Gel electrophoresis 
DNA was separated on 1.0% w/v agarose gels in TAE (40mM Tris-acetate pH 8.0, 
1.0mM EDTA) with 5μg/mL ethidium bromide. DNA samples were mixed with 4x 
loading buffer (12% w/v ficoll 400 and 0.25% w/v Orange G). Quick-Load® 1-kb 
DNA ladder (NEB) was loaded into one lane for molecular weight determination. 
Separation was performed using horizontal electrophoresis performed at 80V for 10-
20 in 1x TAE buffer. 
2.2.7 Purification of DNA from agarose gels 
Gels were visualised using a UV transluminator and appropriate bands excised with 
a fresh razor. DNA was then purified from the agarose using Nucleospin® Gel and 
PCR clean-up kit (MACHEREY-NAGEL) as per manufacturer’s user manual. 
2.2.8 Sequencing 
Sequencing reactions were performed by Lightrun™ sequencing (GATC-biotech). 
Sequence quality was visually assessed using 4peaks (Nucleobytes). 
2.3 Bacterial techniques 
2.3.1 Bacterial strains used 
Medium-throughput expression screens used several proprietary bacterial strains, 
predominantly based on BL21 (DE3) E. coli. There strains were: BL21 (New 
England BioLabs), BL21 Star™ (ThermoFisher, referred to as BL21*), BL21AI 
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(ThermoFisher) SoluBL21™ (amsbio), Lemo21 (NEB), Rosetta™ 2 (Merck 
Millipore) and Shuffle® T7 competent cells (NEB). 
Plasmid storage and propagation was performed using DH5α117, with the exception 
of Gateway®-compatible empty vectors, which were stored in ccdB survival™ 2 
competent cells (Invitrogen).   
Glycerol stocks were made with 0.6mL saturated LB overnight culture plus 20% 
glycerol, stored in 1.5mL sterile eppendorf tubes and stored at -80°C. 
 Agrobacterium tumefaciens GV3101118, which carry an inactive tumour-inducing co-
plasmid pMP90119 were used for transient transformation of Nicotiana benthamiana 
leaves. Cells were grown on L media supplemented with rifampicin and gentamycin 
for chromosomal and inactive pMP90 selection respectively.  
2.3.2 Preparation of chemically competent E. coli 
Chemically competent E. coli were transformed as described by Hanahan117  with 
some modifications. A single colony of competent cells  was selected from a freshly-
streaked LB-agar plate and  used to inoculate 10mL of LB broth, subsequently 
grown at 37°C overnight (~16h) with constant shaking at 200rpm. This overnight 
culture was then used to inoculate 200mL fresh LB broth, which was grown under 
conditions described above until an OD600 = 0.3 was reached. The cells were then 
chilled on ice for 10 minutes prior to being harvested by 10 minutes centrifugation at 
1,500g at 4°C. Supernatant was removed and the pellets re-suspended in 80mL 
TFB1 (100mM rubidium chloride, 10mM calcium chloride, 50mM manganese 
chloride, 30mM potassium acetate, 15% v/v glycerol, pH 5.8). Cells were again 
pelleted by centrifugation, supernatant discarded and re-suspended in 8mL TFB2 
(10mM MOPS pH 6.5, 10mM rubidium chloride, 75mM  calcium chloride, 15% v/v 
glycerol). 50μL of re-suspended cells were then aliquoted into pre-chilled sterile 
1.5mL Eppendorf tubes, flash-frozen in liquid nitrogen, and stored at -80°C until use.  
2.3.3 Transformation of chemically competent E. coli 
For transformations, aliquots of competent cells were thawed on ice, and 50-100ng 
DNA added. Cells were incubated on ice for a further 30-45 minutes before heat 
shock treatment of 30-60 seconds at 42°C, followed by the addition of 450µL LB 
and incubation on ice for one minute. Cells were left to recover for 45-60 minutes by 
incubation at 37°C with shaking at 180-200rpm. Typically 50µL or 100µL of recovery 
were plated on LB-agar supplemented with a selective antibiotic, and incubated at 
37°C overnight.  
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2.3.4 Transformation of electro-competent A. tumefaciens  
Electro-competent A. tumefaciens strain GV301 were thawed on ice for ~10 minutes 
before being added to a pre-chilled electroporation cuvette (GeneFlow) and 1μL 
purified plasmid added (30-100ng). Cells were then shocked at 2,500V, and 
recovered for 1 hour incubation in 450μL of LB at 28°C with constant shaking. 20μL 
and 40μL aliquots of recovery were plated on L or LB agar supplemented with 
rifampicin, and spectinomycin or kanamycin as appropriate.  
2.4 High-throughput screening of R3a constructs 
High-throughput screening of R3a constructs, which had undergone time-course 
digestion was performed as described in Yumerefendi112 and An120, but shall be 
recapped here. Generation of plasmid library was performed by Sri Purhanik. 
Western blotting and analysis was performed with Philippe Mas. 
2.4.1 DNA digestion 
Six plasmids, corresponding to the three N-terminal and 3 C-terminal designed 
regions of R3a, were codon optimised for E. coli expression any synthesised by 
Shinegene Molecular Biotech Inc. These plasmids were then transformed into 
DH5α, with single colonies used to inoculate fresh LB media and incubated 
overnight at 37°C. Cells were pelleted by centrifugation and DNA extracted by 
alkaline lysis. Cells were re-suspended in 50mM glucose, 25mM Tris pH 8.0, 10mM 
EDTA, to which 2 volumes lysis buffer (0.2M NaOH, and 1% w/v SDS) was added 
and incubated at room temperature for 5 minutes with constant rotation. 
Neutralisation buffer (5M potassium acetate, 13% v/v acetic acid) was added and 
mixed thoroughly before samples were sonicated to remove cell debris. Supernatant 
was added to a fresh tube on ice and DNA extracted by adding an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) and incubation at room temperature for 
10 minutes with constant rotation. Samples were centrifuged at 5,000g for 10 
minutes at 4°C, and the top 15mL of aqueous phase transferred to a fresh tube. 0.1 
volumes 3M sodium acetate and 2.5 volumes isopropanol was added, mixed, and 
incubated for 1 hour at -80°C. Supernatant was removed and 70% ethanol added to 
the pellet, centrifuged for 15 minutes, and supernatant removed and sample air 
dried. Salts and RNA were removed using a QIAprep spin miniprep kit (QIAGEN), 
as per manufacturer’s recommendations.  
Vectors were linearised by digestion with NsiI and NotI (LRR libraries), or AscI and 
AatII (CC-NBARC) libraries. Restriction enzymes were purchased from NEB, and 
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reactions carried out as per manufacturer’s guidelines. DNA was extracted and 
purified as described in Section 2.2.7. Time-course digestion was performed with 
33.3ng/μL DNA and 100U/μg DNA ExonucleaseIII. Reactions were performed with 
4μg DNA in NEB reaction buffer1 with an additional 5mM NaCl at 22°C in a total 
volume of 120μL.  2μL of digestion mix was removed each minute and quenched in 
NT buffer (Nucleospin® extract kit II Machery-nagel), with quenched samples 
heated to 70°C for 10 minutes. Digested plasmid were then desalted using 
Nucleospin® extract II kit, before treatment with Mung Bean Nuclease for 30 
minutes at 30°C to produce blunt ends for ligation. Blunt-ended vectors were 
cleaned using Nucleospin® extract kit, and treated with pfu for 10 minutes at 72°C. 
2.4.2 DNA library purification 
Polished, blunt-end plasmids were separated on a 0.5% Agarose gel (Section 2.2.6) 
performed at 80V for 1-2 hours at 4°C to generate library smears. High molecular-
weight, medium molecular-weight and low molecular weight regions were then 
excised using a sterile razor, DNA extracted and purified for each sub-library 
separately as described in Section 2.2.7.   
2.4.3 Bacterial transformation and picking 
Purified libraries were ligated using a Rapid ligation kit (Roche) and transformed into 
50μL of BL21AI cells as described in Section 2.3.3, with 10μL and 100μL aliquots of 
recovery plated to determine the transformation efficiency. Recovery mixture was 
plated on 22 x 22cm Genetix plates with LB agar with kanamycin to produce 3x 
oversampled libraries and incubated overnight.  
Once well-defined, opaque colonies were visible they were picked using a colony-
picking robot and deposited in 384-well plates containing TB media (1.2% w/v 
Typtone, 2.4% w/v Yeast extract, 0.4% v/v glycerol) plus Hogness modified freezing 
medium (HMFM- 25mM K2HPO4 10mM KH2PO4 , 2.85mM disodium citrate, and 3% 
glycerol, 250μM MgSO4) and 0.1M phosphate buffer. Plates were then incubated at 
37°C overnight with constant shaking. Once cultures had reached saturation, they 
were stored at -80°C as master plates.  
2.4.4 High-throughput protein expression 
384-well plates were thawed at room temperature before being transferred to 
identical plates containing only TB media, kanamycin and chloramphenicol, which 
were grown overnight at 37°C with constant orbital shaking. 
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Overnight cultures were then stamped in triplicate onto Hybond Extra nitrocellulose 
membranes (Amersham) placed on top of two 22 x 22cm LB-agar plates. These 
plates were incubated at 37°C overnight to allow visible colonies to form. 
Membranes were then transferred from LB-agar media plates to plates 
supplemented with 50μM biotin and 0.2% arabinose to induce expression. These 
plates were then incubated for 4-5 hours at 25°C. 
2.4.5 Cell lysis 
Cells were lysed by placing blotting paper that had been pre-soaked in alkaline-lysis 
solution (0.5M NaOH, 1.5M NaCl) directly on top of the nitrocellulose membranes 
and incubating for 10 minutes. Nitrocellulose membranes were then transferred to 
blotting paper pre-soaked with neutralising solution (1M Tris-HCl pH 7.5, 1.5M 
NaCl) and incubated at room temperature for 5 minutes, with this neutralisation step 
repeated 3-4 times. Membranes were then incubated with 2x SSC buffer (0.3M 
NaCl, 30mM trisodium citrate) for 15 minutes and cell debris removed by gentle 
scraping with a glass spreader. 
2.4.6 Western blotting 
Once cell debris had been removed membranes were washed with PBS + 0.1% v/v 
TWEEN 20 (PBS-T). Membranes were then blocked overnight at 10°C with 
SuperBlock™ buffer (ThermoFisher). Following blocking, membranes were washed 
in PBS-T, and then incubated with mouse α-his tag antibody for 1 hour at 10°C. 
Following three rounds of washing with PBS-T, membranes were incubated with 
rabbit α-mouse secondary antibody conjugated to Alexa532, and Streptavidin 
conjugated to Alexa488 for 1 hour at 10°C with constant rotation. Membranes were 
washed three times in PBS-T and once in dH2O for 5 minutes before being loaded 
onto a Typhoon 9400 scanner (GE Healthcare). Data collection was optimised at 
excitation λ= 488nm with a 520 BP emission filter, and at excitation λ= 532nm with 
555 BP emission filter to reach saturation with the highest-intensity spots. 
2.4.7 Protein expression of best constructs 
Once signal intensity had been recorded for each spot using Visual grid, the data 
were exported to Microsoft Excel for triplicate averaging and ranking. Averaged 
signal intensities were normalised against average histidine background signal, with 
constructs with normalised signal intensity ≤1 omitted from further data analysis. 
Biotin signals were averaged and normalised as described above, and normalised 
values used to rank constructs. The top 48-ranking constructs from the N-terminal 
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libraries and top 47 ranking constructs for the C-terminal libraries were selected for 
further experiments. 
10μL of each top-ranking construct was transferred from thawed TB-HMFM master 
plates to a 96 deep-well plate with 1mL TB media supplemented with kanamycin 
and chloramphenicol, with MBP added as a positive control to well 96. This plate 
was then incubated overnight at 37°C with constant shaking, with 40μL of saturated 
colony transferred to 24 deep-well plates containing 4mL TB media plus kanamycin 
and chloramphenicol. This 96-well plated was then incubated for a further 8-10 
hours at 25°C, 10% glycerol added, and stored at -80°C. 
24-well plates were incubated at 37°C for 3-4 hours, until OD600 approached 0.6-0.8, 
and induced by the addition of 0.2% L-arabinose. Protein expression was performed 
at 25°C overnight.   
2.4.8 Low-stringency purification and western blot of best constructs 
Cells were pelleted by centrifugation, supernatant removed, and pellets re-
suspended in 3mL re-suspension buffer (20mM Tris pH 8, 250mM NaCl, 20% 
sucrose). After 10 minutes resuspension by constant shaking at 10°C, re-
suspended cells were supplemented with 0.25mg/mL lysozyme and incubated for 
20-30 minutes at 4°C with constant shaking. Sphaeroplasts were centrifuged for 20 
minutes at 2,250g, supernatant carefully removed, and pellets frozen at -80°C for 30 
minutes. 
Sphaeroplasts were lysed by thawing at room temperature with the addition of 
10mM Tris-HCl pH 7.0, 0.5% Brij and 10U Benzonase and incubated for 10 
minutes. Plates were centrifuged at 4°C for 30 minutes at 2,250g and supernatant 
loaded into 96-well plates containing 100μL Ni2+-NTA resin (QIAGEN) which had 
been washed in wash solution (50mM sodium phosphate pH 7.0, 300mM NaCl, 
5mM imidazole), and incubated for 30-60 minutes at 4°C. Beads were washed and 
bound proteins eluted (50mM sodium phosphate pH 7.0 300mM NaCl, 300mM 
imidazole) using a Tecan liquid handling robot. Samples were then separated by 
SDS-PAGE run at 75mA for 140-150 minutes, transferred to membranes for 
western blotting (Section 2.4.6), and probed as described in Section 2.4.6.  
2.5 Rational design of protein constructs 
The translated sequences for S. tuberosum R3a, S. lycopersicum I-2, S. demissum 
R2, S. bulbocastrum Rpi-blb2, S. lycopersicum NRC1 and N. benthamiana NRC1-
like were subject to bioinformatic analysis using a suite of different online servers.  
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PFAM was used to identify likely boundaries for the NBARC domain. Typically the 
predicted C-terminal boundary occurred prior to the conserved “MHD” motif, and so 
this boundary was extended to include this region. The extent of this addition was 
determined by predicted secondary structures after this motif and predictions of 
disordered regions. NBARCs were typically extended to include an additional β- 
strand following the MHD motif and following α-helices until a region of significant 
disorder was identified.  
Secondary structure predictions were performed by PHYRE2121, which also 
generated 3D homology models. 3D structures were also used as a guide to identify 
self-contained structures, however when designing boundaries secondary structures 
took precedence, i.e. if a homology model predicts termination of a secondary 
structure into a disordered loop region, whereas secondary structure predictions 
suggest that the secondary structure element extends into this putative disordered 
region, the construct boundaries are extended to include this 2° structure 
predication. 
Disorder predictions were performed by RONN122, and likely LRR regions identified 
by LRRfinder  (http://www.lrrfinder.com/), to supplement the information described 
above. 
2.6 Medium-throughput E. coli expression screening 
Medium-throughput screening in E. coli was performed by transferring single 
colonies to 24-well deep-well plates with 4mL LB and appropriate antibiotic. Plates 
were incubated overnight at 37°C with constant shaking, and 200-500μL saturated 
overnight culture transferred to a fresh 24-well deep well plate with 4mL of LB, 
Power broth™ or AIM. These plates were then incubated at 37°C with constant 
shaking for 3-6 hours, until average OD600 approximated 0.5-0.8. Once the target 
OD was reached plates were put on ice to rapidly chill. After ~5 minutes wells were 
supplemented with the appropriate treatment (0.4-0.5% ethanol, 0.4-0.5% DMSO, 
5-10% glycerol) and induced by the addition of either 1mM IPTG or 0.2% L-
arabinose. 
Cells were harvested by centrifugation in a Sorval Legend centrifuge at 2,500g for 
15 minutes at 4°C. Supernatant was discarded and pellets re-suspended in 400-
800μL A1 buffer supplemented with either cOmplete EDTA-free protease inhibitor 
cocktail, or 0.5mM PMSF. Plates were put on ice and cells lysed by sonication for 1-
2 minutes, with sonication performed for 1 second followed by 3 seconds pause. 
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Cell debris was removed by centrifuging plates in a Sorval Legend centrifuge for 45 
minutes at 2,500g at 4°C. 
30μL of supernatant was mixed with 10μL 4x SDS-loading buffer and heated to 
95°C for 3-5 minutes, before loading onto a 17% SDS-PAGE gel. Gels were run for 
50-60 minutes at 120V and stained with InstantBlue™ coomassie® stain. 
2.7 Transient transformation of N. benthamiana 
Transient transformation of N. benthamiana was performed as described in 
Kapila123 with the following modifications: 10-20μL of A. tumefaciens glycerol stock 
derived from a single colony were plated on LB agar supplemented with the 
appropriate antibiotics, and allowed to grow for two days at 28°C. The resulting lawn 
was then transferred to sterile 5mL tubes and re-suspended in 2mL infiltration buffer 
(10mM MES pH 5.6, 10mM MgCl2, 150μM acetosyringone) for OD measurements. 
Cultures were then diluted to the appropriate OD and left for 2-5 hours before being 
syringe infiltrated into leaf three or four of 4-week old Nicotiana benthamiana.  
For pOPIN-TRBO R3a domain expression and purification A. tumefaciens were re-
suspended to an OD600 of 1.2. For R3a-AVR3a interaction studies, an OD600 of 0.3 
for effectors in pK7-FLAG and 0.5 for R3a in pCB302-3 was used.  
2.8 Protein purification  
2.8.1 Purification of soluble protein from E. coli 
50mL of LB broth was inoculated by scraping cells from a glycerol stock and 
incubated for 16h at 37°C with constant shaking at 200-230rpm. 20mL of this 
overnight culture was used to inoculate 1L fresh media, which was incubated as 
above until the target OD600= 0.4-0.7 was reached. Depending on the optimal 
induction regime determined by small-volume screening, expression was then either 
initiated by addition of 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG), or IPTG 
addition delayed until cultures had been chilled on ice for 5-10 minutes and treated 
with either 0.4-0.5% dimethyl sulfoxide (DMSO), 0.4% ethanol, or 10% glycerol. For 
protein expression from BL21AI cells induction was performed in an identical 
manner, however with the addition of 0.2% arabinose instead of IPTG. Post-
induction cultures were incubated for 16-20h at 18°C with constant shaking at 200-
230rpm. 
Cells were harvested by 10 minutes centrifugation at 6,000g in an Evolution RT floor 
centrifuge (Sorvall), the supernatant discarded and cell pellets stored at -80°C until 
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required. Pellets were re-suspended in buffer A1 (50mM Tris-HCl pH 8.0, 50mM 
glycine, 5% glycerol, 500mM NaCl and 20mM imidazole) plus protease inhibitor 
cocktail, and lysed by sonication for 1-3 minutes, depending on cell density, at 40% 
amplitude. After sonication the lysed cells were transferred to oakridge centrifuge 
tubes and centrifuged at ~37,000g for 30 minutes in an Evolution RC centrifuge 
(Sorvall) to separate insoluble cell components. The resulting supernatant was then 
diluted with A1 buffer plus protease inhibitor to a volume of approximately 50mL per 
litre original culture and flowed through nickel immobilised metal affinity column 
(IMAC) to collect histidine-tagged proteins.  
Immobilised proteins were washed with three column volumes of A1 buffer before 
elution in 10mL buffer B1. The eluate was then loaded on to a HiLoad superdex 75 
26/600 preparative gel filtration column, pre-equilibrated with A4 buffer (20mM 
HEPES pH 7.5, 150mM NaCl). 8mL fractions were collected in clean 24-deep-well 
plates and stored at 4°C until use.  
2.8.2 Generating SeMet protein from E. coli 
E. coli carrying the pOPIN-S3C:NRC1NBARC were grown overnight in minimal media 
consisting of M9 (0.6% w/v Na2HPO4, 0.3% w/v KH2PO4 , 0.05%w/v NaCl, 0.1% w/v 
NH4Cl) 0.4% w/v glucose, 2mM MgSO4, 0.1mM CaCl2, 0.8% w/v each Val, Phe, Ile, 
Leu, glu, Lys, Arg, Ser, Thr, Tyr, His, Gln, Trp, 0.001% thiamine, supplemented with 
Carbenicillin. Cells were pelleted by centrifugation at 5,000g for 10 minutes and 
washed twice in 20mL M9 plus carbenicillin, before being re-suspended in 20ml M9 
and Carbenicillin. This was used to inoculate 2xL of minimal media (described 
above), and cultures incubated at 37°C for 6-8 hours with constant shaking. When 
cells reach an OD600 of 0.3, 0.01% w/v Thr, Lys, Phe, 0.005% w/v Leu, Ile Val, and 
0.006% w/v selenomethionine was added. Cells were grown for a further 45 minutes 
at 37°C before induction overnight at 18°C was initiated by the addition of 1mM 
IPTG. 
2.8.3 Purification of proteins from Insect cells 
Proteins were purified from Sf9 pellets as recommended by the OPPF 
(https://www.oppf.rc-harwell.ac.uk/OPPF/protocols/index.jsp). Frozen cell pellets 
were re-suspended in ~30mL lysis buffer (50mM Tris-HCl pH 7.5, 500mM NaCl, 
30mM imidazole, 0.2% TWEEN20, and cOmplete EDTA protease inhibitor cocktail 
tablets) and lysed using a cell disruptor (Constant Systems Ltd) at 14,000psi. 
Following lysis, 10-50μL benzonase was added, and incubated at room temperature 
for 15 minutes.  Cell debris was removed by centrifugation for 30-40 minutes at 
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30,000g in an Evolution RC floor centrifuge (Sorvall) at 4°C. Supernatant was 
passed through minisart® 0.45μM filters (Sartorius), with additional incubation with 
benzonase if required, before loading onto a 5mL His-trap FF column pre-
equilibrated with equilibration buffer (50mM Tric-HCl pH 7.5, 500mM NaCl, and 
30mM imidazole). Bound proteins were eluted by the addition of 500mM imidazole 
with eluate loaded directly onto a sepharose S75 gel filtration column pre-
equilibrated with IC running buffer (30mM Tris-HCl pH 7.5, 200mM NaCl, 1mM 
TCEP). 
Fractions containing the target protein were pooled and concentrated (Section 
2.8.7) to <20mL before tag removal by incubation with 3C protease at 4°C 
overnight. Tagged protein and protease was removed by subtractive IMAC using a 
5mL His-trap FF column pre-equilibrated as described above. Unbound protein and 
3x column-volume washes were collected and assessed for purity by SDS-PAGE. 
Buffer exchange was performed by several rounds of concentration (Section 2.8.8) 
and dilution in A4 buffer before being concentrated to ~8mg/mL. 
2.8.4 Protein purification from N. benthamiana  
Four-to-five-week old N. benthamiana leaves were harvested (three-to-four days 
post-infiltration for transient expression), the mid-vein removed, frozen in liquid 
nitrogen and stored at -80°C. Tissue was then ground to a powder in liquid nitrogen, 
and 0.5g powder added into pre-chilled 2mL screw cap tubes. Each tube was left on 
ice for 1 minute before 1.0mL extraction buffer (10% glycerol, 25mM Tris-HCl pH 
7.5, 1mM EDTA, 150mM NaCl, 10mM DTT, 0.1% TWEEN 20, and 0.02% w/v 
poly(vinylpolypyrrolidone)) was added, the tubes vortexed thoroughly and then left 
on ice for 30 minutes. After incubation samples were again thoroughly vortexed 
before centrifugation at 30,000g for 10 minutes to pellet cell debris. Supernatant 
was then transferred to fresh, chilled 1.5mL eppendorfs and centrifuged as above 
until no plant debris was present in the supernatant, which was then transferred to 
fresh Eppendorf tubes for imunnoprecipitation experiments (Section 2.14.2) or 
western blotting (Section 2.15). 
For larger-scale purification of R3a domains, 3-4 N. benthamiana leaves 5 days 
after infiltration were harvested and treated as described as above. Typically 1.5 - 
2.5g of ground tissue was transferred to chilled tubes to which 2x v/w extraction 
buffer (described above) was added and mixed by vortexing. After 30 minutes 
incubation on ice with 2-3 rounds of additional vortexing, tubes were centrifuged for 
45 minutes at 4,500rpm in a Legend® RT centrifuge (Sorvall) at 5-10°C. 
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Supernatant was then passed through 0.45μm filters before being loaded onto a 
pre-equilibrated IMAC column. Low stringency purifications involved the addition of 
15mM imidazole to samples prior to loading onto a 5mL His-trap FF column, high 
stringency purifications were performed by the addition of 30mM imidazole prior to 
loading on a 1mL His-Trap FF column. Columns were then washed with 3x column 
volume of A1 buffer before bound proteins eluted by washing with 2-3 column 
volumes B1 buffer. 
 
2.8.5 SDS-PAGE 
SDS-PAGE was performed as described by Laemmelli with some modifications. 
12% or 17% w/v polyacrylamide resolving gels were made by diluting 30% 
acrylamide-bis-acrylamide (37.5:1) solution (Severn Biotech ltd) in 375mM Tris-HCl 
pH 8.8 with 0.1% w/v SDS. Immediately prior to pouring 0.1% w/v ammonium 
persulphate and 0.04% v/v N,N,N’,N’-tetramethylethylenediamine were added and 
mixed. Resolving gels were poured between two Mini-Protean® system (BioRad) 
glass plates with 1mm separation to circa 2mL below the top of the shorter plate, 
and water-saturated butanol carefully applied to the top of the gels whilst setting to 
ensure a level boundary between resolving and stacking gels. Butanol was removed 
prior to pouring 5% stacking gels (5% acrylamide-bis-acrylamide (37.5:1) solution, 
63mM Tris-HCl pH 6.8 0.1% w/v SDS, with 0.1% w/v ammonium persulphate and 
0.1% v/v N,N,N’,N’-tetramethylethylenediamine added immediately prior to pouring) 
to the top of the gels. Plastic combs were inserted into the stacking gel whilst liquid. 
Once set these gels were wrapped in clingfilm and stored in a humid environment at 
4°C. 
Protein separation was performed by placing gels in a BioRad miniPROTEAN® tetra 
cell system. The plastic combs were removed to allow sample loading, and 
chambers filled with SDS-running buffer (25mM Tris-HCl, 250mM NaCl, and 0.1% 
w/v SDS) ensuring that gels were covered by running buffer. Protein samples were 
prepared by heating to 95°C for 3-4 minutes in 4x SDS-loading buffer (final 
concentrations: 50mM Tris-HCl pH 6.8, 0.1M DDT,  2% w/v SDS, 0.1% 
bromophenol blue and 10% glycerol). To enable molecular weight determination, 
protein samples were loaded alongside a molecular weight ladder- either SeeBlue® 
Plus 2 pre-stained protein standard (ThermoFisher), or RunBlue prestained dual 
colour markers (Expedeon) for SDS-PAGE coomassie staining, or PageRuler™ 
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Plus prestained protein ladder (ThermoFisher) for protein separation preceding 
western blotting experiments. 
2.8.6 Staining SDS-PAGE gels 
Gels were stained by incubation with InstantBlue™ Coomassie stain at room 
temperature for a minimum of 30 minutes before de-staining with de-ionised H2O. 
2.8.7 Protein concentration measurement 
As standard protein concentration was determined by measuring absorbance at 
280nm using a nanodrop spectrophotometer. Protein concentration of wild-type 
NRC1 NBARC domain and point mutants for enzymatic and binding assays was 
determined by infrared absorbance using a direct-detect® spectrophotometer 
(Merck Millipore). Protein concentrations for crystallisation experiments refer to A280 
measurements. 
2.8.8 Protein concentration 
Purified protein was concentrated using Sartorius protein concentrators. 10kDa 
molecular-weight cut-off concentrators were used for NRC1 NBARC domain; 5kDa 
cut-off concentrators were used for all other proteins. Proteins were concentrated by 
multiple rounds of centrifugation at 7,000g for 15 minutes until the target 
concentration was achieved. 
2.9 Dynamic light scattering 
Dynamic light scattering (DLS) was performed using a DynaPro™ Titan dynamic 
light scattering instrument (Wyatt Technology). For size determination of NRC1 
NBARC particles in solution, protein was diluted to 1mg/mL in A4 buffer before 
filtering with a 0.1μm Ultrafree® centrifugal PVDF filter (Merck Millipore) by 
centrifugation on a bench top centrifuge at 12,000g for 60 seconds.  
Assessment of R3a construct #1 aggregation was performed by diluting 1 volume 
purified protein in 9 volumes 0.1M buffer before filtering as described above. 
DLS readings were taken at 25°C with 10 readings taken every second for 10 
seconds per sample. Typically laser power was reduced to 30% for consistent 
signal intensity. Data were assessed with DYNAMICS V6 software (Wyatt 
Technology), and species <0.1nm omitted from analysis.   
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2.10 Yeast 2-hybrid 
Yeast (Saccharomyces cerevisiae) transformations were performed using the 
ProQuest® Two-Hybrid with slight modifications. The ProQuest® Y2H system uses 
the low-copy number (ARS/CEN) vectors to reduce overexpression effects, and 
Gateway®-compatible vectors to allow fusion of genes of interest to GAL4 DNA 
binding domain and the GAL4 activation domain. Interacting proteins fused to these 
domains recapitulate the activity of the GAL4 transcription factor. By using a yeast 
strain that is auxotrophic for histidine, and having the synthesis of the gene required 
to allow growth on media lacking this amino acid (HIS3) under the control of a 
GAL4-responsive promoter, interacting proteins can be identified by their ability to 
grow on histidine-deficient media (Figure 2.10.1). 
 
Figure 2.10.1 Schematic of protein interaction-dependent activation of gene expression in 
yeast 2-hybrid 
 
2.10.1 Yeast transformation 
A single colony of yeast strain MaV203 was placed into 10mL of YPAD liquid media 
using a flamed loop, and incubated overnight at 28°C with constant shaking at 190-
220 rpm. OD600 of the culture was measured by adding 100μL of overnight culture to 
900µL fresh YPAD, and overnight culture diluted to give 40mL of culture at OD600= 
0.4. This culture was split into two sterile falcon tubes, sealed with parafilm and 
incubated at 28°C with constant shaking for 2-3 hours. Cells were pelleted by 
centrifugation for 5 minutes at 1,600g using a Legend® RT centrifuge (Sorvall®). 
Supernatant was removed, and pellets washed by re-suspending in autoclaved, de-
ionised H2O. Washed cells were pelleted, with supernatant discarded as above, and 
cells resuspended in a total volume of 500μL yeast resuspension buffer (5mM Tris-
HCl pH 7.5, 100mM Lithium acetate, 5mM EDTA). Cells were then incubated at 
room temperature for 10 minutes before 10μL of re-suspended cells were added to 
10μL pre-prepared DNA samples. 
In the Proquest® yeast 2-hybrid system HIS3 gene expression is driven by GAL4-
responsive promoter elements (Left). Right: GAL4 activity is only recapitulated upon the 
interaction of two proteins (X and Y), which are fused separately to the GAL4 DNA binding 
and activating domains. Taken from the ProQuest™ two-hybrid manual, Invitrogen.  
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DNA samples consisted of 10μg pre-prepared salmon sperm DNA (sheared by 
sonication, heat denatured and rapidly chilled on ice) mixed with 200ng of each prey 
and bait vector. 70μL transformation buffer (10mM Tris-HCl pH 7.5, 100mM lithium 
acetate, 1mM EDTA, 40% w/v PEG 3350) was added to each yeast-DNA 
combination and mixed by gentle pipetting. Cells were then incubated for 30-45 
minutes at 28°C before the addition of DMSO, mixed by pipetting, and heat-shocked 
at 42°C for 7 minutes. Cells were pelleted by 1 minute centrifugation in a Sorvall® 
Legend RT centrifuge at 1,600g at room temperature. Supernatant was discarded 
and cells re-suspended in 100µL autoclaved de-ionised H2O before being plated 
onto SC-LT selective agar plates, sealed with parafilm, and incubated at 28°C for 3-
4 days.   
2.10.2 Yeast 2-hybrid assays 
 Single colonies of co-transformed yeast were re-suspended in 100µL distilled water 
in microcentrifuge tubes. 2μL of re-suspended cells were spotted out onto SC-LT 
and SC-LTH plates supplemented with 10mM, 7.5mM or 5mM 3-amino-1,2,4-
triazole (3AT). Plates were incubated overnight at 28°C and inspected for colony 
growth. Plates were then incubated at room temperature overnight for up to five 
days, or until a clear growth phenotype could be observed.  
2.11  Analytical gel filtration 
Analytical gel filtration was performed at 4°C by loading ~100μL of protein onto a 
superdex™ S75 10/300 GE sepharose column. For NRC1 NBARC size 
determination, protein was diluted to 50μM in A4 buffer prior to loading. Analytical 
gel filtration to detect NRC1 CC/NBARC complex formation was performed by 
diluting NRC1 NBARC to 1mg/mL in the required amount of coiled-coil to give 1:1, 
1:2, 1:4 and 1:10 ratios in approximately 120μL. These proteins were then 
incubated on ice for >1 hour, or at 4°C overnight before loading onto the column.    
Calibration curves were produced by Lennart Wirthmueller. 
2.12 Circular dichroism 
Circular dichroism was performed using a Chirascan™ Plus (AppliedPhotophysics), 
with spectra measured from 180-260nm. Protein was diluted into phosphate buffer 
to 0.1mg/mL and spectra gathered in 1nm steps. Readings were taken with empty 
sample chamber to allow absorption measurements and spectra recorded in 
triplicate including buffer only samples to allow buffer subtraction.  
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2.13 SAXS 
Small-angle X-ray scattering (SAXS) experiments were performed at Diamond Light 
Source (Oxfordshire), beamline B21. For each sample 18 frames of 10 seconds 
exposure were collected. Data were collected for NRC1 NBARC at 10, 5, 2.5, 1.25, 
0.625 and 0.3125mg/mL in 20mM HEPES pH7.5 with 150mM NaCl.  
Data were processed using Scatter (Rambo et al). Frames were visual inspected for 
radiation damage by plotting I vs Rg and removing outlying frames from further 
analysis. Buffer frames were averaged and subtracted from the averaged 
experimental data to allow evaluation of inter-particle interactions with intensity vs 
scattering angle plots. Rg and porod values were determined manually as 
recommended in the Bioisis tutorial (http://www.bioisis.net/tutorial). 
2.14 Antibody techniques 
2.14.1 Conjugation of anti-R3a antibodies to Dynabeads 
Sheep α-rabbit magnetic Dynabeads® (ThermoFisher) were prepared as per 
manufacturer’s guidelines. Beads were washed and resuspended in 0.1M PBS with 
1mM EDTA, and incubated with 1.2μL α-R3a antibodies per 100μL beads for 30 
minutes on ice. Tubes were placed in a magnetic rack and supernatant removed. 
Beads were then re-suspended in conjugation buffer (20mM sodium phosphate pH 
7.5, 150mM NaCl) containing 5mM BS3 (bis(sulfosuccinimidyl)suberate), and 
incubated at room temperature for 30 minutes with constant rotation. Cross-linking 
reactions were quenched by the addition of 1M Tris-HCl pH 7.5 to a final 
concentration of 50mM, and incubated for a further 15 minutes with constant 
rotation.  
To compare the effects of conjugation, beads were washed and re-suspended in 
conjugation buffer with α-R3a antibodies as described above. Prior to separation on 
a magnetic rack, half of the solution was removed and placed into a fresh pre-chilled 
tube on ice. Following conjugation of the remaining half, both sets of beads were 
washed in 3x volumes of conjugation buffer. 
2.14.2 Protein immunoprecipitation  
For IP experiments using sheep α-rabbit beads that had not been pre-conjugated to 
R3a antibodies, clarified plant lysate (Section 2.8.4) was incubated with the primary 
antibody for 15-30 minutes on ice prior to the addition on 40-100μL of washed 
sheep α-rabbit Dynabeads®. For IP experiments using Dynabeads pre-conjugated 
 Page 63 of 232 
 
to α-R3a antibodies, this first incubation step was omitted and 40-100μL washed, 
conjugated beads was added to clarified plant lysate. Magnetic beads were then 
incubated with samples for 1-2 hours at 4°C with constant rotation.  
Beads were washed by separating beads from solution with a magnetic rack and 
gentle pipetting off supernatant, followed by resuspension in ~3 volumes 0.1M PBS 
+ 150mM NaCl. This process was repeated three times before bound proteins were 
eluted in either 50-100µL SDS-loading buffer incubated at 72°C for seven minutes 
with constant rotation, or 30-50μL sodium citrate pH 2.0 at room temperature for 
seven minutes with constant rotation. Acid eluted proteins were then neutralised by 
addition of 3μL 1M Tris-HCl pH 7.5 before the addition of 4xSDS-loading buffer and 
heating to 95°C for 3-5 minutes.   
2.15  Western blotting 
2.15.1  Protein transfer 
Proteins were transferred to Immobilon-P® PVDF membranes (Merck Millipore) by 
electrophoresis using a Mini Trans-Blot® cell (Biorad). Transfers were performed in 
Bjerrum transfer buffer (48mM Tris pH 9.3, 39mM glycine, 20% v/v methanol) 
supplemented with 0.0125 w/v SDS, with membranes first equilibrated in methanol 
for 5 minutes. Transfers were performed at 4°C overnight at 90mA.   
2.15.2 Antibody probing 
Membranes were blocked by incubation with 10-20mL TBS-T with 5% w/v milk 
powder for 1 hour at room temperature, with blocking solution then removed. 
Primary antibodies (typically α-R3a antibodies) were added in a 1:8,000 dilution to 
fresh blocking solution, with 8mL added to each membrane. Antibodies were 
incubated with the membranes for an hour at room temperature before being 
removed, and the membranes washed three times in 15-20mL TBS-T. Following 
washing, secondary antibodies (horseradish peroxidase-conjugated α-rabbit 
antibodies) were diluted 1:6,000 in blocking buffer, 8mL of which was then added to 
each membrane, and incubated for an hour at room temperature. This buffer was 
then removed, membranes washed 3 times in TBS-T and once in TBS. Secondary 
antibodies were visualised by application of SuperSignal™ West Pico and Femto 
chemiluminescent substrate (ThermoFisher) combined in a 1:3 ratio. 
Chemiluminescence was detected by either autoradiogram or using an ImageQuant 
LAS 500 spectrophotometer (GE Healthcare). 
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FLAG-tagged proteins were detected using rat α-FLAG primary antibodies and 
alkaline phosphatase (AP) conjugated α-rat antibodies as described above. AP-
conjugated antibodies were visualised by the application of 5-bromo-4-chloro-3-
indolyl phosphate (BCIP), and Nitro blue tetrazolium chloride (NBT). In the presence 
of AP these two substrates precipitate to form insoluble purple and blue dyes 
respectively. Membranes were incubated with BCIP and NBT until dark bands were 
visible before being washed with dH2O. 
2.15.3  Ponceau staining of membranes 
Staining of total proteins present on nitrocellulose membranes was performed by 
incubation of membranes with 15-20mL Ponceau S stain (0.1% w/v Ponceau S in 
5% v/v acetic acid). Once bands were clearly visible, with minimal background 
staining, membranes were washed with dH2O. 
2.16  Crystallographic techniques 
2.16.1  Initial crystallisation screens 
In order to produce crystals suitable for X-ray diffraction experiments, proteins must 
form large, repeating structures, ultimately leading to the formation of macroscopic 
crystals. In vapour diffusion experiments these repeating structures are formed in 
response to increasing protein concentration as water diffuses from the drop, 
containing a low concentration of solutes, to the reservoir, which contains a higher 
concentration of solutes (Figure 2.16.1). As the drop and reservoir equilibrate 
protein concentration increases to the point where it precipitates out of solution. If 
the conditions allow this precipitation to occur in a slow, controlled manner, then 
precipitation can lead to crystal formation and growth. The conditions required to 
support such controlled crystallisation are typically narrow, and unless multiple 
conditions are met (for example the right precipitant, salt and pH combinations) the 
result will be uncontrolled precipitation of the protein. 
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Figure 2.16.1 Schematic of a sitting drop vapour-diffusion experiment 
 
Formation of macroscopic crystals relies on two stages: crystal nucleation and 
crystal growth. Given the diverse parameters that can affect the ability of proteins to 
crystallise, initial crystallisation experiments often focus on “sparse-matrix” screens. 
These screens are designed to test diverse regions of crystallisation space to find 
conditions that may support crystal formation.  
To identify suitable conditions for the crystallisation of NRC1 NBARC domain, seven 
commercial 96-well screens were used for sitting-drop vapour diffusion 
experiments:, PEG suite, and Ammonium sulphate suite  from QIAGEN; PACT, 
JCSG , Structure screen, Shotgun screen, and Morpheus screen  from Molecular 
Dimensions. Sitting drop experiments were performed in MRC crystallisation plates 
(molecular dimensions), which contain two wells per reservoir. Each crystallisation 
condition was tested using a 1:1 mix (total drop volume 0.6μL) of reservoir solution, 
with protein at 10mg/mL and 5mg/mL. Plates were sealed and kept at 20°C to for 
the duration of crystallisation experiments. NRC1 NBARC domain was found to 
crystallise in <16 hours, typically forming small comet-like crystals in multiple 
conditions, over a range of pH and with a variety of molecular weight PEGs.  
2.16.2 Crystal optimisation 
As the conditions that allow controlled protein precipitation are specific for each 
protein, and influenced by many factors, sparse-matrix screens are unlikely to 
sample the best conditions for crystallisation. Unless crystals from initial screens are 
In sitting drop vapour-diffusion experiments, a chamber is partially filled with a crystallisation 
solution containing, amongst other things, a precipitant. A small volume of this reservoir 
solution is mixed with protein, and a small drop deposited within the chamber. The chamber 
is then sealed, and the drop equilibrates with the reservoir conditions, gradually increasing 
the concentration of protein within the drop. Modified from Hampton Research.  
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particularly well formed and large, optimisation experiments are performed to 
systematically test crystallisation space around these initial conditions to improve 
conditions for crystal growth. 
Crystal optimisations were performed in 48-well sitting-drop MRC Maxi plates 
(molecular dimensions) around the most promising conditions identified in the 
original crystallisation conditions: 0.1M MMT (MES, malic acid, Tris- QIAGEN) pH 
5.0 and 25% PEG 1500. PEG by pH screens were typically performed using 2% 
steps in PEG concentration from 21-31%, against 0.5 step changes in pH from 4.0 
to 6.0, with a 1:1 ratio of protein to reservoir condition in a total drop volume of 2μL. 
This optimisation indicated that crystals were improved at lower PEG 
concentrations. Below pH 4.5 heavy precipitate was observed and above pH 5.0 
only clear drops were seen. Repeated rounds of similar optimisations were 
performed to identify the best crystallisation conditions as 6-12% PEG 1500, 0.1M 
MMT pH 4.5 (PEG optimum varying between protein purifications).   
Similar optimisations were performed by varying protein concentration in 1mg/mL 
steps from 4-12mg/mL against pH 4.5 conditions with 6-12% PEG 1.5K, with an 
ideal protein concentration of 6-8mg/mL identified.  
2.16.3 Microseeding 
Crystal microseeding allows sampling of conditions that may be able to facilitate 
crystal growth, but are not suitable for nucleation- such as having too low an initial 
concentration of precipitant. Crystal micro-seed stock was produced from either 
purified NBARC domain grown in 0.1M MMT pH 4.5 with 8% PEG 1500, or NBARC 
domain that had been incubated with a 10-fold excess of ATP-γ-S overnight prior to 
growth in 0.1M MIB buffer (sodium malonate, imidazole, boric acid- QIAGEN) pH 
5.0 and 25% PEG 1500. Crystals were mechanically disrupted in the growth drop 
before being transferred to a fresh Eppendorf. The total volume of the reservoir was 
transferred to this tube and crystals further disrupted by several short bursts of 
vortexing. This seed stock was then flash-frozen in liquid nitrogen and stored at -
80°C until use.  
Sparse-matrix microseeding experiments were performed with an Oryx Nano liquid 
handling robot as described above, with each drop consisting 0.3μL protein, 0.3μL 
reservoir condition and 0.1μL seed stock. 
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2.16.4  Additive screening 
Additive screens were performed in two sets of 48-well plates. 130µL of 8% PEG 
1500, 0.1M MMT pH 4.5 was added to each reservoir with 20μL of SilverBullets Bio 
screen (Hamilton Research). Screens were set up using an Oryx Nano liquid 
handling robot to deposit 1μL of protein at 8mg/mL and 1μL reservoir condition to 
each well. Plates were sealed and stored at 20°C for crystallisation. Heavy 
precipitation was seen in all crystallisation conditions in <16 hours. Screens were 
repeated with 5µL SilverBullet screen added to 145μL reservoir conditions, without 
any improvement to precipitation. 
2.16.5  Cryoprotection of crystals and heavy atom soaking for data 
collection 
Protein diffraction experiments were performed at low temperature, with crystals 
sitting in a stream of liquid nitrogen having been first flash-frozen in liquid nitrogen 
(~68K). This flash freezing can result ice crystals forming either within the crystal or 
in the mother liquor. Ice crystal formation within solvent channels in protein crystals 
or within the loop holding the crystal can lead to interfering diffraction patterns, 
making data processing of protein-diffraction difficult. By using cryoprotectants, the 
formation of ice crystals is significantly reduced. This reduction in ice formation can 
be performed in two ways- firstly by the replacement of water within solvent 
channels with a cryoprotectant agent such as ethylene glycol or glycerol, or by 
replacement of water surrounding the crystal with oils that do not penetrate the 
crystal. We used the former method to protect crystals upon freezing.  
To make cryprotectants that would not stress the crystals, or dissolve them, 
solutions similar to the reservoir conditions supporting crystal growth were used. 
Typically cryoprotectants used a concentration of precipitant 2-4% higher than in the 
corresponding reservoir condition, and supplemented with 20% ethylene glycol. 
Crystals were transferred from sitting drops in which they formed to small drops of 
cryoprotectant where they were washed by gently moving the crystal through the 
solution. These crystals were then transferred to a loop-holding cassette in liquid 
nitrogen. 
Solutions for heavy-atom soaks were based on reservoir conditions permitting 
crystal growth, with precipitant increased 2-4%, and 0.5M potassium iodide or 
potassium iodide added. Crystals were transferred to small drops of these solutions 
and soaked for 60-90 seconds. To protect these crystals during freezing 
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cryoprotectants were produced as described above, but with the inclusion of 0.5M 
potassium iodide or bromide.  
2.16.6 Data collection 
All X-ray diffraction experiments were performed at Diamond Light Source 
(Oxfordshire). Native and Bromide peak data were collected on beamline DLS-i02, 
Iodide and Selenium peak data sets were collected on beamline DLS-i04, and data 
collections from Sf9-derived protein crystals were performed on beamline DLS-i03.  
Native datasets were collected at λ=0.9795Å, bromide-soaked crystals at λ= 
0.9150Å, iodide peak collection at λ= 2.0000Å and selenium peak at λ=0.9797Å. 
3-5 test images at a maximum resolution of 3.0-3.2Å were collected with Ω=0.5° and 
separated by 45° rotation to allow assessment of likely diffraction resolutions and 
development of data collection strategies using EDNA124. 
2.16.7 Data processing 
Data were processed using the xia2 pipeline with XDS and pointless. XDS is a 
programme suite that will index, integrate, and scale data collected from CCD and 
similar devices. Firstly the program identifies background pixel intensities, and 
locates diffraction spots. Secondly it indexes reflections to give a spacegroup for the 
unit cell, and evaluates the intensity of all spots on the frame. Finally XDS scales 
the reflection intensities, removes outliers and generates reflection statistics. 
Pointless assigns likely Laue groups consistent with the crystal class determined by 
XDS. This is performed by assessing the unmerged data from XDS to look for 
potentially symmetry-related reflections and systemic absences. Pointless assess 
all possible Laue groups within the cell parameter constraints and scoring them on 
the basis of identifiable potential systemic absences.    
The process of assigning unit cell parameters, crystal orientation and space group is 
based on predicting where in reciprocal space Bragg’s law is satisfied, and 
assigning Miller indices (hkl) to the reflections. These parameters are refined to give 
the best estimate of expected hkl positions. By recording the intensity of reflections 
it is possible to assign intensities to each spot (Ihkl). Once the unit cell is determined 
it is possible to predict where reflections are expected to appear, and by identifying 
reflections that are not recorded (systemic absences) it is possible to assign a Laue 
group to the crystal.  
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2.16.8  Obtaining phases 
The electron density within a crystal can be thought of as a complex wave. As such 
it can be recreated using a fourier transform, which is the sum of a serious of simple 
waves. Equation 1 shows how electron density at a particular position or volume of 
the crystal (p(x,y,z)) can be reproduced. 
 
 
Where V is the volume of the unit cell, |Fhkl| is the inverse of the recorded intensities 
for spots at position hkl. Here we see how recorded spot positions and intensities 
hkl (|Fhkl|) contribute to the final electron density map. The term α′hkl denotes the 
phase of the spot hkl, however this information is not recorded during X-ray 
diffraction experiments.  
In order to reproduce an electron density map we need to calculate phases for each 
recorded reflection. This can be done in two main ways- through molecular 
replacement and experimental methods. Molecular replacement uses proteins 
believed to be structurally similar to the target protein and tries to “find” the molecule 
in the experimental unit cell by a series of rotation and translation functions. This is 
performed by generating a Patterson map (a map of the inter-atomic vectors, which 
does not require phase information) of the known and unknown proteins and 
rotating one relative to the other until they align. Once the search model (known 
structure) has been placed in the unit cell it is possible to calculate the phases of the 
experimental diffraction to recreate the electron density of the protein of interest. 
Phase information contributes greatly to the derived electron density map, and so 
molecular replacement can introduce significant bias into the resulting structure 
(Figure 2.16.2). 
Equation 1 Fourier sum to generate electron density 
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Figure 2.16.2 Demonstration of structural bias introduced by phases 
 
Alternatively it is possible to approximate phases using experimental techniques. To 
do so heavy atoms (HA) are introduced into the crystal (either at the point of protein 
synthesis or by soaking existing crystals in a HA-containing solution). These HA-
derived crystals can be used in two ways- either the effect they have on the intensity 
of spot intensity (isomorphous replacement), or by utilising the ability of these atoms 
to absorb X-rays of a particular wavelength (anomalous dispersion), which was 
used in this project.   
To solve the structure of NRC1 NBARC domain phases were experimentally 
determined by single wavelength anomalous dispersion (SAD). This method relies 
on the ability for heavy atoms to absorb X-ray radiation at specific wavelengths, 
which are then reemitted with slight shifts in phase and amplitude. Under these 
conditions Friedl’s law (stating that the intensity of two symmetry-related reflections 
is equal, Ihkl = I-h-k-l) is no longer valid. The anomalous differences between Friedl 
pairs can then be used to locate the anomalous scatterers in the unit cell 
The structure of a duck (A.), representing the structure of an unknown protein, and cat 
(C.), representing a known structure to be used as a search model. B. and C. show the 
fourier transform of each structure. E. shows the application of the phases from the cat 
transform (D.) to the amplitudes of the duck transform (B.). Transforming E. leads to the 
generation of a cat-like structure (F.). Taken from K. Cowtan 
(http://www.ysbl.york.ac.uk/~cowtan/fourier/magic.html) 
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(substructure solution) and calculate phases. These phases can then be 
“bootstrapped” to all atoms in the atoms give an initial approximation of the electron 
density. 
 For NRC1 NBARC, SAD was performed with SeMet, bromide and iodide-derived 
data. Structure solution was performed by PHENIX AutoSol, which uses Hybrid 
substructure search (Hyss) to locate anomalous scatterers. Although anomalous 
signal was detected for all HA derivatives, only SeMet data produced a valid 
solution. 
To investigate the effect of growing crystals at a different pH, or from an alternative 
protein source (insect cell expression) molecular replacement was performed using 
the most complete structure of NRC1 with ADP and some regions of the model 
removed. As molecular replacement can introduce bias into the resulting electron 
density, removal of these features allows us to determine whether the resulting 
solution is valid. Non-valid solutions generally result in electron density identical to 
the existing model, whereas valid solutions usually result in additional features, such 
as electron density where we would expect ADP to be present- as was the case for 
MR into these alternative crystals.    
2.17 ATPase assays 
2.17.1 Linked enzymatic assay 
The NBARC domain of NRC1 was screened for ATPase using either a modified 
Malachite green assay125 or a linked enzymatic reaction adapted from Nørby125.  
The linked assay uses the ability of pyruvate kinase (PK) to dephosphorylate 
phosphoenolpyruvic acid (PEP) to pyruvate using ADP as a phosphate-acceptor. 
The pyruvate is then converted to lactate by lactate dehydrogenase (LDH) in a 
reaction which oxidises the cofactor NADH to NAD+. Conversion of NADH to NAD+ 
results in a decrease in absorption at 340nm. ATPase activity of a protein can 
therefore be deduced by looking at the rate of decrease in absorption at 340nm as 
ATP is converted to ADP.  
Reactions were carried out at 25°C in flat-bottomed 96-well plates using an 
Ultrospec 3300 pro (GE healthcare Life Sciences) to record the absorption at 340 
nm every minute for 30 minutes. Initial readings at 340nm of the primed reactions 
(reaction buffer, PK, LDH and NRC1 NBARC) were taken every minute for 10 
minutes prior to the addition of ATP to establish a baseline absorbance 
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 Primed reactions were made by adding 1.5µL PK/LDH solution (Sigma Aldrich), 
800µM PEP, 400µM NADH and 1µM NRC1 NBARC. Reactions were then initiated 
by the addition of 1mM ATP. 
2.17.2 Malachite green 
Malachite green assays to detect release of free phosphate were performed as 
described in Lanzetta125 with modifications. ATPase assays were performed in 96-
well clear, flat bottomed plates. 5μL of 100μM protein in A4 buffer (20mM HEPES 
pH 7.5, 150mM NaCl) was added to 5μL of 2x reaction buffer (20mM HEPES, 4mM 
MgCl2, 2mM ATP) and incubated for 1 hour at room temperature. Reactions were 
quenched by the addition of 90µL malachite green reagent (1M HCl, 8.5mM 
ammonium molybdate, 1.2mM malachite green, 0.1% Triton N101) and incubated 
for 15 minutes. Absorbance at 630nm was recorded using an Ultrospec 3300 pro 
(GE healthcare Life Sciences) plate reader. 
A range of reaction buffers were used in initial screens to take into account various 
potential requirements for ATPase activity of NRC1 NBARC based on previous 
investigations into the ATPase activity of I-2, Apaf-1 and a number of other STAND 
proteins. Briefly the buffers varied in pH (6.5, 7.0, 7.5), buffer component (50mM 
Tris-HCl or 20mM HEPES), mono- and di-valent cation availibilty (5mM Mg2+ 
invariable as either MgCl2 or MgSO4) with or without 5mM MnCl2, either 150 or 
50mM NaCl or 50mM KCl), the addition of divalent anions (50mM (NH4)2SO4), the 
addition of 10% glycerol, and the reducing agent dithiothreitol (DTT, 1.5mM). 
None of the screened buffers significantly affected ATPase activity of WT NRC1 
NBARC, and so ATPase assays for NRC1 NBARC mutants were performed in 
20mM HEPES pH 7.5, 75mM NaCl, 5mM MgCl2 and 2mM ATP. 
2.18 DNA binding assays 
2.18.1 SPR 
DNA binding capabilities of purified NRC1 NBARC domain were assessed via 
surface plasmon resonance (SPR) using the reusable DNA capture technology 
(ReDCaT, Stevenson et al). Binding assays were performed by Clare Stevenson 
using a Biacore T200 system (GE Healthcare). Assays were performed at 20°C, 
with 50nm, 100nm and 500nm NRC1 NBARC tested against 20bp, 30bp and 40bp 
double-stranded DNA oligonucelotides (oligonucleotide sequences found in 
Appendix).   
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2.18.2  Fluorescence Anisotropy 
Fluorescence anisotropy was performed using single-stranded 5′-fluorescein-
labelled oligonucleotide (Appendix). Anisotropy was measured using a Synergy™ 
H4 plate reader (BioTek®). Reactions were set up with 150nM oligonucleotide and 
performed at room temperature. After the addition of protein into DNA-containing 
buffer (20mM TRIS pH 7.5, 100mM NaCl), samples were incubated for 20 minutes 
to allow signal to stabilise before recording polarized fluorescent signals.  
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3.1 Introduction- Biochemical investigations into R-protein 
function 
In the two decades since the first R-protein was cloned, our understanding of their 
function and behaviour at the cellular and genetic level has grown dramatically. We 
now have numerous examples of R-genes and their specificities- from the highly 
specific R3a/AVR3a interaction, disrupted by changes in only two amino acids of the 
effector126, to the ability of Mi-1 to detect both nematode and aphid effectors127. 
Models for effector recognition from direct interactions128, to the guard hypothesis57, 
to the more complex decoy hypothesis70, have all been proposed on the basis of 
genetic analysis and cell-biology experiments. By separating R-proteins into their 
constituent domains and expressing these in planta it is possible to form hypotheses 
about the regulation of R-proteins post-translation. 
Our understanding of the biochemistry of these proteins, an important tool for 
validation of many of these hypotheses, has lagged significantly behind our 
understanding at the genetic and cellular level. This lack of information is a large 
obstacle to the rational improvement of R-protein function. Models explaining R-
protein regulation are qualitatively useful in making broad predictions about 
responses to changes in R-protein coding sequence, and can be used to rationalise 
a number of mutant phenotypes. However, these models lack the details required to 
make de novo predictions of R-protein behaviour in response to many specific 
mutations. Multiple studies have indicated that individual R-protein domains 
associate89 and it is believed to be through these intramolecular interactions that R-
proteins are kept in a signalling competent, but inactive, state129. How strong these 
interactions are, and how variable these interactions may be has not been 
demonstrated, and would be difficult to address simply through in planta 
investigations.  
The strength of these intramolecular interactions has implications on the likely 
success of manipulating R-proteins for crop improvement- if the interactions 
between the domains are weak then it can be expected that the proteins are 
capable of spontaneously switching to an active conformation and back without 
detrimental effects on the plant. In such a system the R-protein would be more 
tolerant to mutations that affect these interactions, for example mutations in the LRR 
that allow recognition of additional AVR proteins but also perturb the inhibitory 
interactions between the LRR and NBARC domain. If, however, these interactions 
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are highly stable then it may be expected that only mutations which do not affect 
these interaction interfaces can be tolerated without additional mutations to affect 
other aspects of the system. Work with the CNL Rx highlights this issue- mutations 
introduced to expand the responsiveness of Rx lead to a creeping autoactive (cell 
death) phenotype, rendering the increased responsiveness of little use in the 
context of crop improvement. To overcome this the researchers performed a second 
round of random mutagenesis to identify additional changes that would allow 
expanded recognition without compromising regulation9.  
The primary cause of the disparity between the available data from phenotypic 
screens and biochemical data has been the difficulties of obtaining sufficient yields 
of well-expressed protein in a form that can be used in sensitive in vitro assays. 
Beyond the expression of MLA10 and Rx coiled-coil domains in E. coli, remaining 
studies have either relied on truncated domains103, refolded protein102, or very low 
levels of protein expressed in eukaryotic systems86, 130. 
For example, primary work investigating the function of predicted Walker-A and 
Walker-B motifs seen in the NBARC domain of R-proteins, which are also found in 
proteins that bind and hydrolyse ATP or GTP, relied on refolded protein purified 
from inclusion bodies102. The data indicated that although these proteins are able to 
facilitate conversion of ATP to ADP, this reaction is slow by enzymatic standards. 
As the authors note, multiple bands corresponding to either degradation products or 
premature termination of protein translation are present in these assay, which would 
make accurate protein quantification and thus rate measurements more difficult to 
accurately calculate. Due to the difficulties of distinguishing potential artefacts 
associated with refolding, we focused on identifying solubly expressed protein for 
our investigations.  
When examples of soluble R-protein domains are identified, it can lead to novel 
discoveries- Fenyk et al investigated the biochemical function of the nucleotide 
binding (NB) domain of R-proteins when expressed solubly in E. coli. Using these 
materials, the researchers were able to demonstrate that these domains displayed 
phosphatase abilities- hydrolysing ATP not only to ADP as would be expected, but 
also producing AMP, something which would not be anticipated by general models 
based on in vivo data103. 
Two independent studies by Maekawa et al86 and Williams et al130 were recently 
able to demonstrate the expression of full-length MLA27 from barley in insect cells, 
and the resistance protein M from flax in yeast respectively. Despite the low levels 
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of expression both groups were able to quantify the ATP and ADP occupancy of the 
purified proteins, giving the first direct demonstration of the links between activation 
state and ligand binding. The expression of these two full-length proteins represents 
a huge step forward for biochemists interested in characterising intracellular plant 
immune receptors, however further investigations are hampered by the low yields of 
protein. 
Traditional approaches to screen for soluble protein typically use a suite of 
bioinformatics programmes to look for predicted structural domains, disordered 
regions and secondary structure elements to try and rationalise areas of the protein 
that are most likely to produce well behaving constructs. It is possible to use both de 
novo and comparative methods to characterised proteins to aid construct design. 
Protein secondary structures are highly influenced by primary sequence, and so α-
helices, β-strands and intrinsically disordered regions can be predicted using only 
primary sequence. A number of databases can be used to identify probable domain 
boundaries- PFAM131 for example is a useful tool to identify common functional 
domains, which can be combined with secondary structure analysis to allow 
informed construct design. Similarly, homology modelling can be used to identify 
regions that are predicted to form distinct structural features and improve the 
chances of producing a biologically representative construct. This approach can be 
described as low- to medium throughput as screens are typically limited by the 
infrastructure available and information on which to base construct boundaries.  
As obtaining soluble R-protein has proven non-trivial in the past, we took multiple 
approaches to getting well-folded, solubly expressed R-protein. Initially our work 
focussed on utilising modern techniques that may have been unavailable to 
previous groups interested in the biochemistry of R-proteins to identify soluble 
constructs for expression in E. coli. From there we moved on to explore traditional 
construct design to obtain soluble protein from E. coli, before expanding our 
expression systems to include Sf9 expression (insect cells), and N. benthamiana. 
This chapter will discuss the results of these screening experiments, briefly outlining 
the basis of each method. Full methodologies can be found in Chapter 2. 
3.2 High-throughput screening of a high-profile R-protein 
3.2.1 Rationale and theory 
We initially focussed on intensively screening a single R-protein that has been well 
studied historically, and continues to be the subject of active research. We used 
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these criteria so that any structural or biochemical data produced would be 
supported by previous work, and that the tools to further probe the biological 
relevance of any biochemical data would be well-developed. For these reasons we 
decided to focus on S. tuberosum R3a, as its function with regards to recognition of 
P. infestans AVR3a alleles has been well characterised126, 132-134.  
We hypothesised that as high-impact targets, multiple attempts to produce soluble 
R-proteins will already have been made using traditional methods. We took the lack 
of published data using soluble, heterologously expressed proteins as evidence that 
these approaches were insufficient, and therefore decided to collaborate with a 
group specialising in screening proteins for soluble expression.  
Darren Hart’s group at the EMBL in Grenoble have established a system allowing 
the high-throughput screening of a library of truncations of a gene of interest in E. 
coli using an N-terminal histidine tag and a C-terminal biotin-acceptor peptide (BAP) 
(Figure 3.2.1 A)135. The N-terminal histidine tag can be used for protein purification 
using standard nickel IMAC columns, and also to help assess the stability of each 
protein. Biotinylation of the BAP can be used to predict the solubility and stability of 
proteins expressed in E. coli; post-translational biotinylation of proteins is dependent 
on the ability of the modifying enzyme to access the target protein or substrate, in 
this case the BAP. If the protein expressed is misfolded or insoluble it will form 
inclusion bodies, rendering the BAP inaccessible for post-translational modification. 
The misfolded protein will therefore undergo little or no biotinylation, and the use of 
fluorophore-conjugated streptavidin can be used to measure relative biotinylation 
efficiency (Figure 3.2.1 B).  By using time-course digest of a gene of interest, and 
ligating these fragments into the dual-tag vector, this system selects areas of 
sequence space that would not normally be sampled through traditional 
approaches. Colony-picking robots, growing bacteria directly onto nitrocellulose 
membranes and a dual-tagging system, with different excitation and emission 
spectra, make it possible to screen thousands of constructs in a short amount of 
time.  
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Figure 3.2.1 Schematic demonstrating the use of dual-tagged pESPRIT vector for solubility 
screening 
 
3.3 Results and Discussion  
Creation of the library 
Note: Time-course digestion and ligation into the bacterial expression vector was 
performed by Sri Puranik prior to my arrival in Grenoble. All high-throughput 
screening (including both fluorometric screens and western blotting) was performed 
at EMBL in Grenoble with D. Hart’s group. Medium-throughput confirmatory screens 
and downstream expression and processing was performed at JIC. Initial 
expression screens were performed by myself and Sri, with construct ranking and 
western blotting performed by myself and Philippe Mas. 
(A.) Cartoon representation of the results of protein expression using the dual-tagged 
pESPRIT vector. Ligation of time-course digested gene into the vector results in an 
N-terminal histidine tag fusion and a C-terminal biotin-acceptor peptide (BAP). Biotin 
is added to the BAP as an endogenous post-translational modification in E. coli. 
After cell lysis this fragment can be probed for the presence of the histidine tag using 
specific antibodies and for biotinylation with fluorophore-conjugated streptavidin. 
(B.) Representation of the fate of proteins expressed in E. coli and how this is used to 
probe for soluble expression. Soluble, stable proteins are efficiently biotinylated, 
resulting in a strong signal when probed with fluorophore-conjugated streptavidin. 
Unstable or insoluble proteins are either degraded or form inclusion bodies, which 
are less accessible for biotinylation. Measuring both the anti-histidine and anti-biotin 
signals allows determination of the fate of fusion proteins in E. coli. 
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In this project we used R3a coding sequence that had been codon optimised for 
expression in E. coli, and had internal NsiI and AscI sites silenced by synonymous 
mutation synthesised by Shinegene. To generate a non-biased library of R3a 
constructs we used time-course digestion of the gene of interest using DNA 
exonuclease III. We produced two libraries separated at the approximate boundary 
between the NBARC and LRR domains, corresponding roughly to the N- and C-
terminal halves of the protein, and used unidirectional digests to generate the gene 
truncations: 5ʹ->3ʹ digestions for the library corresponding to the C-terminal half of 
the protein, and 3ʹ->5ʹ digests for the library corresponding to the N-terminal half of 
the protein. As these unidirectional digests would create libraries with constant 3ʹ or 
5ʹ ends that could potentially affect the solubility and expression of the genes in E. 
coli, we produced three separate pESPRIT vectors with different 3ʹ or 5ʹ ends for 
each half of the gene, giving a total of six pESPRIT-R3a vectors (Figure 3.3.1). 
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Figure 3.3.1 Translated sequences of N-terminal (left) and C-terminal (right) halves of R3a 
used for library creation 
 
The R3a ORF was translated and divided into an N-terminal half (left) and C-terminal 
half (right). The predicted coiled-coil domain is highlighted in red, the predicted 
NBARC domain in yellow and putative LRR domain in green. Each half of the protein 
was subdivided to produce three sub-libraries, which would give fixed termini during 
time-course digestion. Fixed termini are denoted by †, and the direction of digestion 
indicated by arrows. 
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In order to produce unidirectional digestion libraries, N-terminal encoding and C-
terminal encoding vectors were cut by restriction with AatII and AscI, and NsiI and 
NotI respectively to produce exonucleaseIII susceptible ends. The three N-terminal 
encoding and the three C-terminal encoding linearised vectors were pooled for time-
course digestion. Time course digestion was performed by the addition of ExoIII to 
the pooled vectors, with 1µL aliquots removed each minute and quenched in 2M 
NaCl. Mung bean exonuclease (MBE) treatment was used to produce blunt ends for 
vector ligatation. The MBE treated pooled vectors were then run on a 0.5% agarose 
gel to produce two library smears (N- and C-terminal libraries) and subdivided into 
large, medium and small sub-libraries- this step is important as it allows the 
definition of minimum vector size to promote the selection of biologically relevant 
fragments, and to prevent small fragment dominance for bacterial transformation 
(Figure 3.3.2). The sub-library smears were excised and purified before being 
treated with T4 DNA ligase to circularise the vectors.  
 
Figure 3.3.2 DNA smear resulting from time-course digestion of the N-terminal R3a libraries 
 
The circularised N-terminal and C-terminal libraries were transformed into BL21 
RILAI (BL21AI) strain E. coli, plated on large LB-Agar plates, supplemented with 
kanamycin and chloramphenicol, and left to grow overnight at 37°C to produce 
colonies. Colonies were picked robotically, placed in 384-well plates containing TB- 
HMFM media (terrific broth with hogness modified freezing media- Section 2.4.4), 
Time-course digestion of the N-terminal pESPRIT-R3a vectors visualised as a 
smear on a 0.5% agarose gel. The three vectors corresponding to the N-terminal 
half of R3a with unique fixed termini were pooled and digested by exonuclease III, 
with aliquots removed and quenched every minute. The smear was then 
subdivided into large, medium and small sub-libraries (to prevent smaller 
fragments dominating downstream processing) and these sub-libraries excised 
and DNA extracted for bacterial transformations. 
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and allowed to grow to saturation overnight before storage at -80°C. We selected 
11,000 colonies for the N-terminal library and 12,000 colonies from the C-terminal 
library, oversampling to compensate for the introduction of internal stop codons and 
frame-shifts, producing a total of 60 384-well reference plates stored -80°C. 
 
3.3.1 Library screening 
To screen the library, reference plates were thawed at room temperature and used 
to inoculate fresh 384-well plates containing TB. These plates were grown overnight 
at 37°C with constant shaking, and overnight cultures were then stamped in a grid 
layout in triplicate onto nitrocellulose membranes, which were placed onto LB agar 
plates. These plates were incubated at 25°C overnight to allow bacterial growth 
before the membranes were transferred to LB agar plates supplemented with both 
0.2% arabinose, to induce gene expression, and biotin to allow biotinylation of the 
recombinant protein. Induction was performed for 4-5 hours at 30°C.  
Cells were lysed by subjecting the membranes to alkaline buffer. This allows 
expressed proteins to bind directly to the nitrocellulose membrane at the point 
where the colony was stamped, and thus allows results of expression screening to 
be linked directly back to the appropriate well from the reference culture plates. The 
membranes were washed to remove insoluble and non-proteinaceous cell lysate, 
and probed to detect the presence of the N- and C-terminal tags. Mouse α-histidine 
antibodies were added to each membrane, and incubated for one hour with 
constant rotation. The membranes were then washed before the addition of both the 
secondary antibody (alexa 532-conjugated α-mouse), and the fluorophore-
conjugated streptavidin.    
The stained membranes were then scanned using a Typhoon scanner to detect 
fluorescence, and the intensity of the signals recorded (Figure 3.3.3).  
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Figure 3.3.3 In situ western blot showing anti-histidine and streptavidin signal of bacterial 
colonies expressing recombinant R3a fragments 
 
Intensities of both the anti-histidine and streptavidin signals were averaged over the 
three replicates and the colonies were ranked by intensity of the histidine signal. 
The top-ranking 48 N-terminal library constructs and the top 47 C-terminal 
constructs were selected for further testing, with maltose-binding protein (MBP) 
included as a positive control. These colonies were picked from the reference plates 
and used to inoculate a 96-deep-well plate containing TB. This plate was incubated 
overnight at 37°C before 10% glycerol added and stored at -80°C for downstream 
screening.  
To test for solubility during expression in liquid culture and identify false-positives, 
the 96 constructs were grown at small scale (4mL cultures). Expression was 
induced by the addition of arabinose, and cultures incubated at 25°C overnight. 
Cultures were pelleted and sphaeroplasts prepared as described in Section 2.4.5. 
Left: Bacteria gridded onto six nitrocellulose membranes and incubated to form colonies, 
which were then induced with IPTG. Lysing the colonies directly on a nitrocellulose 
membrane in alkaline solution allows the proteins expressed in each colony to bind in place, 
and so single spots can be attributed to individual wells from the 384-well reference plates. 
Once proteins are bound to the membrane, anti-histidine antibodies and streptavidin can be 
applied, and by using fluorescent probes it is possible to identify and quantify colonies 
expressing one, or both tags.  Right: close up of a section of nitrocellulose membrane. 
Green indicates the presence of biotinylated proteins, red shows histidine-tagged proteins, 
co-localisation appears as yellow.  
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Sphaeroplasts were lysed by freeze-thaw, and the addition of a lysis buffer 
containing 0.5% Brij. Solubility was tested by low-stringency nickel purification of 
soluble lysate, clarified by centrifugation, followed by western blotting (Figure 3.3.4).  
 
Left: α-histidine signal Right: α-biotin signal
 
Figure 3.3.4 Western blot analysis of small-scale growth and expression of the top 95 
colonies identified in the fluorometric screen 
 
As can be seen by the number of blank lanes for either the α-histidine signal or the 
α-BAP signal, the fluorometric screening was susceptible to false-positives, 
reducing the number of constructs available for downstream screening. 
The highest ranking 48 colonies for the N-terminal half and the highest ranking 47 colonies for 
the C-terminal half of R3a were selected for small-scale protein expression in liquid media. 
After expression was induced, lysate underwent low-stringency nickel IMAC and separation by 
SDS-PAGE. Probing with α-histidine antibodies (left) and fluorophore-conjugated streptavidin 
(right) reveals a large number of colonies selected from the fluorometric screen that do not 
appear to produce histidine-tagged, or biotinylated proteins (such as lanes 70-74). Constructs 
numbered 1-48 are the ranked-values of colonies for the N-terminal R3a library, colonies 49-95 
are the top-ranking colonies 47 colonies on the basis of fluorescent signal (where colony 49 
represents the highest scoring colony and 95 represents the 47th highest-scoring colony). Lanes 
highlighted in yellow indicate constructs capable of soluble expression at small-scale tests. 
Lanes highlighted in red indicate constructs taken through for large-scale expression and tag 
removal. 
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Positive colonies identified in the western-blotting screen were tested for 
reproducibility in small-scale screens, and soluble yield in the absence of IMAC 
purification. These colonies were grown in 24-well plates with 4mL LB overnight at 
37°C with constant shaking. Overnight cultures were used to inoculate fresh media 
and allowed to grow for ~4 hours to reach an approximate OD600 of 0.6. Culture 
densities varied widely, typically from 0.3 to 0.9, possibly due to the effects of leaky 
expression of different constructs. Expression was induced by the addition of 0.2% 
arabinose and the cultures incubated at either 37°C for a further 4 hours or at 18°C 
overnight. Cells were pelleted by centrifugation and lysed in 0.4-0.8mL lysis buffer 
(500mM NaCl, 20mM HEPES pH 7.5, 0.5mM PMSF) by sonication. Insoluble 
lysates were removed by centrifugation and clarified lysate loaded onto 17% SDS-
PAGE gels to check expression by coomassie staining (Figure 3.3.5).  
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Figure 3.3.5 SDS-PAGE and coomassie staining of small-scale expression screens to 
assess solubility of positive candidates from low-stringency IMAC and western blotting 
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We were able to identify few well-expressing constructs under these conditions, and 
so performed screens to optimise expression conditions. Constructs were 
transformed into SoluBL21, BL21* and C41 strains of E. coli to look for strain-
dependent expression effects. SoluBL21 and BL21* were both chosen due to their 
purported efficacy for producing soluble protein, with the inclusion of C41 cells as 
these cells are able to express many toxic proteins.  
 Alongside screening different bacterial strains we investigated the effect of different 
additives on protein solubility. Strain-by-additive screens were performed by 
growing individual constructs in 24-well plates in LB overnight, and using these 
cultures to inoculate fresh 24-well plates, typically screening two constructs in three 
expression strains with wells set up in quadruplicate. When cultures had reached 
OD600 of 0.6 +/- 0.3 they were rapidly chilled on ice and subjected to the appropriate 
additive (0.4% ethanol, 0.5% DMSO, 10% glycerol, or 0.5mL LB) immediately prior 
to induction with 1mM isopropyl β-D-1-thiogalactopyranoside (IPTG), or 0.2% 
arabinose for BL21AI strain. A typical 24-well block layout is described in Figure 
3.3.6 
1 2 3 4 5 6
A LB LB LB LB LB LB
B DMSO DMSO DMSO DMSO DMSO DMSO
C Ethanol Ethanol Ethanol Ethanol Ethanol Ethanol
D Glycerol Glycerol Glycerol Glycerol Glycerol Glycerol
BL21 SoluBL21 BL21* BL21 SoluBL21 BL21*
Construct 1 Construct 2
 
Figure 3.3.6 Typical layout of a 24-well plate used to optimize soluble expression of 
recombinant R3a fragments 
Colonies were grown in 24-well blocks at 37°C and induced by the addition of 0.2% 
arabinose once average OD600 reached 0.6. Whole-cell lysates show accumulation of unique 
bands for most constructs tested, however comparison with total soluble protein shows very 
little enrichment for the majority of constructs. Bands corresponding to solubly expressing 
recombinant proteins are indicated by *. Lane numbers refer to colony ranked values from 
fluorometric screening. Performing induction at 18°C (not shown) resulted in improved 
solubility for very few constructs. 
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Cells were left at 18°C with constant shaking for protein expression to continue for 
16 hours. Plates were then processed as described in Section 2.6. Using this 
method it was possible to identify expression conditions that appeared to give a 
significant boost to soluble expression of certain constructs (Figure 3.3.7). The 
conditions allowing soluble expression of R3a constructs are summarised in Table 
3.3.1. 
LB only
+0.5% 
DMSO
Whole-cell lysate Soluble fraction
*
 
Figure 3.3.7 Coomassie stained SDS-PAGE gel showing the boost in soluble expression by 
the addition of 0.5% DMSO 
 
To allow medium-throughput screening of strain and additive conditions that may boost soluble 
expression of constructs, bacterial growth and expression was performed in 24-well blocks. These 
blocks were typically divided to allow testing of two constructs, each in three expression strains- 
for example columns 1, 2 and 3 may contain soluBL21, BL21* and C41 transformed with construct 
1. These bacteria were grown overnight and used to inoculate fresh media in quadruplicate (lanes 
A, B, C and D) and allowed to grow to an OD600 of 0.6. Once the target OD was reached, blocks 
were chilled on ice and supplemented with either 0.5% DMSO, 0.4% ethanol, 10% glycerol or 
0.5mL LB immediately prior to the addition of 1mM IPTG. After incubation for a further 16 hours at 
18°C cells were pelleted by centrifugation in the plates and soluble expression assessed by SDS-
PAGE. 
Additive screens were able to identify specific conditions that could lead to dramatic 
increases in soluble protein expression. In this example supplementing the growth 
media of construct #66 in BL21AI with 0.5% DMSO lead to a much stronger band in the 
total soluble protein extract (bottom left panel) than when expression was performed in 
LB alone (Top panels). The band predicted to correspond to soluble construct #66 is 
highlighted by *. 
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These constructs, named as their ranked values from the fluorometric solubility 
screens, were sent for sequencing to prioritise those most likely to yield biologically 
interesting protein. The regions of R3a covered by these constructs are shown 
schematically in Figure 3.3.8. Purified plasmid for constructs #1, #15 and #55 were 
treated with BspE1 to cleave the BAP and re-ligated to give R3a fragments fused to 
a single, N-terminal, histidine tag that could be removed post-translationally by TEV 
protease. As the BAP is a small tag predicted to have little effect on the solubility of 
the fusion proteins, these constructs were then used for large-scale protein 
purification after sequencing confirmed BAP removal and proper re-ligation. 
Construct Strain Media Additive 
#1(21-120) 
BL21
AI
 LB - 
soluBL21 LB DMSO 
#3(161-589) SoluBL21 LB DMSO 
#4(161-228) BL21
AI
 LB - 
#5(21-224) 
 
soluBL21 LB DMSO 
BL21* LB - 
#15(161-410) 
 
soluBL21 LB DMSO 
soluBL21 AIM - 
#48 (Frame shift) 
 
soluBL21 AIM DMSO 
soluBL21 LB DMSO 
#55(1143-1282) 
 
BL21
AI
 LB DMSO 
BL21
AI
 LB Glycerol 
#58(1141-1282) BL21* LB - 
#66(1180-1282) BL21
AI
 LB DMSO 
#75(1181-1282) BL21
AI
 LB - 
#77(1227-1282) BL21
AI
 LB 37°C 
#78(1150-1282) BL21
AI
 LB 37°C 
#84(1185-1282) 
 
BL21
AI
 LB DMSO 
BL21
AI
 LB Glycerol 
#90(1186-1282) BL21
AI
 LB 37°C 
#93(21-343) BL21
AI
 LB 37°C 
 
Table 3.3.1 Summary of conditions required for soluble expression of R3a 
constructs 
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Coiled-coil NBARC Leucine-rich repeat regionN COOH
#5
#15
#55
#66
#84
#1
#4 #58
#75
#75
#78
#3
#93
 
Figure 3.3.8 Cartoon representation of the regions covered by solubly-expressing 
R3a fragments 
Screening multiple strain and additive combinations allowed the soluble expression of 
several R3a fragments. Construct numbers relate to their rankings from fluorometric 
screening and numbers in parentheses denote the amino-acids of R3a these constructs 
span. All protein inductions for growth in LB media were performed by rapidly chilling 
cultures prior to addition of 0.2% arabinose (for BL21AI) or 1mM IPTG. Protein 
expression was performed for 16 hours at 18°C as standard- constructs that expressed 
solubly only when grown at 37°C for 4 hours are highlighted in the “additive” column. 
DMSO indicates constructs that required the addition of 0.5% DMSO prior to induction 
for soluble expression. Those labelled glycerol required the addition of 10% glycerol, 
and those marked with “-“ required no additive to produce soluble protein. Growth and 
expression in auto-induction media (AIM) was performed by inoculating fresh AIM with 
saturated overnight cultures to a target OD520 of 0.05, and expression performed for 16 
hours at 18°C. 
Constructs encoding R3a fragments that could be expressed solubly were sent for 
sequencing to prioritise those of most biological interest. The sections of R3a each of 
these construct spans is approximated by the bar length and positioning (for example 
construct #1 spans ~ ¾ of R3a’s predicted coiled-coil domain, whereas construct #5 
extends to include a small section of the NBARC domain). No soluble constructs starting 
from the native N-terminus were identified, however soluble constructs were found to 
begin at both the start of the predicted CC domain, and the end of this region. Only LRR 
constructs using the endogenous C-terminus were identified as expressing solubly, with 
no examples of soluble expression from either alternative C-terminal regions.  
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3.3.2 Large-scale expression of single, N-terminally tagged R3a 
fragments 
Removal of the biotin-acceptor tag for the pESPRIT vector and re-ligation allows 
expression of individual constructs with only an N-terminal histidine tag that can be 
removed proteolytically. We removed the C-terminal BAP from several constructs 
that were identified as screening solubly and re-screened these for soluble 
expression. Three of the resulting constructs were identified as expressing solubly 
in E. coli and so were used for large-scale expression and purification. 
3.3.2.1  R3a construct #1 (coiled-coil region) 
 
Construct #1∆BAP (R3a21-120) was expressed in 8xL of LB in soluBL21 with the 
addition of 0.5% DMSO immediately prior to induction with 1mM IPTG and protein 
expression performed for 16 hours at 18°C. Cells were pelleted by centrifugation, 
re-suspended in A1 buffer (500mM NaCl, 20mM HEPES pH 7.5, 10% glycerol) with 
protease inhibitor cocktail, and cells lysed by sonication. Insoluble cell debris were 
removed by centrifugation and the clarified lysate underwent a two-step purification 
programme- nickel-affinity IMAC on a pre-equilibrated 5mL column, followed by 
preparative gel filtration using a sepharose S75 superdex column. Analysis of the 
fractions by SDS-PAGE indicated that the construct was still expressed solubly 
following BAP removal, and could be purified with few contaminants (Figure 3.3.9).  
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Figure 3.3.9 Size-exclusion chromatography purification of construct #1 following 
nickel-affinity IMAC 
 
When the protein was concentrated it was discovered that above ~0.5mg/mL it 
precipitated. In order to overcome this issue, dynamic light scattering (DLS) was 
used to identify buffer conditions in which the protein may be less likely to form 
insoluble aggregates. Protein concentrated to 0.5mg/mL was diluted 1:1 with the 
appropriate buffer conditions and incubated for 30 minutes prior to DLS 
measurements. 
Size-exclusion chromatography of soluble protein from 8L expression of construct #1 
without the C-terminal biotin acceptor peptide (BAP) after total soluble protein has been 
purified by nickel-affinity IMAC to enrich histidine-tagged protein. Gel filtration trace (top) 
shows the protein eluting as two major peaks- one corresponding to the void-volume of 
the column (peak 1, ~110mL), and a second peak at approximately 160mL. Void-volume 
elution is indicative of either insoluble protein, or the formation of large (>75kDa) 
complexes or aggregates. SDS-PAGE analysis of both peaks (bottom) shows a band of 
the expected molecular mass for this construct, indicated by arrow, in both the void-
volume, and non-void-volume peaks, with few contaminants. The main contaminant co-
eluting across all fractions is highlighted by *; the absence of further contaminants under 
peak 1 may be indicative of construct #1 aggregation, rather than forming a complex with 
contaminating proteins. 
* 
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Initial screens using additives frequently used to decrease the polydispersity of 
proteins prior to setting up crystallisation trials were unable to identify single 
components capable of significantly decreasing the average particle size in solution 
(Table 3.3.2). 
Treatment R (nm) MW (kDa) 
KCl 31.7 10913 
CaCl2 47.2 27752 
NH4Cl 31.1 10504 
(CH3)2AsO2H 29.6 9310 
Na2SO4 39.1 17925 
LiCl 32.2 11325 
NaCl 29.5 9217 
Table 3.3.2 Effect of protein additives on particle radius by DLS 
 
Although certain additives can prevent aggregation of specific proteins, this 
phenomenon is difficult to generalise, and DLS is not suitable for high-throughput 
screens. As none of these commonly used additives had a significant effect on the 
average particle size, we decided to take a more systematic approach using a more 
generalised method. A key determinant of protein-protein interactions is the buffer 
pH, as this can have a dramatic effect on side-chain charges and thus the 
properties of interaction interfaces. Additionally, the presence of salts such as 
sodium chloride can stabilise proteins in solution, or disrupt salt bridges. We 
therefore decided to perform a pH and NaCl screen to identify improved buffer 
conditions, around which further optimisations could be performed (Table 3.3.3). 
 
 
 
DLS measurements of the average particle size of R3a construct #1 and corresponding 
predicted molecular weight. Dilution of construct #1 into 0.1M solutions containing either 
cacodylic acid or NaCl resulted in a small decrease in molecular mass, although well 
above the predicted molecular mass of monomeric protein (~14.5kDa). 
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pH NaCl (mM) R (nm) MW (kDa) 
6.5 0 50.6 32628 
6.5 500 109.1 197185 
7 0 54.6 39073 
7 500 38.2 16925 
7.5 0 16 2213 
7.5 500 3.2 51 
8 0 6.7 292 
8 500 41.3 20297 
8.5 0 5.6 192 
8.5 500 34.4 13297 
 
Table 3.3.3 pH and salt screen to identify suitable buffer conditions for non-
aggregated R3a construct #1 
 
Incubation of the protein at pH 7.5, with the addition of 500mM NaCl led to a 
significant decrease in particle size, and corresponding decrease in predicted 
molecular weight in solution. As the addition of sodium chloride did not have a 
predictable effect on the behaviour of this protein, in many cases the addition of the 
salt led to an increase in particle size, we decided to assay the effect of increasing 
salt concentration on particle size at pH 7.5 (Table 3.3.4). 
 
 
 
 
DLS screening of purified R3a construct #1 against different pH Bis Tris propane 
(BTP) buffer with and without 500mM NaCl found that diluting the protein in buffer 
at pH 7.5 with 500mM NaCl led to a dramatic decrease in particle size and 
corresponding predicted molecular weight. Interestingly the addition of NaCl did not 
have a predictable effect on particle size, with added salt leading to an increase in 
particle size at pH 6.5, 8.0 and 8.5.  
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NaCl (mM) R (nm) MW (kDa) 
0 15.2 1949 
100 4.7 125 
200 5.2 159 
300 5.5 181 
400 ND ND 
500 1.4 8 
 
Table 3.3.4 Effect of increasing salt concentration on size of R3a construct #1 
aggregates 
Measurements of particle size appeared to indicate a dramatic decrease in 
response to increasing salt concentration, which would suggest that under these 
conditions the protein is less likely to form aggregates. The last two conditions 
however, suggested that the protein had formed particles with a molecular mass 
significantly less than that of a monomer. Furthermore, comparison of the particle 
size at pH 7.5 with 500mM NaCl from this assay with identical conditions performed 
at an earlier time point (Table 3.3.3) showed a significant difference in predicted 
molecular mass. 
We suspected that this dramatic change in molecular mass was related not to 
reduction of aggregation, but by the protein undergoing degradation. We tested this 
by running SDS-PAGE of samples of protein collected over multiple time points and 
found that the protein was degrading over time (Figure 3.3.10). This degradation 
meant that we were unable to identify conditions reducing protein aggregation, and 
thus were unable to further purify this construct.  
DLS measurements of particle size of R3a construct #1 diluted in BTP pH 7.5 
supplemented with increasing concentrations of NaCl showed erratic responses to 
salt, however generally the addition of NaCl decreased average particle size. No 
condition was identified that corresponded to a predicted molecular mass of 
monomeric (14.5kDa) or dimeric protein (29.0kDa). The last two conditions indicate 
a molecular mass smaller than that of monomeric protein, and more importantly, 
smaller than identical conditions from previous experiments (pH 7.5 + 500mM NaCl 
with a particle radius of 50nm, Table 3). ND- not determined. 
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Figure 3.3.10 SDS-PAGE analysis of R3a construct #1 stability over time 
 
3.3.2.2 R3a construct # 66 (C-terminal LRR region) 
 
Construct #66∆BAP (R3a1180-1282) in BL21AI was grown in 8L of LB and induced with 
arabinose with 0.5% DMSO added immediately before induction. Protein expression 
continued for 16 hours at 18°C. Cell harvesting, and lysis were performed in the 
same manner as construct #1. Protein was purified by nickel IMAC followed by gel 
filtration on a superdex sepharose S75 column (Figure 3.3.11). 
Coomassie stained 17% SDS-PAGE gel of construct #1 samples taken from 3, 5, 7 
and 14 days storage at 4°C. The end lane shows protein sample flash frozen in liquid 
nitrogen and stored at -80°C after 24 hours storage at 4°C. Arrow indicates predicted 
size of construct, migration to lower molecular mass, indicative of degradation may 
indicate loss of N-terminal histidine tag. 
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Figure 3.3.11 R3a construct #66 purification  
 
A large proportion of this protein eluted in the void-volume of the column, indicating 
either a complex with high molecular-weight contaminants, or formation of large 
aggregates. SDS-PAGE reveals that protein eluting away from the void volume 
(peak 2) migrates as lower molecular mass protein than expected. This lower 
molecular mass species could be either degradation of the target protein, or may be 
an undesired contaminant co-purifying with this construct. Low yields of the protein 
meant that we were unable to perform N-terminal tag cleavage and a second round 
of purification with this construct. 
 
 
 
Top: preparative gel filtration of R3a #66 following IMAC. A significant proportion of 
protein is present in the column void-volume (~110mL), suggesting large molecular 
weight or insolubility. 
Bottom: SDS-PAGE and coomassie staining of fractions eluting from the column. Peak 1 
fractions consist of a protein of the expected molecular weight, with a high-molecular 
weight contaminant co-eluting. Peak 2, distinct from the void-volume, is populated by 
proteins with a lower than anticipated molecular mass, indicating either a contaminant, 
or degradation of the target protein. 
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3.3.2.3 R3a construct # 15 (N-terminal NBARC region) 
 
The yield and purity of construct #15 was investigated by purification of this protein 
from 8L of soluBL21 E. coli. At the point of induction with 1mM IPTG, cultures were 
supplemented with 0.5% DMSO, and protein expression performed for 16 hours at 
18°C. Soluble protein was purified by IMAC and gel filtration (Figure 3.3.12). 
 
Figure 3.3.12 gel filtration trace of R3a construct #15∆BAP  
 
The low A280 of the protein fractions, combined with the presence of multiple peaks 
(seen as “shoulders” where they overlap) indicate that despite the large cultures 
used, total soluble protein yields remain very low, and unlikely to be high-purity.  
In a further attempt to improve yields of purified protein, these three constructs were 
cloned into the pOPIN-F vector, which uses 3C protease to post-translationally 
cleave the N-terminal histidine tag. However, this change in vector did not lead to a 
significant increase in protein yield or purity (data not shown).  
Purification of R3a construct #15∆BAP after nickel-affinity IMAC suggests a large 
proportion of the protein is insoluble or in large molecular-weight complexes, with a 
relatively large elution peak at 110mL (column void-volume). A second major peak can 
be identified at approximately 175mL with a minor peak that partially overlaps, at 
approximately 160mL. These additional peaks may indicate different oligomeric states, 
co-purification with contaminants, or degradation of target protein during purification.  
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3.4 Rational design of R3a constructs 
3.4.1 Defining construct boundaries 
Alongside the assessment of the constructs from the high-throughput screening, a 
number of R3a constructs were designed using traditional bioinformatics-led 
approaches. Scorer2.0 (http://coiledcoils.chm.bris.ac.uk/Scorer/), PFAM 
(http://pfam.xfam.org/) and LRRfinder (http://www.lrrfinder.com/lrrfinder.php) were 
used to identify putative boundaries for the coiled-coil, NBARC and LRR domains 
respectively. This information was supplemented with RONN disorder analysis 
(https://www.strubi.ox.ac.uk/RONN) to try and limit the inclusion of N- or C- terminal 
disordered regions in the constructs. As PFAM predictions of the NBARC domain 
did not extend to cover the MHD motif, a highly conserved motif shown to be 
involved in the regulation and activation of several R-proteins, the NBARC construct 
was extended to include this region. Secondary structure prediction by PHYRE2 
was used to prevent construct termination mid-secondary structure, which may 
destabilise expressed proteins. A summary of these predictions and the eventual 
domain boundaries used is presented in Table 3.4.1.  
 
Prediction Notes Boundaries 
used
Rationale
CC 29-119 Start mid-helix 20-160 Includes additional helix (124-150)
NBARC (PFAM) 180-463 Excludes MHD motif 161-583 Includes MHD and surrounding SS 
elements
LRR (PFAM) 585-1238 Terminates in disordered 
region
584-1249 Extends to end of β-strand
LRR
(LRR FINDER)
412-1282 Start within predicted 
NBARC
N-terminal 
disorder
-
C-terminal 
disorder
1153-1238
 
Table 3.4.1 Summary of R3a domain boundaries 
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3.4.2 Cloning and expression screening 
These domains were cloned into the pOPIN-F (hist-tag:ORF) and pOPIN-M (his-
tag:MBP:ORF) vectors and screened for soluble expression as described in Section 
2.8.1. A construct spanning the coiled-coil domain of R3a in pOPIN-F (R3a20-160) 
appeared to express well in small-scale screens in soluBL21 (Figure 3.4.1), and so 
was selected for large-scale expression. We were unable to identify conditions that 
resulted in soluble expression of either the NBARC or LRR domain when assessed 
by SDS-PAGE and coomassie staining. 
 
Figure 3.4.1 Total soluble protein from R3a CCF-1 expression trials 
R3a domain boundaries were predicted using multiple bioinformatic servers. The CC domain 
was extended to include an N-terminal helix omitted from the Scorer2.0 CC prediction. PFAM 
prediction of the NBARC domain terminated before the highly conserved MHD motif, and so 
this construct was extended to include this motif, as well as the neighbouring secondary 
structure elements to increase stability and preserve biological context for this region. As 
LRR domains are highly variable and poorly characterised, both PFAM and LRRfinder were 
used to determine the start of this region. Given the difficulties in confidently predicting this 
structural unit, the LRR was designed to begin at the point of NBARC termination. Disorder 
prediction by RONN identified no significant disorder at the N-terminus of R3a and an island 
of disorder towards the C-terminus, however the very C-terminal region was not predicted to 
be intrinsically disordered. Additional information regarding the predicted secondary structure 
elements was provided by PHYRE2 and used to limit premature termination within structured 
regions. 
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250mL of LB was used to grow R3a20-160 overnight at 37°C with constant shaking. 
This overnight culture was then used to inoculate 4L of LB, which were grown to an 
OD600 0.6 before being rapidly chilled on ice. Protein expression was induced by the 
addition of 1mM IPTG, and cultures incubated at 18°C for 16 hours. Clarified lysate 
was produced as described in Section 2.8.1, and purified in a two-step procedure; 
nickel IMAC followed by gel filtration on a superdex S75 sepharose column.  
SDS-PAGE of the fractions following gel filtration showed a number of contaminants 
co-eluting with the target protein, however the large amounts of protein of the 
correct approximate molecular mass indicated that a second round of purification 
may remove these contaminants while retaining sufficient yields of target protein. 
Fractions were pooled and concentrated to ~10mL, with no signs of aggregation, 
and the N-terminal histidine tag removed by incubation with 3C protease overnight 
at 4°C. Cleaved protein was purified by nickel-affinity IMAC, with flow-through and 
washes collected and pooled to <5mL. This protein solution was then loaded onto a 
superdex S75 column for buffer exchange, further purification, and to check that the 
protein eluted away from void-volume, which would indicate protein aggregation or 
insoluble protein (Figure 3.4.2).  
Coomassie stained SDS-PAGE gel of expression trials of the coiled-coil domain of R3a 
in soluBL21 show good levels of soluble protein under three of four expression 
conditions. Bacterial cultures were incubated at 18°C with constant shaking after 
induction with 1mM IPTG. Arrow indicates band migration consistent with the predicted 
molecular weight of the construct.  
 Page 101 of 232 
 
-10.00
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
0.00 50.00 100.00 150.00 200.00
A
2
8
0
 (
m
A
U
)
Elution volume (mL)
36 kDa
16 kDa
50 kDa
64 kDa
98 kDa
250 kDa
6 kDa
 
Figure 3.4.2 Gel filtration trace and collected fractions of R3a20-160 after his-tag 
removal 
 
Gel-filtration traces of the construct following histidine tag removal showed that the 
protein eluted as a single, broad peak with a maximum absorbance at 160.7mL, 
which correlates to a protein with molecular mass of approximately 38.8kDa, which 
does not correspond well to either dimeric (~32.2kDa) or trimeric (~48.3kDa) 
protein. However, this method is not very appropriate for accurate protein mass 
determination in this instance, as a key assumption if that the proteins are roughly 
globular. Coiled-coil proteins such as MLA10 may take on a much more elongated 
structure86, altering the way in which they migrate through the column.  SDS-PAGE 
analysis of the fractions (Figure 3.4.2, bottom) showed that the protein eluted with 
very few contaminants, and so these fractions were pooled and concentrated. This 
protein was expected to migrate with the lysozyme MW marker band (16kDa), 
however the band corresponding to the target protein has an apparent lower 
molecular mass. Native protein was sent for intact mass spectrometry (MS), and a 
R3a20-160 treated overnight with 3C protease was purified by nickel IMAC to remove 
residual tagged protein, 3C protease and negatively charged contaminants. Flow-through 
and washed were pooled and concentrated to <5mL to improve resolution of size-
exclusion chromatography. Top, separation of proteins on a superdex S75 column shows 
a predominant peak at ~160mL with a minor, less well defined peak at ~120mL. Bottom, 
SDS-PAGE of fractions collected from the major peak shows a single band of 
approximately the correct molecular mass with few contaminants or degradation products.  
 Page 102 of 232 
 
single peak corresponding to a mass of 16192.0Da identified (Appendix), which is 
within the margin of error for the predicted mass 16191.39Da.  
Despite being very similar to construct #1 identified in the high-throughput screen 
(the difference being a C-terminal extension of 40 amino acids), this coiled-coil 
construct showed none of the issues with aggregation or stability, and so was 
determined to be appropriate for down-stream experiments.  
3.5 Medium-throughput screening of Solanaceous coiled-coil R-
proteins 
Note: Cloning was performed by Richard Hughes (JIC). Initial screens in E. coli 
were performed by Richard Hughes and Heather Rada at Oxford Protein Production 
Facility. Screening in insect cells was performed by Heather Rada. 
Having demonstrated that rational design of R-protein constructs was able to yield 
soluble protein from E. coli expression, we decided to investigate whether other R-
protein domains could be expressed solubly, as the differences in protein 
sequences between these proteins may result in differences in expression in this 
heterologous system. We additionally broadened our expression systems to include 
both E. coli and insect cells as we hypothesised that the complex eukaryotic cell 
environment may be more suitable for the expression of these proteins.  
3.5.1 Construct design 
Constructs spanning the full-length ORF, predicted coiled-coil, NBARC and LRR 
domains were designed for Solanum tuberosum R3a, S. demissum R2, S. 
lycopersicum I-2, S. bulbocastrum Rpi-blb2, S. lycopersicum NRC1 and N. 
benthamiana NRC1-like following a similar workflow as described for R3a in Section 
3.4.1. The results from these prediction servers are summarized in Table 3.5.1. As 
we were able to express the coiled-coil domain of R3a, we also used sequence 
alignments between these R-proteins and R3a to help define the boundaries for the 
coiled-coil domains. Each construct was cloned into pOPIN-F and pOPIN-S3C 
(his:SUMO:ORF) and transformed into the E. coli strains LEMO and Rossetta 2, as 
well as used in baculovirus-mediated transformation of insect-cell cultures. 
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Table 3.5.1 Summary of domain predictions and domain boundaries used for R-protein 
cloning 
 
 Page 104 of 232 
 
3.5.2 Initial Screens (performed at OPPF by R. Hughes) 
Transformants were placed in 96-deep-well plates and grown in PowerBroth (PB) 
overnight at 37°C with constant shaking. Overnight cultures were used to inoculate 
3mL of fresh PB in four 24-well blocks, and incubated until an average OD600 of 0.5 
was reached. Cultures were cooled to approximately 20°C before gene expression 
induced by the addition of 1mM IPTG, with expression continuing at 18°C overnight. 
1mL of overnight culture was transferred to a 96-deep-well block and cells pelleted 
by centrifugation. After centrifugation, media was removed and cells frozen at -80°C 
for over 20 minutes. Cells were lysed by thawing at room temperature and 
resuspension in buffer containing detergent (TWEEN 20) and lysis clarified by 
centrifugation. 1mL soluble extract was added to a 96-well flat bottomed plate 
containing washed Ni-NTA magnetic beads and incubated for 30 minutes. Beads 
were removed magnetically, washed, and bound proteins eluted before loading onto 
SDS-PAGE gels for separation and visualising by coomassie staining (Figure 3.5.1). 
Medium-throughput screens of E. coli expression were able to identify soluble 
expression of the coiled-coil domains of R3a, I-2, R2, NRC1 and NRC1-like, and the 
NBARC domain of NRC1 all in pOPIN-S3C in BL21 LEMO cells. Interestingly the 
results of expression trials in insect cells were unable to identify any constructs 
expressing solubly that were not found in the E. coli screen (data not shown).  
We then tested these constructs in-house to see if this soluble expression was 
reproducible, and whether soluble expression could be seen without the initial low-
stringency nickel IMAC and detergent. These constructs were grown in LB overnight 
at 37°C, and overnight cultures was used to inoculate 2L fresh PB. Once cells had 
reached an OD600 of 0.6, cultures were rapidly chilled, induced by the addition of 
1mM IPTG and incubated at 18°C for 16 hours. Cell pellets were re-suspended in 
A1 buffer with protease inhibitor, lysed by sonication and processed as described in 
Section 2.8.1. Clarified lysate was purified by nickel IMAC followed by gel filtration 
to assess solubility. All six constructs appeared to express solubly under these 
conditions, although yields were not very high. 
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Figure 3.5.1 Coomassie stained SDS-PAGE of E. coli expressed R-proteins and 
their domains in pOPIN-F and pOPIN-S3C 
 
3.5.3 Large-scale expression and purification 
Having identified conditions allowing for soluble expression, we decided to test 
large-scale expression of these constructs to determine approximate protein yields 
and purity.  
4L of PB was inoculated with overnight cultures for each construct and induced by 
addition of 1mM IPTG after rapid chilling on ice. Cultures were grown for a further 
16 hours at 18°C, and harvested and processed as described in Section 2.8.1. 
Clarified lysates were loaded onto pre-equilibrated Ni-NTA columns and bound 
proteins eluted directly onto a superdex S75 column. Fractions were collected only 
when a minimum A280 threshold had been reached, with the exception of NRC1 
coiled-coil domain for which all fractions were collected, as this construct lacks 
tryptophan residues required for efficient absorbance at this wavelength. The coiled-
coil domain appeared to express solubly, however low yield meant that the A280 did 
not reach the threshold for collection (20mAU), and so purity could not be assessed. 
The coiled-coil domains of I-2, NRC1 and NRC1-like, as well as the NBARC domain 
from NRC1 all expressed reasonably well. Gel filtration fractions for these proteins 
were pooled individually, and the N-terminal tag removed by overnight incubation 
with 3C protease at 4°C. The coiled-coil domain of R3a expressed solubly in this 
SDS-PAGE soluble extract from E. coli expressing CNL R-proteins and their domains 
cloned into pOPIN-F and pOPIN-S3C following nickel IMAC shows a number of soluble 
constructs. Positive constructs are clearly identifiable in lanes: 5 (R3aCC-F); 6 (R3aLRR-
S3C); 7 (R3aFL-S3C); 13 (R2CC-S3C); 15 (R2CC-S3C); 21 (I-2CC-S3C). Gel from Richard 
Hughes. 
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instance, however yields were too low for the protein to undergo tag removal, and 
given the identification of a well-expressing construct this protein was not prioritised 
for purification. Purification of coiled-coil domains of R2, I-2, NRC1, and NRC1-like 
can be seen in Figure 3.5.2    
 
Figure 3.5.2 Purification of the coiled-coil domains of solanaceous CNL coiled-coils 
 
3.6 Troubleshooting NRC1 NBARC point mutant expression 
The NBARC domain of NRC1 has been a major part of the work performed in this 
project. A detailed explanation of the work performed with this construct is 
presented in Chapter 6.  Generation of mutants in this protein has been of high 
importance, and multiple approaches taken to obtain material. As such we present 
here a short explanation of the insect cell expression screens performed to generate 
material. 
Point mutants in the NBARC domain of NRC1 could not be expressed solubly in E. 
coli despite extensive screening efforts. As the wild-type protein could be expressed 
Two-step purification of coiled-coil domains of CNLs in pOPIN-S3C by nickel IMAC 
followed by gel filtration. A.) The coiled-coil domain of R2 appears to show some soluble 
expression, however due to low yields (minimum A280 for collection of 20mAU not 
exceeded) fractions could not be collected for SDS-PAGE. B). SDS-PAGE and gel 
filtration of I-2 coiled-coil domain following tag removal. C.) SDS-PAGE of pooled and 
concentrated NRC1-like coiled-coil following tag removal and gel filtration (trace shown 
to the right) D.) SDS-PAGE and gel filtration trace for NRC1 coiled-coil following tag 
removal. Protein yields for this construct were reasonable- low A280 recorded results from 
a lack of absorbing residues in this protein.  
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in insect cells with only an N-terminal histidine tag, we screened the point mutants in 
both pOPIN-F and pOPIN-S3C for soluble expression in this expression system. 
Surprisingly we were unable to detect expression of four of the seven point mutants 
in insect cells regardless of the tag used. Only one mutant appeared to express to a 
similar level as the wild-type protein, with marginal expression for the remaining two 
(Figure 3.6.1). 
6.5 kDa
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24 kDa
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45 kDa
66 kDa
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Figure 3.6.1 Low-stringency purification of NRC1 point mutants expressed in Sf9 
cells 
 
These three constructs (wild-type, D268N and D268N_D267N) were then scaled up 
to 2.5L insect cell expression, pelleted and frozen at -80°C. Pellets were thawed in 
lysis buffer and lysed by cell disruption (Constant Cell disruption systems). Cell 
lysate was clarified by centrifugation. Benzonase was added to the supernatant and 
incubated at room temperature for 15-30 minutes before passing the supernatant 
through 0.45µm filters. Proteins were then purified in a two-step process, similar to 
that of E. coli-derived proteins, however using buffers optimised for insect-cell 
purification. IMAC was performed using Ni2+-NTA matrices equilibrated with insect 
cell A1 (Section 2.1.8.2) and gel filtration performed with a superdex S75 column 
SDS-PAGE of baculovirus-mediated expression of NRC1 NBARC point mutants in insect 
cells. 1) pOPIN-F:K191A, 2) pOPIN-F:D481V 3) pOPIN-F:H480F , 4) pOPIN-F:H480A 5) 
pOPIN-F:D268N 6) pOPIN-S3C:D267N 7) pOPIN-F:D267N_D268N 8) pOPIN-F:WT 
9)pOPIN-S3C:K191A 10) pOPIN-S3C:D481V 11) pOPIN-S3C:H480F 12) pOPIN-
S3C:H480A 13) pOPIN-F:D267N 14) pOPIN-S3C:D267N_D268N 15) pOPIN-S3C:WT. 
Intensity of bands suggests that NRC1D268N in pOPIN-F may express to a similar level to 
wild-type protein, with NRC1D267N and NRC1D267N_D268N also expressing solubly, however 
to a much lower level.  
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pre-equilibrated with insect cell A4 running buffer. After gel filtration, fractions 
containing the target protein were pooled and concentrated to <10mL for removal of 
the N-terminal histidine tag by incubation with 3C protease at 4°C overnight. NRC1 
D268N_D268N did not reach a suitable level of purity or yield for tag cleavage. The 
cleaved proteins were then purified by IMAC to remove tagged protein and 
protease, and assessment of purity by SDS-PAGE indicated that these proteins had 
reached sufficient purity for downstream experiments without requiring an additional 
round of gel filtration (Figure 3.6.2). 
1 2 3MW
 
Figure 3.6.2 SDS-PAGE gel of purified NRC1 NBARC and point mutant from E. coli 
and insect cell expression 
 
3.7 In planta expression of R3a domains 
One potential reason for the difficulties of expressing R-proteins in E. coli is the lack 
of plant protein-chaperones that may have co-evolved to aid R-protein folding, such 
as the dependency of I-2 on the presence of the chaperone RSI2136, or the more 
general reliance on the HSP90-RAR1-SGT1 co-chaperones137, 138. To address this, 
the NBARC and LRR domains of R3a identified in Section 3.4.1 were cloned into a 
modified version of the pTRBO vector. This vector, which uses the CaMV 35S 
promoter to drive expression, was modified by Richard Hughes to include the N-
terminal histidine tag and restriction sites from the pOPIN-F vector. The same PCR 
products used to clone the domains into the E. coli expression vectors pOPIN-F and 
Final purified NRC1 NBARC domain used in downstream experiments. 1) WT protein 
derived from E. coli expression, 2) WT protein purified from insect cells, 3) NRC1 
NBARCD268N, purified from insect cells.  
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pOPIN-S3C were used for the cloning reaction. Cloning was performed as 
described in Section 2.2.2, and 5μL of cloning reaction was transformed into DH5α. 
Transformants were plated on LB agar supplemented with kanamycin and 
incubated at 37°C overnight. Single colonies were selected and grown in LB liquid 
media with kanamycin overnight at 37°C. These liquid cultures were pelleted for 
DNA purification (Section 2.2.5) and sent for sequencing using the Cauliflower 
Mosaic virus (CMV) 35S promoter primer (Appendix). 
Positive plasmids were transformed into Agrobacterium tumefaciens strain GV301.3 
by electroporation, plated on L agar and grown for 48 hours at 28°C. Single colonies 
were selected and screened for the presence of the insert by PCR using the CMV 
35S promoter primer and gene-specific reverse primer. Positive colonies were 
grown as liquid cultures for two days to be used for transient transformation of N. 
benthamiana. A. tumefaciens cells were pelleted by centrifugation and re-
suspended in infiltration buffer (10mM MES pH 5.6, 10mM MgCl2, and 150μM 
acetosyringone) to an OD600 of 1.2-1.5. After 2-4 hours incubation re-suspended A. 
tumefaciens were pressure infiltrated into five four-week old N. benthamiana leaves. 
After 5 days, leaves were harvested, frozen in liquid nitrogen and stored at -80°C. 
To isolate soluble protein, leaves were ground in liquid nitrogen with a chilled mortar 
and pestle, and 0.5mg powdered leaf aliquoted into 2mL screw-top tubes on dry ice. 
Cells were lysed by thawing in 2x v/w lysis buffer for 30 minutes on ice with several 
rounds of vortexing. Cell debris was removed by centrifugation and the clarified 
lysate pooled for all replicates. Clarified lysates were filtered with 0.45μm filters 
before being loaded onto a pre-equilibrated nickel column. For low-stringency 
purification 15mM imidazole was added to supernatant prior to loading onto a 5mL 
HisTrap FF column. Columns were then washed with three column-volumes of 
wash buffer (50mM Tris-HCl pH 8.0, 500mM NaCl, 10mM NaCl, 5% v/v glycerol) 
before eluting in 3 column-volumes of B1 buffer (Figure 3.7.1). 
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Figure 3.7.1 Low-stringency purification of R3a domains from N. benthamiana 
  
We were unable to detect significant accumulation of any of the constructs by SDS-
PAGE, although a number of eluting proteins are visible. High-stringency 
purifications, with 30mM imidazole added to samples prior to loading onto a 1mL 
HisTrap FF column did not result in accumulation of protein bands at the 
appropriate molecular weight. It is possible that these protein domains are subject to 
post-translational control to prevent appreciable accumulation in planta despite the 
use of high-expression promoters. 
 
3.8 Discussion 
Prior to this project, we suspected that the structure and in vitro biochemistry of R-
proteins has been the subject of far fewer published investigations than their 
behaviour at the genetic level and cellular level due to difficulties associated with 
obtaining sufficient yields of suitable protein. We have undertaken extensive 
screens to try and obtain R-protein constructs that would express solubly in E. coli, 
insect cells and N. benthamiana. A large portion of our efforts have been focussed 
on E. coli as our expression system of choice. We focussed on this expression 
Low stringency purification of soluble proteins from N. benthamiana does not result in 
accumulation of protein bands of the correct size, which are not found in wild-type tissue 
extract. 
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system for a number of reasons: the cells are easily transformable, they grow 
rapidly on simple media, there exist multiple strains and expression vectors, 
medium/high-throughput screens are relatively straight forward and less time 
intensive than other systems, scale-up of expression is relatively straightforward 
requiring little specialist equipment, and once appropriate conditions are identified, 
they are often able to produce large amount of protein. There are significant 
drawbacks to using such a simple prokaryotic system- most E. coli strains are 
unable to catalyse disulphide bridges, they are unable to apply many post-
translational modifications, such as glycosylation that may aid stability or solubility, 
and they lack some of the more complex chaperones that may have co-evolved with 
the target protein and may be required for correct folding.   
By screening constructs against a wide range of experimental conditions we have 
been able to produce soluble R-protein domains for downstream experiments, 
suggesting that at least some of the difficulties associated with expression of these 
protein domains may be overcome by the right combination of construct, strain and 
expression conditions. As we have not been able to rationalise why certain 
constructs expressed in specific conditions, groups wishing to investigate these 
proteins in vitro will most likely have to undertake similar, intensive approaches to 
obtain the raw material for downstream investigations. 
In addition to the two published examples of soluble coiled-coils we have been able 
to identify a further four solanaceous coiled-coil domains that can be purified from E. 
coli, those of R3a, I-2, NRC1 and NRC1-like. There are many questions regarding 
the behaviour and structure of coiled-coil domains which have yet to be resolved 
through in vivo methods- whether there is a representative fold similar to MLA10 or 
Rx, how these coiled-coils interact with downstream signalling partners, and how 
these signalling domains are kept in a signalling-competent, inactive state. By 
increasing the number of examples of R-protein coiled-coil domains available for 
study, we hope to be able to understand what generalisations can be made about 
the behaviour of these proteins, and better understand how they affect R-protein 
function.   
Additionally we have been able to produce, to our knowledge for the first time, a 
soluble NBARC domain from a plant R-protein with relatively high yields and purity. 
With this new material we hope to better probe this domain, pivotal to the proper 
regulation of many R-proteins. Producing protein solubly will allow us to deconvolute 
some of the issues regarding the homogeneity of refolded protein, and may lead to 
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novel insights about the behaviour of this protein domain in planta. Alongside 
exploring the biochemistry of this domain, the reasonable yield and reproducibility of 
the purifications allows for structural investigations using techniques such as x-ray 
crystallography and small-angle x-ray scattering. It is hoped that high-quality, high 
resolution data about the structure of the NBARC domain will give us insight into the 
evolution of this domain, allow an understanding of the subtle changes that may 
distinguish the “on” state with “off” state in the context of the full-length protein, and 
explain the mechanistic basis for the importance of certain conserved motifs. 
Although we were able to express a number of constructs in E. coli, this approach 
has a number of limitations. Most surprising was the inability for E. coli to express 
many point mutants in the NBARC domain of NRC1 solubly. This inability to 
produce soluble protein is difficult to explain- the point mutations were predicted to 
have very different effects on the biochemistry of this protein, whilst minimising any 
effects on the overall structure. From work trying to produce apo-NBARC domain 
we may have expected that mutations preventing nucleotide binding, such as the P-
loop K191A mutation, would result in unstable, and therefore insoluble protein. What 
we did not anticipate is that mutations that were predicted to have little effect on the 
ligand occupancy of the protein would also lead to issues with expression.  
As we were unable to overcome these issues with expression in E. coli, we chose to 
explore alternative systems to produce these proteins- primarily insect cell 
expression. Our initial expectations were that this system would give lower overall 
yields than proteins expressed in E. coli, but that it would still be possible to purify 
the majority of these proteins using a complex eukaryotic environment. Surprisingly 
we were unable to produce most point mutants in this system- wild-type protein and 
the point mutant D268N both expressed very well, and the double mutant 
D267N_D268N appeared to be solubly expressed, however to such low yields that 
we were unable to purify this protein sufficiently for use in our assays.  
Throughout this project we have been unable to produce and purify solubly 
expressing R-protein LRR domains, regardless of the expression system used. 
Plant cytoplasmic LRR domains as a whole remain uncharacterised and so 
predictions rely on either mammalian LRR domains, or more frequently, 
extracellular plant LRR domains such as that of the brassinosteroid receptor BRI1, 
FLS2, or immune receptors from animal systems. In the context of R-protein 
biology, the LRR domain is of great interest. Just as the NBARC domain defines the 
activation state of the protein, the LRR is predicted to be responsible for effector 
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detection and auto-inhibition. Studies wishing to expand recognition of have relied 
on random mutagenesis and labour-intensive screens of many hundreds of 
variations to try and identify desired phenotypes. Structural and biochemical 
analyses of this domain are unlikely to be a silver bullet allowing rationalised mutant 
design de novo, but may allow more targeted mutagenesis, making such screens 
more manageable. Beyond simply allowing rational manipulation of R-protein 
recognition, the LRR is believed to be key to auto-inhibition of R-proteins, and so 
our description of the behaviour of these proteins will remain incomplete until we are 
able to investigate the behaviour of this domain, its affinities and plasticity, more 
thoroughly.   
The soluble expression and purification of full-length R-proteins remains an 
unsolved issue for studying these proteins biochemically. Regardless of the 
expression system used we were unable to see significant accumulation of soluble 
protein in either the simple prokaryotic E. coli expression system, or in more 
complex eukaryotic environments. This study, although screening intensively for 
soluble protein, was not exhaustive and there remain a number of alternative 
expression systems to be explored by interested groups: yeast expression systems 
have been used previously to produce small amounts of soluble protein, and it may 
be that a similar medium-throughput screen of multiple R-proteins will result in 
increased soluble yields of different domains, or even full-length protein. As the 
mechanism which prevents significant accumulation of R-proteins in planta is not 
yet fully understood, there remains the potential to use specific plant hosts for 
heterologous expression of R-proteins- it may be that using a host separated by 
sufficient evolutionary time from the target R-protein may bypass such regulatory 
mechanisms.  
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4.1 Introduction- INF1, AVR3a and R3a, PTI and ETI 
Plant immunity can be thought of as several layers of increasingly specific plant 
responses to microbes. Initial detection of the presence of broad classes of microbe 
is mediated by the detection of conserved, essential molecular motifs (PAMPs), and 
leads to an effective immune response termed PAMP-triggered immunity (PTI). As 
these PAMPS cannot be lost or significantly altered without a fitness cost, 
populations of the pathogen arise expressing specific effectors to supress 
recognition, or negate the responses that these PAMPs trigger. These effectors may 
act in the apoplast to inhibit defensive proteins or block molecule perception, or may 
act in the plant’s cytoplasm to disrupt cell signalling, alter transcription or manipulate 
key host proteins (Section 1.3.2).   
In response to the susceptibility brought about by these effectors, plants can evolve 
specific R-proteins, capable of detecting these effectors and restoring an immune 
response (Section 1.4). Once activated by the presence of an effector, R-proteins 
must generate a signal for an immune response to be mounted at the cellular level. 
Although examples of signal transduction proteins have been identified for certain 
aspects of plant immunity (for example mitogen-activated protein kinases, MAPKs, 
involved in PTI), R-protein-specific signalling networks remain very poorly 
characterised.   
The interactions between P. infestans and solanaceous plants are a well-studied 
example of host-pathogen co-evolution and so we used this pathosystem to explore 
how a particular R-protein (R3a) might be detecting its cognate effector, and to look 
for interacting signalling components. 
4.1.1 INF and the Phytophthora-Solanaceae pathosystem 
Phytophthora spp. produce a family of small secreted proteins known as elicitins 
that induce defence responses in a number of plant species139. INF1 is a 10kDa 
cysteine-rich elicitin produced by P. infestans, the expression of which shows 
developmental regulation140, and when recognised causes rapid immune responses 
in Nicotiana spp. in an HSP90/HSP70-dependent manner141. In N. benthamiana 
recognition of INF1 is mediated by direct interaction with the lectin-like 
transmembrane protein NbLRK1142 and requires the co-receptor BAK1143. 
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Recognition leads to localized cell-death, a more extreme response than those 
typically associated with PTI, which is very effective at preventing the spread of the 
hemi-biotroph P. infestans. 
The role of INF1 in P. infestans as a PAMP is an interesting one. Recognition by 
plant species limits host range and therefore incurs a fitness cost, yet the protein is 
maintained in all populations as is the case for canonical PAMPs like flagellin and 
fungal chitin. Expression of the protein however does not seem to be essential to 
the microbe. Isolates recovered from East Germany (at the time the German 
Democratic Republic) in 1976-77 showed a loss of INF1 production144. These 
isolates were still able to complete their lifecycle, and later experimental silencing of 
the INF1 gene led to an ability of P. infestans to colonise a normally non-host plant 
(N. benthamiana)145. The fact that isolates without INF1 expression were both 
geographically and temporally restricted (isolates from later time periods in the 
same region having regained INF1 expression) suggests that these populations 
were less fit, despite the protein apparently being non-essential for development or 
infection under these conditions. In order to remain virulent whilst mainlining INF1 
production, P. infestans populations have evolved proteins to manipulate 
prospective hosts. 
4.1.2 AVR3a and effector-triggered susceptibility 
Similar to the production of AvrPto to allow P. syringae growth without triggering 
flg22-mediated resistance, P. infestans has evolved cytoplasmic effectors that can 
supress INF1-induced cell death (ICD). AVR3a is one such effector found in all P. 
infestans isolates to date, with very few polymorphisms. European isolates of P. 
infestans show two predominant alleles of AVR3a, with only three positions showing 
non-synonymous mutations. Prior to the introgression of R3a from S. demissum into 
the crop plant S. tuberosum (Section 4.1.3), the predominant AVR3a allele was 
AVR3aC19_K80_I103, however the introduction of R3a led to the emergence of a virulent 
allele AVR3aS19_E80_M103, which cannot be recognised by R3a132. Of the three 
polymorphic sites only two, position 80 and 103, are found in the functional effector 
domain downstream of the RXLR translocation motif, and so these two alleles will 
be referred to as AVR3aKI and AVR3aEM respectively. The introduction of R3a into 
commercial varieties of potato led to a dramatic decrease in the prevalence of 
AVR3aKI, however the allele still persists in some natural populations146. A possible 
explanation for this persistence is due to the different extents to which AVR3a 
alleles are able to suppress ICD. AVR3aKI is able to almost completely abolish the 
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INF1-mediated immune response, whereas AVR3aEM is much less effective at 
preventing this cell death126, which reduces the infectivity of the pathogen. The 
availability of hosts lacking R3a may therefore determine whether an ability to 
efficiently suppress ICD is favoured over the ability to evade recognition by R3a. 
Interestingly the ability of AVR3a to supress ICD appears to be mediated by a 
different region of the protein than those responsible for R3a recognition132. 
4.1.3 R3a and effector-triggered immunity 
The locus  giving resistance to P. infestans race 3, termed the R3 locus, was first 
mapped to a distal position on S. tuberosum chromosome 11147, with subsequent 
work identifying this as a complex locus consisting of at least two functional R-
genes148. The cloning of the R3a gene, giving resistance to P. infestans strains 
expressing the virulence factor AVR3a, was aided by the synteny between this 
region of S. tuberosum chromosome 11 and the SL8 region of S. lycopersicum, 
known to harbour the resistance gene I-2149. This co-linearity, along with knowledge 
of I2C-1 coding sequence, R3a-associated markers, and the use of bacterial 
artificial chromosomes ultimately led to the cloning of a 4176bp region encoding a 
1282 amino acid predicted CNL, which was able to confer resistance to P. infestans 
races expressing AVR3a.  
When R3a becomes activated in response to the presence of AVR3aKI, the result is 
a rapid, localised HR that can be reconstituted in the model plant N. benthamiana, 
enabling a wide range of functional studies to be performed more easily. Mutagenic 
screens indicate that R3a LRR is important for recognition of AVR3a, and that 
specific mutations in this region allows R3a to respond to both AVR3aKI and the 
normally avirulent AVR3aEM allele7, 8. Cell localisation experiments suggest that 
recognition of AVR3aKI may lead to re-localisation of R3a to endosomal 
compartments, contrasting with the re-localisation of the TNL RPS4 and CNL 
MLA10, both of which require nuclear localisation for an immune repsonse150, 151. 
Interestingly, in this instance the autoactive R3aD501V mutant that triggers rapid cell 
death in the absence of AVR3a does not show endosomal localization.  
4.1.4 Using R3a to investigate R-protein signalling 
The signalling events downstream of effector perception by R-proteins, particularly 
CNLs, are largely uncharacterised. There are a number of possible explanations for 
the apparent difficulties in elucidating signalling components, however in the case of 
R3a one of the most significant obstacles is that the addition of commonly used tags 
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to R3a results in a loss of AVR3a-dependent HR152. Although we cannot be certain 
that the reason for this inactivation is due to interference with required protein-
protein interactions, it is possible that fusion of R3a to epitope tags results in steric 
interference with normal inter- and intra- molecular associations. 
Overexpression of the coiled-coil domain of MLA10 leads to effector-independent 
cell death153, suggesting that this region of the protein is responsible for interacting 
with downstream signalling partners to trigger HR. The coiled-coil domain of Rx has 
been shown to interact with the host protein RanGap2, which is required for 
effective immune responses to Potato virus X88. We hypothesised that the coiled-
coil domain of R3a may therefore be involved in either triggering signalling 
cascades leading to cell death, or may associate with required host proteins, and so 
investigations into this domain may reveal novel R-protein interactors. In order to 
purify and detect plant-expressed R3a in an active state we generated R3a-specific 
antibodies raised against E. coli-derived R3aCC for immunoprecipitation (IP) 
experiments. 
4.2 Results 
Note: All western blot and pulldown experiments were performed with Marina 
Franceschetti. Figure 1.2.12 was produced by M. Franceschetti and N. benthamiana 
tissue expressing S. lycopersicum I-2 for figure 1.2.13 was kindly provided by A. 
Giannakopoulou. 
4.2.1 Purification of R3a CC domain 
Bacterial expression of the coiled-coil domain of R3a was performed as identified in 
Section 3.4.2. 6L of E. coli carrying the pOPIN-F:R3aCC vector were grown in LB at 
37°C to an OD600 of 0.6, chilled on ice, and induced with 1mM IPTG. Following 16 
hours of protein expression at 18°C, cells were harvested and lysed by sonication. 
Cell debris was removed by centrifugation, and the clarified lysate loaded onto a 
pre-equilibrated nickel affinity column. Bound proteins were eluted in a single step 
with 500mM imidazole and loaded onto a superdex S75 26/300 sepharose column. 
Fractions eluting from the column were assessed by SDS-PAGE to identify those 
containing the protein of interest with minimal contamination (Figure 4.2.1).   
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Figure 4.2.1 progression of R3a CC expression and initial purification 
 
Histidine-tagged R3a coiled-coil domain eluted from the gel filtration column in a 
broad peak of over 50mL. Fractions containing the protein were pooled and 
concentrated before addition of 3C protease to remove the N-terminal histidine tag. 
Cleaved histidine tag and protease were removed by subtractive IMAC through a 
pre-equilibrated nickel affinity column. The flow-through and washes were 
concentrated to <5mL and loaded onto an S75 column for SEC. This second round 
of SEC resulted in a tighter elution peak, consisting of the R3a coiled-coil domain 
with few visible contaminants (Figure 4.2.2). 
A) From left to right. Molecular weight marker, uninduced, whole cell and soluble 
protein samples of pOPIN-F:R3aCC E. coli. Induction was performed by adding 
1mM IPTG to litre cultures at OD600 which had been chilled to below 25C. 
B) SDS-PAGE of pOPIN-F:R3aCC soluble extract eluting from an S75 preparative 
gel filtration column. The first two lanes correspond to the void-volume of the 
column, indicating aggregation of the protein.  
C) A280 trace of pOPIN-F:R3aCC preparative gel filtration. Protein eluted over a 
large volume, which may be indicative of multiple oligomeric states or protein-
matrix interactions. 
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Figure 4.2.2 Final purification of R3a coiled-coil domain 
 
Unlike the partial coiled-coil construct identified in Section 3.3.2.1, which differs from 
this by the omission of ~20 C-terminal residues, this purified protein showed no 
issues during concentration, and remained stable when stored at 4°C for over 4 
weeks.  
4.2.2 Generation of anti-R3a-CC antibodies 
To allow monitoring of untagged, functional R3a we used the purified CC domain to 
generate R3a-specific antibodies. 4mg of purified R3a coiled-coil domain was sent 
to Eurogentec for production of α-R3a antibodies in rabbit. Two rabbits (referred to 
here as rabbit 1 and rabbit 2) were used for antibody generation, and serum 
samples used to assess background signal (Figure 4.2.3, left). Neither rabbit’s pre-
immune serum showed a signal at ~150kDa, which would mask signal for R3a 
detection, and so both underwent a three-month course of antibody production by 
repeated exposure to purified R3a CC domain. Following this course of antibody 
production we tested sera from both rabbits to assess both background signal and 
ability to detect R3a expressed under the CaMV 35S promoter in stable transgenic 
N. benthamiana (R3a transgenics, or R3aTG) (Figure 4.2.3, Right).  
A). SDS-PAGE of fractions from second round of preparative gel filtration following tag 
removal.  
B). Gel filtration trace of R3aCC eluting from a superdex S75 column. Protein elutes much 
tighter after tag removal, peaking at ~160mL, with very little to no protein in the column 
void-volume.  
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Figure 4.2.3 Pre- and post- immunisation serum from rabbit 1 and rabbit 2 
 
Both sera showed a clear signal at ~150kDa against R3aTG extract, however there 
was also a signal detected that corresponds to a slightly higher molecular mass 
(~160-170kDa) when these antibodies were used against wild-type N. benthamiana 
Left. Pre-immune serum from rabbit 1 (top) and rabbit 2(bottom). Both rabbits show some 
degree non-specific binding to N. benthamiana extract prior to challenge with R3aCC 
domain, however neither show a response to the purified protein. 
Right. Following a course of R3aCC immunisation both rabbits show strong signal for both 
R3a expressed in planta and the purified coiled-coil domain. Rabbit 2 appears to give 
lower overall background signal relative to R3a-specific signal, indicating fewer non-
specific interactions.   
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soluble extract, which was most noticeable for rabbit 2. A key aim of this project was 
to use these antibodies to immunoprecipitate R3a from N. benthamiana and identify 
proteins R3a interacts with in the absence of AVR3a. As the high background signal 
from Rabbit 1 serum would lead to an increase in false-positives, by identifying 
these off-target proteins and their potential interactors, we decided to focus on 
Rabbit 2 antibodies. 
Although the total background signal from rabbit 2 was significantly lower than that 
of rabbit 1, we believed that the high-molecular weight non-specific signal was 
fainter in rabbit 1, which may make discriminating between R3a and this similar 
mass, non-specific band easier. We therefore had total IgG purified from both 
rabbits, which was stored in 10μL aliquots at -80°C until required. 
4.2.3 Immunoprecipitation of untagged R3a to probe for interactors 
Given the limited knowledge regarding R-protein interactions with host proteins, and 
the loss of HR in when R3a is tagged, we used the generated α-R3a antibodies to 
immunoprecipitate (IP) R3a from N. benthamiana tissue for IP-mass spectrometry 
experiments to identify interacting proteins.  
4-5 week old N. benthamiana leaves, stably transformed to express untagged R3a 
under the CaMV35S promoter (R3aTG), were harvested, mid-veins removed, and 
frozen in liquid nitrogen. Tissue was ground with a pestle and mortar, pre-chilled 
with liquid nitrogen, and ground tissue transferred to chilled tubes, flash frozen, and 
stored at -80°C until use.  
GTEN extraction buffer (10% glycerol, 25mM Tris pH 7.5, 1mM EDTA, 150mM 
NaCl, 10mM DTT, 0.1% TWEEN 20, 0.02% w/v poly(vinylpolypyrrolidone)) was 
added to tissue in a 2:1 v/w ratio on ice, and vortexed to mix. Samples were 
incubated on ice for 30 minutes with periodic vortexing. Cell debris was removed by 
several rounds of centrifugation in a bench-top centrifuge at 13,300g for 10 minutes, 
with supernatant transferred to fresh, pre-chilled tubes each round. Dynabeads® 
(ThermoFisher) sheep α-rabbit magnetic beads were prepared as described in 
Section 2.14.1. Beads were washed, re-suspended and 0.6μL rabbit α-R3a 
antibodies added. Beads were incubated with the antibodies on ice for 30 minutes. 
30μL of prepared beads were added to clarified plant lysate and incubated at 4°C 
for 1-2 hours with constant rotation. Samples were placed in a magnetic rack to 
collect beads, and supernatant removed by gentle pipetting. An aliquot of 
supernatant was used to monitor unbound proteins. After washing, bound proteins 
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were eluted from magnetic beads by incubating beads with 1xSDS protein loading 
buffer (Section 2.8.5) at 72°C for 7 minutes with constant agitation. Input, unbound 
and eluted proteins were then separated on 4-20% polyacrylamide tris-glycine mini-
PROTEAN™ gels (Bio-Rad). Separated proteins were then transferred to PVDF 
membranes overnight to be probed with α-R3a antibodies (Figure 4.2.4).  
*
 
 
Figure 4.2.4 Immunoprecipitation of untagged R3a from stable transgenic N. benthamiana 
 
As the volume used for elution was ~20 times less than the original volume of 
supernatant we would expect a significant concentration of R3a, and thus a much 
stronger signal in the elution lanes relative to the input. The inability to detect R3a in 
the eluate suggests inefficient pulldown by the α-R3a antibodies and magnetic 
beads, and so these conditions are not appropriate to investigate R3a interactions. 
We therefore performed a series of experiments to identify conditions more suitable 
for R3a immunoprecipitation. 
 
4.2.4 Optimising R3a immunoprecipitation conditions 
Immunoprecipitation of a protein relies on strong protein-protein interactions 
between antibodies and the target protein or tag. These interactions can be 
influenced by a number of factors, depending on the nature of the interaction 
interface. Charge-charge interactions are responsive to changes in salt 
concentration, which may interfere with salt-bridge formation. Similarly pH can affect 
side-chain charges and thus disrupt interaction interfaces. Although the original IP 
R3a extracted from R3aTG tissue is clearly visible in the input lane (expected size 
indicated by arrow). Incubation with rabbit α-R3a antibodies and sheep α-rabbit magnetic 
Dynabeads® did not result in accumulation of the protein in eluate samples. Strong 
signal in unbound protein lanes indicates that the α-R3a antibodies are unable to 
immunoprecipitate the protein in these conditions. A non-specific band in the eluate is 
marked with by *. 
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conditions are used as they are close to physiological conditions, it is possible that 
these are sub-optimal conditions for IP of R3a. We therefore monitored the effect 
that changing these two factors had on R3a immunoprecipitation.  
4.2.4.1 Optimising bead conjugation-salt vs pH  
We focused our initial efforts on optimising antibody binding by screening for pH-
dependent effects, and determining whether high salt concentrations were inhibiting 
R3a binding. Transgenic R3a N. benthamiana tissue was ground and divided into 
six 0.5g aliquots. To each aliquot 1mL GTEN buffer was added, containing either 
150mM or 75mM NaCl, buffered to either pH 7.0, 7.5 or 8.0. Tissue was thoroughly 
vortexed and incubated on ice for 30 minutes. Unbound protein was removed by 
placing tubes on a magnetic rack and removing supernatant. After washing beads 
were incubated with 1xSDS loading buffer for seven minutes at 72°C to elute bound 
protein. Samples were then run on a 4-20% polyacrylamide gel, transferred to 
PVDF membranes and probed with α-R3a antibodies (Figure 4.2.5).  
 
Figure 4.2.5 Western blot probing the effects of changing pH and salt concentration of R3a 
immunoprecipitation efficiency 
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Although the elution lanes for this experiment are predominated by non-R3a signal, 
making identification of individual bands difficult, the relative intensity of input to 
unbound sample lanes for all conditions indicates that immunoprecipiatation of R3a 
is not improved under these conditions. 
The smearing seen in the elution lanes was most likely due to dissociation of 
antibody heavy chain during protein elution (Full blots can be seen in Appendix). We 
therefore investigated whether conjugation of α-R3a antibodies to the sheep α-
rabbit antibodies of the beads would decrease background signal, and improve IP 
and detection of R3a. 
 
4.2.4.2 Effect of bead conjugation on pulldown efficiency 
Sheep α-rabbit magnetic Dynabeads were prepared as described in Section 2.14.1. 
Beads were washed and re-suspended in PBS with EDTA. 1.2μL α-R3a antibodies 
from rabbit 2 were added to beads, and incubated on ice for 15-30 minutes. Half of 
the beads were removed and added to a fresh Eppendorf on ice to monitor 
immunoprecipitation in the absence of chemical cross-linking to the Dynabeads 
(referred to throughout as unconjugated beads). The other half were chemically 
conjugated to the α-R3a antibodies by treatment with BS3 
(bis(sulfosuccinimidyl)suberate) as described in Section 2.14.1. Both sets of beads 
were then washed in 400μL Tris and split into a total of four eppendorf tubes: WT 
tissue + conjugated beads, R3aTG + conjugated beads, WT tissue + unconjugated 
beads, and R3TG + unconjugated beads. Total soluble protein from 1g of both wild-
type and R3aTG N. benthamiana was prepared as described in Section (2.8.4). A 
12μL aliquot was removed from each tissue extract and boiled with 4xSDS loading 
buffer as input controls. 800μL of R3aTG soluble extract was then added to the 
corresponding α-R3a bead sample. These mixtures were incubated for 1-2 hours at 
A.) Protein extraction and immunoprecipitation experiments performed in high salt 
(150mM NaCl conditions) in extraction buffer at pH 7.0, 7.5 and 8.0. pH appears 
to have little effect on the efficiency of protein extraction as input signal intensity 
is roughly equal across all input lanes. High non-specific signal in elution lanes 
makes determining the presence of an R3a-specific signal difficult. Equal 
intensity of R3a-specific signal in both unbound protein lanes and input lanes 
indicates that almost all R3a remains unbound to α-R3a beads at each pH. 
B.) Protein extraction and immunoprecipitation performed under low salt (75mM 
NaCl) conditions. High background from anti-body dissociation during protein 
elution results in high background. 
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4°C with constant rotation. Following incubation beads were separated using a 
magnetic rack and the supernatant removed- a 12μL sample of this was boiled in 
4xSDS-loading buffer to monitor the amount of unbound protein. After washing, 
bound protein was eluted in citrate buffer pH 2.0 and 8μL of eluate boiled in SDS-
loading buffer. Samples were then run on a 4-20% polyacrylamide tris-glycine gel 
and protein transferred to a PVDF membrane overnight. This membrane was 
probed with α-R3a antibodies to determine what effect conjugation had on the 
efficiency of immunoprecipitating R3a (Figure 4.2.6). 
 
 
Figure 4.2.6 Comparing the effects of antibody conjugation to magnetic beads on the ability 
to immunoprecipitate R3a. 
 
R3a-specific signal is present in the input control, however no corresponding band 
is detectable in the elution lanes for either conjugated or unconjugated beads. When 
examining the unbound protein sample however, it is apparent that almost no R3a 
protein has been bound by the antibodies when left unconjugated to the beads. A 
band in the unbound sample lane corresponding to the R3a input signal with almost 
no change in intensity relative to the input control indicates equal amounts of protein 
in both the input and unbound samples. For the samples which had the α-R3a 
antibodies conjugated to the beads prior to incubation, we can see a faint band in 
the unbound protein sample corresponding with the input R3a signal, with no signs 
of R3a in the eluate. Chemically conjugating α-R3a antibodies to these magnetic 
R3a signal comparing effect of conjugating α-R3a antibodies to magnetic beads on the 
ability to immunoprecipitate the protein from stable transgenic N. benthamiana. Top 
panel shows α-R3a probing, with R3a signal indicated by *. R3a-specific signal in the 
input loading, with an equivalent band in the unbound protein sample when antibodies 
are pre-conjugated to the beads. A faint α-R3a signal can be seen in the unbound 
protein fraction when antibodies are conjugated. Eluted protein samples do not show a 
specific R3a signal consistent with the mass from the input, despite the low signal in the 
conjugated bead unbound protein fraction. Bottom panel shows ponceau staining of the 
membrane of a ~50kDa band as a loading control.   
WT R3a WT R3a WT R3a WT R3a WT R3a 
Input 
Unbound Elution Unbound Elution 
Unconjugated beads C onjugated beads 
P onceau 
α-- R3a * * * 
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beads did not appear to hinder immunoprecipitation, and appeared to decrease 
non-specific signal following elution. 
We had prioritised rabbit 2 α-R3a antibodies as the lower background signal seen in 
Figure 4.2.3 would result in cleaner immunoprecipitations, and more accurate MS 
data. Having been unable to optimise conditions with this batch of polyclonal 
antibodies we explored the use of rabbit 1 α-R3a antibodies to IP R3a.   
4.2.4.3 Testing antibody-specific effects 
As we had been unable to produce clear enrichment of R3a using antibodies 
derived from rabbit 2, selected for the low overall background signal in serum tests, 
we looked for differences between the two sets of polyclonal antibodies to see 
whether the issues described above were antibody-specific.  
As we were unsure how the antibodies from rabbit 1 would respond to conjugation 
we took a systematic approach comparing the effects of conjugation to magnetic 
beads for both antibodies. Samples were eluted by acid elution (Figure 4.2.7, A) and 
then by boiling the beads in SDS-loading buffer (Figure 4.2.7, B). Acid elution is a 
preferable method for removing bound proteins as it is less likely to strip the light-
chain and heavy-chain of the antibodies, which increase the background signal from 
secondary antibodies for western blotting. We included a subsequent round of 
elution by boiling in SDS loading buffer to ensure low signal was not due to 
inefficient dissociation of bound proteins. Transgenic R3a tissue was prepared as 
described in Section 2.8.4 and supernatant separated into four aliquots, to which 
were added either magnetic beads conjugated to α-R3a antibodies from rabbit 1 or 
rabbit 2, or washed magnetic beads and 1μL of α-R3a antibodies from each rabbit.  
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Figure 4.2.7 Western blot to assess ability of different polyclonal α-R3a antibody batches to 
immunoprecipitate R3a 
 
Both antibodies that were conjugated to magnetic beads, and those that were not 
were unable to show significant enrichment of R3a. The signal detected in the 
unbound samples was roughly equal to the intensity of the signal detected in the 
input lane- that is the aliquot taken from the total soluble protein from R3aTG tissue. 
There were no obvious antibody-dependent effects as both rabbit 1 and rabbit 2 
derived antibodies showed s amounts of R3a in the unbound samples. 
This presumed inability to bind to R3a is further confirmed by the absence of signal 
in eluate of either conjugated or unconjugated samples for both antibodies, despite 
Protein extracted from R3aTG plants added to rabbit 1 or rabbit 2 antibodies that were 
either conjugated to magnetic beads, or mixed with magnetic beads but without 
undergoing the chemical conjugation reaction. Proteins were separated by SDS-PAGE 
and probed using α-R3a antibodies, R3a specific band indicated by arrow. 
A) Input control showing 15μL aliquot from the total protein extract, which was then 
divided and added to each of the four experimental condition (1mL each). Extract was 
then added to α-R3a antibodies either conjugated or left unconjugated with magnetic 
beads. Unbound protein samples represent the proteins present in supernatant after 2 
hours incubation with α-R3a antibodies. Beads were washed and treated with 50µL 
citrate buffer pH 2.0 to elute bound proteins.  
B) Proteins eluting from beads after boiling in 50μL 1xSDS-loading buffer. Following acid 
elution beads were treated with 1xSDS loading buffer and incubated at 72°C for 7 
minutes to test whether absence of acid elution signal is not due to inefficient 
dissociation of R3a from the beads.  Input control is the same as in a). 
170 kDa 
130 kDa 
170 kDa 
130 kDa 
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a predicted concentration effect of approximately 20 fold. The lack of signal in the 
eluate cannot be explained by poor dissociation by acid treatment, as additional 
elution performed by boiling beads in SDS-loading buffer did not lead to an increase 
in signal. 
As we could not explain pulldown inefficiency due to antibody-specific effects we 
investigated whether the protein extraction and binding conditions may have a 
detrimental effect on R3a enrichment.  
4.2.4.4 Protein extraction buffer 
It is possible that a component of the buffers used to extract and bind R3a was 
interfering with R3a-antibody interactions, and so we tested whether a different 
protein extraction buffer would lead to improved R3a purification and enrichment. 
Transgenic R3a tissue was ground in liquid nitrogen and 0.5g transferred to four 
chilled 2mL screw-top tubes. 1mL GTEN extraction buffer (buffer 1) was added to 
two tubes (one with pre-conjugated beads, one with unconjugated beads incubated 
with α-R3a antibodies), and 1mL new extraction buffer adapted from Franceschetti  
et al (2011)154 (50mM Tris pH 7.5, 5mM MgCl2 10% glycerol, 1% triton X-100, 1mM 
PMSF, 2% PIC) added to the other two tubes. Samples were vortexed and 
incubated on ice for 30 minutes to liberate soluble protein. Cell debris was removed 
by centrifugation and the supernatant added to tubes containing magnetic beads 
conjugated to α-R3a antibodies derived from either rabbit 1 or rabbit 2 (Figure 
4.2.8). 
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Figure 4.2.8 Effect of buffer composition on R3a extraction and immunoprecipitation 
 
Replacement of GTEN-based buffer with an alternative buffer resulted in a loss of 
R3a signal in sample input lanes, despite using the same tissue and equivalent total 
protein extraction as determined by ponceau staining. We concluded that 
replacement of GTEN buffer is unlikely to result in dramatic improvements in R3a 
extraction and immunoprecipitation. Finally we decided to test whether the inability 
to immunopreciptate the coiled-coil domain was an intrinsic property of these 
antibodies, rather than inappropriate experimental conditions. 
A. Comparison of two buffers on the ability to liberate soluble R3a and the 
effect of buffer composition on IP efficiency. Extracted soluble protein, 
shown in “input” lanes, was added to beads that had either previously 
been conjugated to α-R3a antibodies from rabbit 2, or washed and left 
unconjugated with antibodies added prior to sample mixing.  Buffer 1 
shows good R3a signal in the input, but no defined signal for eluting R3a 
either with conjugated or unconjugated beads. Buffer 2 does not seem to 
be able to liberate soluble R3a.   
B. As in A., but with immunoprecipitation performed using α-R3a antibodies 
from rabbit 1. Both membranes were probed with antibodies from rabbit 2. 
Buffer 1 and 2 were tested and run on the same blot. They have been 
separated here to aid interpretation. Set A. and B. represent separate blots.  
~50 kDa → 
~50 kDa → 
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4.2.4.5 Immunoprecipitation of purified coiled-coil domain 
Having been unable to optimise pulldown conditions we proposed two hypothesise 
to explain the inability of the polyclonal antibodies to immunoprecipitate to R3a in 
these experiments: either the biology of native R3a does not permit binding, such as 
by burying the coiled-coil domain in a stable interaction, or these antibodies are for 
some technical reason unable to interact with both R3a, and the beads required to 
immunoprecipitate the protein. 
To distinguish between these two scenarios we used α-R3a antibodies to pulldown 
R3a from transgenic tissue, heat-treated R3a tissue extract (to test whether low 
pulldown efficiency is due to specific native conformation), purified R3a coiled-coil 
domain (to test whether the conjugated beads are capable of immunoprecipitating 
isolated protein), and purified coiled-coil domain added to N. benthamiana leaf 
extract (to test whether the low immunoprecipitation efficacy is due to sequestration 
of the coiled-coil domain by interacting proteins). 
 R3aTG tissue was ground and soluble protein extracted as described above. 
Soluble extract was then divided into two aliquots, one of which underwent heat 
treatment by incubation at 95°C for seven minutes, before being cooled on ice. An 
aliquot of frozen R3a coiled-coil domain (Section 3.4.2) was thawed on ice and 10ng 
added to 1mL of GTEN extraction buffer. To test whether the coiled-coil domain was 
being sequestered by host proteins and thus unavailable for immunoprecipitation, 
0.5g of wild-type N. benthamiana leaf tissue was ground in liquid nitrogen and 
added to a chilled 2mL screw-top tube with 1mL GTEN extraction buffer. Soluble 
protein was prepared in the same way as R3aTG tissue, and 10ng purified coiled-
coil domain added to the wild-type extract, and extraction buffer only. 30μL of 
magnetic beads conjugated to α-R3a antibodies from rabbit 2 were added to each 
sample and incubated for 1-2 hours at 4°C with constant end-over-end rotation. 
Unbound protein was removed by separating beads with a magnetic rack and 
removing supernatant. Beads were then washed and eluted by the addition of 0.1M 
citrate buffer pH 2.0 incubated at room temperature for 10 minutes. Samples were 
boiled in SDS-loading buffer and loaded onto a 4-20% polyacrylamide gel (Figure 
4.2.9). 
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Figure 4.2.9 Immunoprecipitation of native, denatured transgenic R3a and purified R3a 
coiled-coil domain 
 
Despite the ability to detect R3a in the input for both native and heat-denatured R3a 
extract, we were unable to detect appropriate signal following immunoprecipitation. 
This suggests that an inability to IP the protein is not a result of native R3a 
conformations. There is no signal for purified coiled-coil following acid elution in ~40 
fold smaller volume than the input, indicating that there has been no appreciable 
concentration of the protein in these conditions.   
We have been unable to explain the lack of R3a-enrichment following 
immunoprecipitation by antibody batch-specific effects, effect of magnetic bead 
treatment, buffer components, interference by high salt concentration, or pH-
dependent effects. This final experiment leads us to conclude that the inability to IP 
R3a is not due to the native conformation of the protein, indicated by the negative 
result with heat treated R3a extract. Nor is it due to protein-protein interactions in 
plant cell extract as we were unable to IP coiled-coil domain at >90% purity in the 
absence of host proteins. We concluded therefore that these antibodies are not 
Samples of soluble extract from transgenic R3a N. benthamiana tissue extract, the 
same extract after boiling to denature proteins, R3a CC domain purified from E. coli,  
and wild-type N. benthamiana extract with purified R3a CC domain. R3a signal is 
indicated by *. Although unable to detect the purified coiled-coil domain in the input, 
concentration by eluting in a smaller volume relative to input samples should allow this 
protein to be detected even with low-efficiency IP. 
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suitable for co-IP and mass-spectrometry experiments to determine interacting 
partners in this manner. However, as these antibodies are able to detect R3a, they 
can be used for targeted co-immunoprecipitation experiments.  
4.2.5 Probing for R3a-AVR3a interactions 
Multiple methods for AVR detection by R-proteins have been suggested using two 
key mechanisms: direct and indirect perception. Direct perception is the simplest 
mechanism to explain R-protein activation. The effector physically associates with 
an R-protein leading to activation. In this system R-protein binding of the effector 
allows nucleotide exchange, leading to conformational changes in the NBARC 
domain and release of the coiled-coil domain. The CC domain is then in a 
conformation that allows interaction with downstream signalling components to 
trigger a response. We therefore decided to use co-immunoprecipitation (co-IP) 
experiments test whether R3a perceives AVR3a by forming a stable complex. 
FLAG-tagged AVR3aKI allele was transiently co-expressed with untagged, and 
therefore functional R3a via agrobacterium-mediated transformation of wild-type N. 
benthamiana. Leaf samples were collected two days post-infiltration (prior to the 
onset of visible HR), frozen in liquid nitrogen and stored at -80°C. Soluble protein 
was extracted in GTEN buffer as described above. Clarified lysate was added to α-
FLAG magnetic beads and incubated for two hours at 4°C. Following washing, 
bound proteins were eluted by heating samples to 72°C in 1xSDS buffer and 
separated by SDS-PAGE on a 4-20% polyacrylamide tris-glycine gel. Proteins were 
then transferred to PVDF membranes overnight, to be probed using appropriate 
antibodies (Figure 4.2.10).  
 
Figure 4.2.10 Western blot of AVR3a and R3a co-immunoprecipitation 
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Probing with α-FLAG antibody shows no signal for FLAG-tagged effector in either 
the input or elution lanes, despite FLAG-tagged RFP being clearly visible. We are 
unable therefore to determine whether complex formation occurs. We hypothesised 
that the most likely reason for the absence of the effector in these samples is due to 
its recognition by R3a leading to HR as the protein accumulates in the cytoplasm. 
To overcome this issue we individually expressed the effector and R3a, extracted 
soluble protein, mixed the two extracts to allow complex formation, and then co-IP 
from this mixture. Leaf samples were taken from transgenic R3a plants and from 
wild-type N. benthamiana transiently transformed to express FLAG-tagged AVR3aKI, 
AVR3aEM, or RFP three days post infiltration. This tissue was flash frozen in liquid 
nitrogen and soluble protein extracted as described in Section 2.8.4. 1mL of R3aTG 
soluble extract was added to 1mL of each FLAG-tagged construct, and incubated 
on ice before the addition of α-FLAG magnetic beads. Beads were incubated in the 
plant extract for 1-2 hours at 4°C with constant rotation before being separated from 
the solution using a magnetic rack. Beads were then washed, and the bound 
proteins eluted by incubating beads in citrate buffer pH 2.0 for 5-10 minutes (Figure 
4.2.11). 
25 kDa
10 kDa
35 kDa
170 kDa
130 kDa
* * * * * *
FLAG:AVR3aEM FLAG:AVR3aKI FLAG:RFP 
α-R3a
α-FLAG
 
Figure 4.2.11 Western blot of R3a and FLAG-tagged AVR3a alleles when expressed 
individually and extracts mixed 
Pulldown of FLAG-tagged proteins co-expressed with R3a in N. benthamiana does not 
show signs of complex formation. Top panel shows R3a present in all samples, with a 
large amount of R3a in the unbound protein fraction. No signs of R3a in the eluate is 
indicative the FLAG-tagged proteins are unable to co-IP R3a by forming a stable 
complex. Middle panel shows α-FLAG signal for these samples. Signal is only detectable 
for FLAG:RFP in either input or elution samples, suggesting an absence of 
FLAG:AVR3aKI. Bottom panel shows non-specific FLAG signal as loading control. 
 Page 135 of 232 
 
 
We were unable to detect any signs of co-immunoprecipitation of R3a with FLAG-
tagged effectors. Although α-FLAG signal is low in elution lanes, the complete 
absence of α-R3a signal despite over-exposing the autoradiogram (as seen by 
background spots between 170- and 130kDa markers) leads us to suppose that 
under these conditions the two proteins do not co-immunoprecipitate. As we have 
been unable to immunoprecipitate R3a, we are unable to test this by reciprocal co-
IP experiments. Having been unable to use these antibodies to positively identify 
R3a-interacting proteins by immunoprecipitation, we examined the potential for 
alternate uses of these antibodies. 
4.2.6 Using R3a antibodies to R-protein levels in planta 
The use of these antibodies is not limited to identification of interacting partners, and 
can be used to assess R3a levels in planta and the stability of proteins in response 
to specific mutations.  
Time course experiments showing the accumulation of R3a under the Rpi-vnt1 
promoter were performed by Marina Franceschetti, and can be used to show that 
R3a expression is undetectable until two days post infiltration, with maximum levels 
reached approximately 5 days post infiltration (Figure 4.2.12). This work also 
demonstrates that under this promoter R3a levels remain significantly lower than 
R3aTG plants, where expression is driven by the CaMV 35S promoter. The 
significant increase in protein levels driven by the 35S promoter should be 
considered when testing recognition-induced cell death. High protein levels may 
lead to cell death responses that are not consistent with the behaviour of protein 
under native (or native-like) promoters which accumulate to lower levels. 
Soluble protein extract from transgenic R3a N. benthamiana mixed with the soluble 
extract from N. benthamiana transiently transformed to express FLAG-tagged AVR3aKI, 
AVR3aEM, or RFP. FLAG-tagged proteins are detectable in the input and unbound lanes, 
indicating that these proteins are unable to form a stable complex with R3a under these 
conditions 
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Figure 4.2.12 Time-course of R3a expression in N. benthamiana 
 
Recent work with R3a showing the possibility to expand responses to effectors has 
triggered an interest in whether these changes can be transferred to similar R-
proteins. We tested whether these antibodies were also able to detect the 
homologous protein I-2 from S. lycopersicum, which is able to respond to the 
Fusarium oxysporum effector AVR2.  Western blots of plant extract indicate that 
these antibodies are able to detect I-2 comparably to R3a (Figure 4.2.13). These 
antibodies have since been used to confirm that changes in responses of S. 
lycopersicum I-2 point mutants to different effectors are not due to significant 
changes in protein levels, but most likely reflect bona fide changes in protein 
behaviour155. 
1 2 3 4MW
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Figure 4.2.13 Detection of I-2 by α-R3a antibodies 
 
 
Wild-type N. benthamiana transiently transformed by A. tumefaciens carrying the R3a 
gene in the pCBNptII vector under control by the Rpi-vnt1.1 promoter. Leaf tissue was 
harvested at time points indicated and stored at -80°C until use. 40µg of soluble protein 
was loaded to monitor accumulation of protein over time. 20µg of soluble protein extract 
from stable transgenic R3a N. benthamiana leaf tissue was loaded (far left lane) and 
allows comparison of relative protein levels. Courtesy of M. Franceschetti.    
Lane 1- N. benthamiana transiently expressing S. lycopersicum I-2 three days post 
infiltration, detected by anti-R3a antibodies. Lane 2- Empty vector control. Lane 3- N. 
benthamiana transiently expressing R3a. Lane 4- Stable transgenic N. benthamiana 
expressing R3a. 
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4.3 Discussion 
At the point of writing, little is known about the signalling cascades involved in 
triggering R-protein mediated HR following effector detection, with traditional 
mutagenesis screens yielding little data. Alternative approaches, such as silencing 
screens used to identify NRC1 (Section 5.1), have been able to add to our 
knowledge of HR signalling pathways, indicating that alternative screening methods 
may make significant contributions to the field. 
We decided to use direct methods to try and identify proteins involved in R3a-
specific HR. Co-immunoprecipitation experiments (co-IP) combined with mass-
spectrometry is a powerful way to identify protein-protein interactions, however in 
this approach has been of limited use for understanding R3a function. The reason 
for this is the observation that tagging R3a leads to inactivation and a loss of HR152. 
Although we cannot be certain that the reason for this inactivation is due to 
interference with signalling cascades, the lack of activity indicates that data 
collected in this method may not give a full description of R-protein behaviour in 
planta.  
We decided to circumvent the issues of inactivation when R3a is tagged by 
producing specific antibodies against the R3a coiled-coil domain and to use these 
antibodies to investigate the interactions of untagged and therefore functional R3a 
for the first time. We were able to produce sufficient purified coiled-coil domain to 
generate antibodies, which are able to detect both full-length protein and the 
isolated coiled-coil domain by western blotting. Despite extensive efforts to optimise 
pulldown conditions, we have been unable to use these antibodies to efficiently 
immunoprecipitate R3a from plant extract. We hypothesised that there would be two 
key reasons for this issue- a biological reason, that the native coiled-coil domain is 
inaccessible in planta due to inter- or intra-molecular interactions, and a technical 
reason, that these antibodies are unable to simultaneously bind to and pulldown 
native R3a. Experiments using heat-treated R3a from plant leaves and soluble, 
purified coiled-coil domain expressed in E. coli indicate that the inability of these 
antibodies to immunoprecipitate these proteins is not due to unsuitable 
conformations or masking of interacting interfaces, but may be an intrinsic property 
of these antibodies. 
Despite this limitation these antibodies may still be a valuable resource. Their ability 
to detect full-length I-2 in planta has been used to demonstrate that changes in 
behaviour of a series of point mutants are not related to issues with stability. Such 
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studies would typically rely on inactive, tagged, protein and thus only be a proxy 
measurement of functional protein behaviour.  
Nor does the use of these antibodies to identify R3a (or I-2) interacting partners 
need to be restricted to immunoprecipitation experiments. Native PAGE is a method 
that allows the separation of protein complexes on the basis of mass and isoelectric 
point. It is possible that these antibodies could be used in native PAGE-mass 
spectrometry experiments to detect complexes containing R3a, and the components 
of such complexes. Alternatively these antibodies can be useful for validation of 
candidate interactors. Proteins such as AVR3a can be tagged without affecting their 
detection by R3a, and so it may be possible to tag other proteins predicted to be 
involved in R3a activation and signalling without loss of function. If such candidates 
can be identified then co-IP experiments using the tagged candidate and un-tagged 
R3a are a realistic way to validate interactions in planta. 
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5.1 Introduction 
The modular nature of R-proteins is believed to allow multiple functions to be 
incorporated into a single protein. Essential functions for R-proteins are the ability to 
sense the presence of a pathogenic effector, the ability to transduce this signal to 
allow the plant cell to respond appropriately, and to remain in a signalling-
competent, inactive state. This project focussed on Solanaceous coiled-coil R-
proteins from various hosts- namely S. tuberosum, S. lycopersicum, N. 
benthamiana, and S. bulbocastanum. These proteins consist of an N-terminal 
coiled-coil domain (CC), a nucleotide-binding domain with similarity to Apaf-1, 
various R-proteins and Ced-4 (NBARC domain) and a C-terminal leucine-rich repeat 
region (LRR), each believed to be responsible for different aspects of R-protein 
function (Section 1.6). 
In this generalised model of R-protein regulation the NBARC plays a pivotal role 
acting as a molecular switch, controlling whether the protein is in an active or 
inactive state based on the identity bound nucleotide. To date researchers 
investigating the mechanistic basis for mutant phenotypes in R-proteins in this 
domain have had to rely primarily on homology modelling. For R-proteins the two 
most likely candidate templates for homology modelling are Apaf-1 and CED-4. 
These two proteins share low sequence identity with many R-proteins, typically 
<25%, which reflects the evolutionary diversity of this protein family. Although 
confidence in homology modelling is improved with higher sequence identity, the 
environmental and functional constraints of these proteins is assumed to limit 
structural diversity for these proteins, allowing inference of mechanistic properties in 
the absence of structural studies using more similar proteins.  
NRC1 was first identified in a silencing screen as an important down-stream 
component for multiple plant immune pathways156. Although positioned functionally 
downstream of canonical R-proteins, NRC1 shares a typical CC-NBARC-LRR 
domain arrangement, and has conserved motifs: notably Walker-A, Walker-B, and 
MHD (actually VHD in this protein) motifs. The behaviour of NRC1 reflects other 
CNL proteins in planta: aspartate to valine mutations in the MHD motif lead to 
autoactivation, and loss of the highly conserved Walker-A lysine leads to complete 
inactivation157. On the basis of shared architecture, and predictable responses to 
well-characterised mutations, we believe that the fundamental biochemical and 
structural properties of NRC1 will be applicable to other CNLs.  
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In this project we set out to use the unique tools developed in Chapter 3 to 
structurally characterise NRC1 NBARC. With previously characterised NBARC 
domains all originating from animal homologs (Apaf-1, CED-4, DARK, NLRC4) an 
understanding of a plant-derived NBARC domain can allow investigation of 
structural conservation from a more diverse context. Additionally an experimentally-
derived structure of an NBARC domain from an R-protein may help better interpret 
the importance of conserved motifs, mutant phenotypes and act as a more 
appropriate template for homology models. 
5.2 Results and discussion 
5.2.1 Expression and purification of recombinant NRC1 NBARC 
domain in E. coli and Insect cells 
Note: Cloning of NRC1 NBARC domain was performed by Richard Hughes. Insect 
cell expression was performed by Heater Rata and Joanne Nettleship 
Heterologous expression of pOPIN-S3C:NRC1-NBARC was performed following 
the conditions identified in Section 3.5.3. E. coli carrying the recombinant plasmid 
were grown in PowerBroth media at 37°C with constant shaking until cultures 
reached an OD600 of approximately 0.6. Cultures were then rapidly chilled on ice 
and protein expression induced by addition of 1mM IPTG. Protein expression was 
allowed to continue for 16 hours at 18°C before the cells were harvested by 
centrifugation, re-suspended, and lysed by sonication. Insoluble cell lysates were 
removed by centrifugation and the soluble tagged-protein purified by immobilised 
metal affinity chromatography (IMAC) using a 5mL pre-equilibrated nickel affinity 
column. Further purification was performed by size-exclusion chromatography 
(SEC) following single-step elution of bound proteins from the IMAC column. The 
protein eluted from the column as a broad A280 peak, with a number of contaminants 
co-eluting, as determined by SDS-PAGE (Figure 5.2.1 B). Fractions predicted to 
contain the Sumo-tagged NBARC domain with minimal contaminants were pooled 
and concentrated to 10-20mL; tag removal was performed by incubation with 3C 
protease at 4°C overnight.  
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Figure 5.2.1 Purification of SUMO-tagged NRC1 NBARC 
 
Cleaved protein was purified by subtractive IMAC, flow through and unbound 
washes collected and concentrated to <5mL before a final purification step and 
buffer exchange by SEC. The resulting peak was typically tighter than seen with 
SUMO-tagged protein, and interestingly either eluted at a similar or smaller volume 
as SUMO-tagged protein. Typically decreasing the molecular mass of a protein by 
~20% (removal of a 13kDa tag from a ~50kDa fusion) would be expected to result in 
an observable increase in elution time, as the smaller molecule is able to explore 
more of the column matrix. SDS-PAGE was used to determine the fractions 
A.) Gel filtration trace showing protein eluting from superdex sepharose S75 column. 
Protein elution peaks at ~144mL with total protein elution spanning ~80mL. Void volume 
of the column is ~110mL. A minor elution peak (seen here as a shoulder) at a smaller 
volume indicates a fraction of the protein eluting as a large complex. 
B.) SDS-PAGE of fractions eluting from A. Red arrow indicates SUMO-tagged NRC1 
NBARC. Although NRC1 NBARC is the most abundant single protein in these samples, 
multiple bands indicate low purity and the need for further purification. 
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containing NRC1 NBARC domain at over 90% purity, which were subsequently 
pooled and concentrated for downstream experiments (Figure 5.2.2). 
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Figure 5.2.2 Final purificaton of the NRC1 NBARC domain 
 
Through these two rounds of purification we were able to produce reasonable yields 
(0.5-1mg protein per litre bacterial culture) of protein at high purity. The observation 
that tag cleavage often led to either no change in elution volume, or a decrease in 
elution volume, suggests that the protein may not be monomeric under these 
conditions, however these data are collected from preparative gel filtration and so 
this is explored further in Section 5.2.4. 
Insect cell expression to obtain protein for crystallographic studies, and experiments 
described in Chapter 6, was performed as described in Section 2.8.2. Pelleted cells 
A.) Gel filtration trace for the purification of NRC1 NBARC domain following cleavage of 
N-terminal SUMO tag. Protein elutes clearly from the void-volume (110mL) in a single 
peak centred around 137mL. 
B.) SDS-PAGE of fractions eluting from S75 column. Tag cleavage, IMAC and gel 
filtration results in high-purity protein. In this example the first two lanes are discarded 
due to the presence of a high-molecular weight contaminant. 
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were re-suspended in ~30mL of lysis buffer and lysed by cell disruption at 14 kpsi. 
Lysates were clarified by centrifugation and passed through a 0.45μM filter. Soluble 
protein was purified by IMAC followed by gel filtration. SDS-PAGE of fractions 
following SEC showed that fractions containing the target protein contained few 
contaminants (Figure 5.2.3).  
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Figure 5.2.3 SDS-PAGE of His-tagged NRC1 NBARC domain purified from insect cells 
 
After fractions were pooled and concentrated to <10mL the N-terminal tag was 
removed by incubation with 3C protease at 4°C overnight. Any residual tagged 
proteins, including the 3C protease, were removed by subtractive IMAC. Flow-
through and washes were concentrated and purity confirmed by SDS-PAGE (Figure 
5.2.4). 
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Figure 5.2.4 Assessment of wild-type protein purity from insect cells and E. coli 
 
4-20% Tris-glycine gel stained with coomassie shows few contaminants co-eluting with 
his-tagged NRC1 NBARC domain (indicated by red arrow). 
Wild-type protein derived from either E. coli (WT E) or insect cells (WT IC) separated on 
a 12% SDS- polyacrylamide gel, visualised by coomassie staining.  
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Despite undergoing only a single round of SEC, the purity of insect-cell derived wild-
type protein shows a high level of purity, comparable to that of E. coli derived 
protein following two rounds of IMAC/SEC. 
 
5.2.2 Assessment of folding and thermal stability by circular dichroism 
 
Separation of the purified proteins by SEC indicated that the protein had a distinct 
elution volume, clearly distinguishable from the void-volume of the column. This is 
indicative that the protein does not form high-order oligomers or aggregates, and 
suggests that NRC1 NBARC is able to take on a stable fold when purified from 
heterologous over-expression in E. coli. Circular Dichroism is a method that records 
the spectral absorption of circularly polarized light as it passes through a protein 
solution. Specific wavelengths are differentially absorbed by protein secondary 
structure elements; alpha-helices show a peak in absorption at 208nm with a 
second peak at 222nm, whereas beta-strands typically absorb most strongly at 
218nm and display a positive peak at 196nm. By comparing the transmission 
spectra of proteins of unknown fold with those of known proteins it is possible to 
calculate the secondary structure elements present in a protein. Secondly CD can 
be used to determine whether the introduction of specific point mutations has a 
significant impact on a protein’s secondary structure through comparison with wild-
type protein. Modern CD machines may also be able to measure and regulate 
sample temperature, making it possible to determine the thermal stability of proteins 
by measuring the loss of secondary structures over increasing temperatures. 
NRC1 NBARC protein was prepared as described in section 5.2.1 and concentrated 
to 10mg/mL, as determined by A280. As high salt concentrations and certain buffer 
components (such as HEPES) interfere with CD spectra, the protein was diluted in 
phosphate buffer to 0.1mg/mL to reduce these buffer effects. Spectra were collected 
from 180 to 260nm, with three measurements taken per wavelength per sample. 
Initial characterisation of the secondary structure elements were performed by 
measuring circular dichroism from 185 to 260nm at 20°C (Figure 5.2.5).  
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Figure 5.2.5 Circular dichroism spectrum of NRC1 NBARC 
 
The curve produced shows a predominantly alpha-helix structure, as determined by 
the negative peaks at 222 and 208nm, with a positive peak at 196nm indicating the 
presence of β-strands. We also used CD spectroscopy to look at the effects of 
increasing temperature on the structure of WT NRC1 NBARC. Along with gaining 
information about the thermal tolerance of the protein (a useful proxy for stability), 
different transitions in unfolding can be used to infer structural information, such as 
whether there are defined substructures which may be more susceptible to 
unfolding. Thermal ramping experiments were performed as described above, with 
temperature increases of 1°C each minute from 20°C to 89°C. Analysis by Global 
3™ (AppliedPhotosystems) of CD spectra identifies a single melting transition of 
approximately 54.5°C (Figure 5.2.6) 
Average and buffer subtracted CD spectrum for NRC1 NBARC domain. Data were 
collected in 0.5nm steps in triplicate with buffer signal subtracted to give the final trace.  
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Figure 5.2.6 Thermal melt curves for NRC1 NBARC 
 
With no examples of solubly expressed R-protein NBARC domains published to 
guide the design of well-behaved constructs, we used circular dichroism to 
determine that NRC1 NBARC expressed solubly in E. coli could produce expected 
secondary structures. Furthermore, thermal ramping CD experiments indicate that 
the protein has a reasonably high melting temperature, suggesting that the protein 
is stable in solution and suitable for downstream experiments. 
A.) Three-dimension graph showing circular dichroism (measured in millidegrees, mdeg) 
plotted against wavelength (nm) and temperature (°C). Major deformation in the curve at 
approximately 50°C indicates loss of secondary structure and protein melting. 
B.) Curve monitoring the relative concentration of species in solution against 
temperature. Trace 1 denotes folded NRC1 NBARC, with trace 3 representing melted 
protein. Trace 2 is indicative of an unfolding intermediate. Analysis of data indicates a 
melting temperature of 54°C for NRC1 NBARC. 
 Page 148 of 232 
 
 
5.2.3 Preliminary small-angle X-ray scattering experiments suggest a 
rigid, globular fold 
 
SAXS uses the interactions between proteins in solution and X-rays to determine a 
number of protein characteristics, as such it can supplement other spectroscopic 
methods to assess protein folding and flexibility. Wild-type NRC1 NBARC domain 
was purified as described  above and prepared at 10, 5, 2.5, 1.25, 0.625 and 0.3125 
mg/mL for data collection at Diamond light source (Oxfordshire) beamline B21. 
Buffer samples were taken for subtraction against 18 experimental frames, with 
averaging and subtraction performed by Scatter. Data collected at 1.25mg/mL and 
0.625mg/mL was analysed using the DANESSA automated data processing 
pipeline. Additional manual analysis was performed in Scatter. Manual data 
processing focussed on data collected at 1.25mg/mL (Figure 5.2.7). 
A.
 
B.
 
Figure 5.2.7 Scattering intensity-by-angle plots for NRC1 NBARC 
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Data collected at 1.25mg/mL were used as the basis for these experiments as at 
this concentration showed no signs of inter-particle interactions, a fundamental 
requirement for SAXS experiments. Having established the suitability of this data for 
SAXS analysis we generated normalized Kratky plots to determine the folding and 
symmetry of the protein in solution (Figure 5.2.8). 
 
Figure 5.2.8 Normalized Kratky plot of NRC1 NBARC SAXS 
From the normalised Kratky plot we are to determine that the protein is folded in 
solution, in concordance with CD data indicating the presence of secondary 
structures (Section 5.2.2). A peak marginally to the right of √3 suggests that the 
protein is largely symmetrical in solution. Given the qualitative nature of this plot and 
the incomplete nature of the crystal structure of NRC1 it is not possible to determine 
whether conformational changes have occurred between solution and crystal 
structure. 
A. Plot of all scattering data collected for NRC1 NBARC at 1.25mg/mL. Y-axis 
denotes scattering intensity (log scale) with x-axis showing angle of scattering 
B. Close-up of scattering intensity at low scattering angles. Low scattering angles 
are more susceptible to effects of aggregation or inter-particle repulsion, which 
would be seen as dramatic changes in intensity over increasing scattering 
angles. The smooth progression seen here indicates that there are few inter-
particle interactions at this concentration. 
The dimensionless (normalized) Kratky plot of NRC1 NBARC X-ray scattering. Perfectly 
symmetrical, species show a hyperbolic curve with a peak at √3. NRC1 NBARC shows 
the hyperbolic trace consistent with folded proteins and peaks slightly to the right of √3 
indicating a slight deviation from absolute symmetry.    
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Given our hypothesis regarding the histidine of the MHD motif acting as a locking 
mechanism (Section 7.4) we were interested to see whether NRC1 NBARC domain 
showed rigidity in solution, or whether there was the potential for spontaneous 
dissociation of the ARC2 domain to give a more open conformation, which we would 
predict would lead to spontaneous activation in planta. One way to explore this for 
isolated proteins in solution is to look for the presence of a Porod plateau when data 
is presented in a Porod-Debye plot (Figure 5.2.9). 
 
Porod plateau 
 
Figure 5.2.9 Porod-Debye plot of NRC1 NBARC SAXS  
 
Plateauing of the Porod-Debye plot indicates that there exists a sharp, well-defined 
difference in electron density between NRC1 NBARC and solution. This in turn is a 
qualitative measure of how compact a protein is; flexible proteins show less discrete 
contrast in electron density and so cannot fulfil the assumptions of the Porod-Debye 
fourth power law to give a plateau when scattering data are transformed in this 
manner. Instead, more flexible proteins show a continued increase in q4 x I(q) over 
increasing q4. 
Preliminary SAXS data analysis presented here support the conclusions drawn from 
preparative gel filtration and circular dichroism experiments. The NBARC domain 
produced from E. coli appears to be well-folded, stable in solution and therefore 
suitable for further characterisation. 
   
Plotting SAXS data collected for NRC1 NBARC domain at 1.25mg/mL transformed as 
q4∙I(q) vs q4 (where q is scattering angle in A-1 and I(q) is the intensity of scattering at q) 
allows identification of Porod-plateau for compact proteins. Proteins will only show a 
Porod-plateau in this plot if they fulfil the assumptions of defined homogenous contrast in 
electron density between particle and solvent. 
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5.2.4 Investigating NRC1 NBARC oligomeric state in vitro 
 
Removal of the SUMO tag during purification does not lead to an increase in elution 
volume of the NBARC domain, which would normally be expected when the 
molecular mass of the protein is decreased by ~13kDa. Dynamic light scattering 
(DLS), a method that can be used to approximate the size of a species in solution 
based on its ability to scatter light, indicated that purified NBARC formed species 
with an approximate molecular mass 81kDa in solution (Table 5.2.1). 
Collection Peak R (nm) MW 
(kDa) 
% Mass 
1 1 3.7 72 97.2 
  2 16.2 2266 2.7 
2 1 3.7 70 99.2 
  2 20.3 3861 0.8 
3 1 4.3 102 99.4 
  2 27.6 7902 0.5 
4 1 4 87 97 
  2 17.5 2714 2.9 
Table 5.2.1 Estimation of NRC1 NBARC particle size in solution 
 
Although DLS can be a useful technique for investigating qualitative differences in 
protein behaviour (for example reduction of aggregation in different buffers), it is not 
sensitive enough to infer accurate molecular masses with confidence. In order to 
more accurately determine the size of the protein in solution, we employed 
analytical gel filtration (aGF) using a sepharose 10/300 GE column. Gel filtration is a 
method for separating out proteins based on molecular size and shape by the 
volume required for the protein of interest to pass through a column. In gel filtration 
small molecules are able to permeate the entire column, and are thus able to 
“explore” the inter-pore and inter-particle (in this case sepharose beads) volume, 
leading to a large elution volume. Large molecules are unable to penetrate the 
pores and so can only explore the inter-particle volume, thus eluting in a smaller 
Dynamic light scattering experiments of NRC1 NBARC domain in 20mM HEPES pH 7.5 
and 150mM NaCl shows that the majority of species in solution have an estimates 
molecular weight of 70-102kDa. Averaging data from the most biologically-relevant size 
range gives an approximate mass of 81kDa + 15.5.  
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volume. By comparison against the elution of known molecular weight standards it 
is possible to calculate the molecular mass of an unknown species in solution. 
NRC1 NBARC consistently eluted with a single peak at 10.3mL, corresponding to a 
species with approximate molecular mass of 63kDa (Figure 5.2.10), giving a mass 
intermediate of expect monomer (~40kDa) and dimer (~80kDa). 
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Figure 5.2.10 Analytical gel filtration for wild-type NRC1 NBARC 
 
Analytical gel filtration requires two main criteria for accurate mass determination- 
that the protein be approximately globular, and that the protein does not interact 
with the column matrix. Experiments with NRC1 give somewhat ambiguous results 
as neither identifiable peak aligns well to an expected molecular weight for NRC1 
NBARC. It is possible that these two peaks correspond to NRC1 NBARC as a 
monomer (minor peak) and dimer (major peak) or dimer and trimer, with delayed 
elution due to protein-matrix interactions. Data from DLS suggesting that the major 
species in solution is ~73kDa would favour the latter interpretation, however this is 
not unequivocal.  
5.2.5 Crystallisation of NRC1 NBARC domain 
5.2.5.1 Sparse-matrix screening and optimisation 
Purified NRC1 NBARC domain was prepared as described in Section 5.2.1, with 
fractions showing >90% purity as determined by SDS-PAGE being pooled and 
concentrated to 10mg/mL measured by A280. Commercial sparse-matrix 
crystallisation screens were used to identify appropriate conditions for the 
crystallisation of NRC1 NBARC. Seven different 96-well screens were used (JCSG, 
Structure screen 2, PACT, and Morpheus screens from Molecular dimensions, 
Analytical gel filtration of wild-type NRC1 NBARC domain shows a major elution peak at 
10.3mL. A second minor elution peak is identifiable at 9.546mL, corresponding to 
molecular weights of 63 and 90kDa respectively 
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Ammonium sulphate and PEG suite screens from Qiagen) to maximise the 
sampling of crystallisation space. Screens were set up in 96-well, sitting drop plates 
with two protein concentrations per reservoir (10mg/mL and 5mg/mL) and wells 
dispensed using an OryxNano (Douglas instruments) micro-volume liquid handling 
robot. From these initial screens several conditions capable of initialising crystal 
growth were identified (e.g. Figure 5.2.11). 
 
Figure 5.2.11 PACT screen crystal hits 
 
Many crystals from these initial sparse-matrix screens were too small, showed 
defects such as splits, or were surrounded by heavy precipitation, and so 
optimisation screens were performed to improve these crystals. Optimisations 
typically take the conditions identified in sparse-matrix screens and systematically 
vary conditions in an attempt to produce larger or better formed crystals. 
Optimisation screens performed here were typically in the form of precipitant by pH 
matrices, however changes in ratio of reservoir condition-to-protein volumes in the 
drops, and varying initial protein concentration were also investigated  
The crystals pictured in Figure 5.2.11 were not reproducible in optimisation screens, 
and so alternative conditions were identified from the PACT screen, with 25% PEG 
1500, MMT buffer pH 4.0, 5.0 or 6.0. Precipitant vs pH screens in 48-well, sitting 
drop screens showed that crystallisation could occur at much lower PEG and 
protein concentrations. For native NBARC domain an optimal pH of 4.5-4.6 was 
identified for these conditions, with lower pH leading to rapid and uncontrolled 
Crystals formed from 96-well, sitting drop vapour diffusion experiments. Protein was 
mixed 1:1 with reservoir conditions to a total volume of 0.6uL. Drops show crystal growth 
in 0.1M MES buffer pH 5 and 25% PEG 6000 supplemented with (from left to right) 0.1M 
NH4Cl, 0.1M LiCl, 0.1M NaCl. (Note, left and centre drops formed with initial protein 
concentration 10mg/mL, right drop used initial protein concentration of 5mg/mL). Red 
ovals highlight crystals 
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precipitation and higher pH leading to clear drops. Interestingly, despite thorough 
screening it was not possible to produce NRC1 NBARC crystals without 
considerable precipitate also forming.  
We were not certain that existing crystal structures would be able to be used for 
molecular replacement (MR) for solving the phases for the crystal structure of NRC1 
NBARC, and so prioritised production of protein incorporating the heavy atom (HA) 
selenium (as selenomethioine, SeMet) for crystallisation. Introduction of heavy 
atoms into crystals either incorporated into the protein during synthesis, or by 
soaking crystals in solutions with high concentrations of heavy atoms such as 
bromide or iodide allows us to approximate phases using two methods. Either 
comparisons can be made between the intensity of diffracted spots from HA-derived 
crystals and native crystals (isomorphous replacement), or by using X-rays with a 
wavelength corresponding to the absorption maximum of inner-shell electrons in the 
heavy atoms (SAD). Structure solution by SAD relies on the violation of Friedl’s law: 
that the intensities of symmetry-related reflection are equal, and can be used to 
locate anomalous scatterers (heavy atoms) within the unit cell.  These experimental 
methods were preferable not only because we were unsure about the suitability of 
existing structures for molecular replacement, but also as they are less-susceptible 
to bias than MR.   
SeMet NRC1 NBARC was produced as described in Section 2.8.2 and crystallised 
following the same method as above. The best SeMet crystals were found to form in 
0.1M MMT buffer pH 5.0 with 15% PEG 1500. Crystals were then washed in 
cryoprotectant and frozen in liquid nitrogen before being transported for X-ray 
diffraction experiments.  
5.2.5.2 Screening for alternative crystal forms- seeding and additive screens 
Due to difficulties completing the structure of NRC1 (see Section 5.2.11), 
crystallisation screens were set up to identify new crystal forms using two methods: 
additive screening and seeding. Additive screening typically attempts to improve 
crystals by the use of various ions and small molecules to affect existing 
crystallisation and packing. As the crystals grew most reliable and consistently at pH 
4.5 in 8% PEG 1.5K, two 48-well plates were set up with 130μL of these conditions 
in each reservoir. To each reservoir 20μL of silver bullet additive screen (Hampton 
research corp.) were added and plates monitored for crystallisation. Drops were set 
up as for typical optimisations that had proven to be reproducible, 1μL of protein at 
8mg/mL mixed with 1μL reservoir condition. Heavy precipitate was seen in all 
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conditions, and so the concentration of additive was decreased to a one in 15 
dilution. However, this did not lead to any improvement to the rapid and uncontrolled 
precipitation in the experiment. 
In micro-seeding experiments, fragments of existing crystals to allow crystal growth 
to occur in conditions that do not necessary promote crystal nucleation (Figure 
5.2.12). We used seeding for two main experiments: improve existing crystals by 
iterative seeding, and using seed stocks in sparse-matrix screens to identify new 
crystal forms. To create a seed stock, crystals grown in 11% PEG 1500 at pH 4.5 
were mechanically broken in situ, and then diluted in ~150μL of reservoir solution. 
Crystals were further fragmented by several short bursts of vortexing before being 
rapidly frozen in liquid nitrogen and stored at -80°C until required.  
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Figure 5.2.12 Schematic of crystallisation experiments 
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We hypothesised that protein precipitation seen in NRC1 NBARC crystallisations 
may be limiting the material available for crystal growth once nucleation has 
occurred. We therefore performed iterative seeding experiments, introducing 
nucleation sites before precipitation could occur. Although seeding was able to 
recapitulate and facilitate crystal growth in the existing pH 4.5, PEG 1.5K conditions, 
including reducing the minimum protein and PEG concentrations needed to form 
crystals, there remained a high level of precipitation in conditions supporting 
crystallisation. Iterative rounds of seeding, whereby the best crystals were used to 
produce fresh seed stock to re-seed around the same conditions, resulted in almost 
identical crystals, tapered or split rods with medium- to high levels of precipitation. 
Alternatively sparse-matrix screening using seed stock identified multiple additional 
crystallisation conditions (Table 5.2.2). 
None of the identified conditions yielded better looking crystals, or ones with an 
obviously different morphology. Crystals with different morphologies were desirable 
as they are less likely to share the same pathologies that may have affected 
electron density in existing crystals. Three examples of crystals grown in different 
conditions were flash-frozen and sent to the Diamond light source synchrotron for 
data collection, however no protein diffraction was seen for any of these new forms 
 
 
 
 
The outcome of protein crystallisation experiments is highly sensitive to (amongst other 
things) the concentration of protein and precipitant used. The majority of sparse-matrix 
screens will typically result in clear drops (scenario A.) or uncontrolled precipitation 
(scenario B.). In A. the concentration of protein or precipitant does not reach the threshold 
to initiate crystal formation. In B. initial protein or precipitant concentration results in 
uncontrolled precipitation of the protein before ordered nucleation sites can form. C. shows 
an ideal condition. The as the drop and reservoir equilibrate the protein and precipitant 
concentrations in the drop increases to the point where crystal nucleation sites for. As 
these nucleation sites form, the concentration of protein decreases until nucleation can no 
longer occur and the drop reaches a metastable condition suitable for growth of existing 
micro crystals. Small crystals such as seen in Figure 5.2.11 left-hand panel arise when 
metastable conditions are not reached before depletion of the protein and so significant 
crystal growth cannot occur. D. shows a micro-seeding experiment. Ground crystals act as 
nucleation sites, bypassing the need for the delicate balance between scenario A and B. 
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pH Precipitant Concentration Additive 
5.5 PEG 3K 20.0% - 
5.5 PEG 10K 17.0% 
0.1M Ammonium 
acetate 
5.5 PEG 3350 25.0% 
0.2M Ammonium 
sulphate 
7 PEG 3350 15.0% Succinic acid 
6.5 P550MME_P20K 30.0% Carboxylic acids 
7.5 P550MME_P20K 30.0% Amino acids 
6.5 EDO_P8K 30.0% Divalents 
6.5 MPD_P1K_P3350 37.5% Ethylene glycols 
6.5 MPD_P1K_P3350 37.5% Carboxylic acids 
7.5 MPD_P1K_P3350 37.5% Amino acids 
6.5 P550MME_P20K 30.0% Monosaccharides 
5 PEG 1500 25.0% MIB buffer 
6 PEG 1500 25.0% MIB buffer 
Table 5.2.2 Conditions resulting in NRC1 crystal growth from seeding 
 
5.2.5.3 Screening for improved crystals- alternative protein source 
 
Having tried several methods to improve crystal packing and identify new crystal 
morphologies, we investigated whether protein derived from a different expression 
system may have subtle differences that may lead to changes in crystal packing. 
Wild-type NBARC domain was expressed in Sf9 insect cells by J. Nettleship and H. 
Rada at Oxford Protein Production Facility. Protein was purified from insect cells as 
Summary table for conditions giving rise to the most promising crystals (based on 
morphology) from seeding. PEG: polyethylene glycol. MPD_P1K_P3350: (RS)-2-methyl-
2,4-pentanediol with PEG 1K and polyethylene glycol monomethyl ether 550. EDO_P8K: 
ethylene glycol and PEG 8K. P550MME_P20K: polyethylene glycol monomethyl ether 
500 and PEG 20K. 
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described in Section 2.8.2. Purified protein was then used in PACT 96-well screen 
to identify conditions suitable for crystallisation. Wild-type insect-cell derived protein 
(WTIC) crystallised in similar conditions to the E. coli derived protein, with a 
generally similar morphology: hexagonal rods, with some tapering and splits. On the 
whole, however, these crystals appeared better formed, with less precipitation, 
fewer splits, and a greater proportion growing to form large rods (Figure 5.2.13). 
The most promising crystals were identified in 0.1M HEPES pH 7.5 with 25% PEG 
6K and 0.2M NaCl, and so these conditions were used for optimisations. Initially 
these crystals could not be reproduced, however using a seed stock from E. coli 
derived protein co-crystallised with ATP-γ-S (chosen due to the large number of 
small crystals with very little precipitation), resulted in recapitulation of crystal 
growth. Optimisation of seed stock dilutions (screening undiluted, one in 10 and one 
in 100 dilution in a small PEG-by-pH screen) was able to produce drops containing 
approximately a dozen, large and well-formed crystals when the most dilute seed 
was used. As these crystals appeared well formed and with less precipitate, co-
crystallisations of WTIC NBARC with either ADP or ATP-γ-S using the same protein 
and seed stock were set up. Crystals were formed with both ADP and ATP-γ-S 
present, with the ATP analogue co-crystallisations resulting in smaller, rod-like 
clusters with some individuals for harvesting.   
 
Figure 5.2.13 Crystals of NRC1 NBARC domain purified from insect cells 
 
Wild-type NRC1 NBARC domain purified from insect cells crystallised from sparse-
matrix screens at pH 7.0 in 20% PEG 6K with 0.2M NaCl. Left shows visible light image- 
heavy precipitation makes individual crystal hard to distinguish. Right image shows 
same drop imaged under UV light. Strong fluorescence of protein crystals allows easier 
identification of crystals, and discriminates between protein (fluorescent) and salt (non-
fluorescent) crystals. 
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Crystals identified from this 96-well screen were typically larger than E. coli derived 
counterparts, with more examples of solid, well-formed crystals. Despite these 
general improvements, many crystals displayed splits or multiple crystals forming 
from a single point. 
5.2.6 Data collection 
Native and SeMet crystals were harvested, washed in cryo-protectant (as described 
in Section 2.16.5) and flash frozen in liquid nitrogen prior to shipping to the Diamond 
Light Source in Oxfordshire for data collection. For bromide and iodide SAD 
collections crystals were first soaked for 1 minute in a solution containing 0.5M 
potassium iodide or potassium bromide before washing in cryo-protectant also 
containing KI of KBr (Section 2.16.5). Data collection strategies were developed 
using EDNA following 3-5 test shots (Ω = 0.2°). Native and SeMet datasets were 
collected at λ= 0.9797Å to a resolution of 2.5Å and 3.2Å respectively. Iodide 
datasets were collected at λ= 2.0Å to a resolution of 3.24Å and bromide data sets 
collected at λ= 0.9200Å to a maximum resolution of 3.1Å.  
1250 images were collected for native data sets with a rotation angle (Ω) of 0.15°. 
For selenomethionine data collections 3000 images were collected with Ω = 0.15°. 
Bromide and Iodide datasets consisted of 2150 and 2400 images respectively.  
5.2.7 Data processing and structure solution 
 
Data were processed using the  XIA2 pipeline158 with XDS159 and Pointless160, 161, 
integrating over all images in each dataset. Processed data used for initial structure 
solutions are presented in Table 5.2.3. 
  
NRC1 NBARC  
Selenium peak 
NRC1 NBARC 
 native 
Data collection     
Instrumentation DLS-i04 DLS-i02 
Wavelength (Å) 0.9797 0.9795 
Resolution range (Å) 53.42 - 3.22 55.26 - 2.5 
Space group P64 P64 
Unit cell parameters 
a = b =110.53Å 
 c = 53.32Å 
a = b = 110.53Å 
 c = 53.32Å 
 
α = β = 90° γ = 120° α = β = 90° γ = 120° 
Completeness (%) 100 (100) 100 (100) 
Unique reflections 6159 13066 
Redundancy 21.7 (23) 10.4 (10.3) 
Anomalous redundancy 11.1 (11.6) - 
Rmerge 0.092 (0.815) 0.051 (0.785) 
I/σ(I) 21.2 (5.1) 26.7 (3.2) 
Number SAD sites* 5 - 
 
 Page 160 of 232 
 
Table 5.2.3 Data collection statistics for NRC1 NBARC 
Experimental phasing was performed using PHENIX Autosol162 using single 
wavelength anomalous diffraction (SAD) to give a solution with a figure of merit 
(FOM), a measure of initial phase accuracy, of 0.346. FOM values range from 0 to 1 
with scores above 0.45 classed as very good and between 0.25 and 0.45 as 
marginal. 
Initial phases calculated to 3.2Å were applied to high-resolution data (2.5Å) prior to 
model building. Refinement was performed using Refmac5161, 163 followed by 
manual building in Coot164. 
As the minimum Rfree attainable was greater than 0.3 (the typical cut-off for confident 
interpretation) SAD was performed using iodide- and bromide- soak derived 
datasets to try and improve initial phases (Table 5.2.4).  
  
NRC1 NBARC  
Bromide peak 
NRC1 NBARC  
Iodide peak 
Data collection     
Instrumentation DLS-i02 DLS-i04 
Wavelength (Å) 0.9150 2.0000 
Resolution range (Å) 95.51 - 3.10 95.21 – 3.24 
Space group P64 P64 
Unit cell parameters 
a = b =110.28Å 
 c = 53.35Å 
a = b = 109.94Å 
 c = 53.64Å 
 
α = β = 90° γ = 120° α = β = 90° γ = 120° 
Completeness (%) 99.9 (99.5) 100 (99.7) 
Unique reflections 6886 6036 
Redundancy 22.1 (22.6) 19.4 (20.0) 
Anomalous redundancy 11.3 (11.5) 10.1 (9.7) 
Rmerge 0.151 (0.940) 0.126 (0.771) 
I/σ(I) 24.6 (3.9) 21.4 (4.7) 
Number SAD sites* 3 10 
 
Table 5.2.4 Bromide and Iodide SAD data collection 
 
Phasing using PHENIX Autosol was unable to produce valid phase solutions using 
either of these datasets, and combining phase information from multiple heavy atom 
Data used for experimental phasing and refinement following processing using the Xia2 
automated pipeline. Data presented in parentheses indicate statistics for high-resolution 
shell. *number of SAD sites determined by PHENIX AutoSol. 
Processing of data collected from NRC1 NBARC crystals following heavy atom soaking. 
Numbers in parentheses indicate statistics for highest-resolution shell. *SAD sites 
determined by PHENIX AutoSol HySS. 
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derivatives did not improve initial phases, possibly due to non-isomorphisms 
between crystals. 
5.2.8 Preliminary structure of the NRC1 NBARC domain 
Note: The structure of NRC1 NBARC domain remains incomplete. A key statistic, 
Rfree, which gives an indication of a model’s ability to explain experimental data 
remains at 0.333. Data models with Rfree above 0.3 should be interpreted with 
caution.   
5.2.9 Validating experimental phasing solutions 
 
Phase approximation by SAD using SeMet datasets and phase extension to 2.5Å 
native data in PHENIX AutoSol gave a figure of merit (FOM) of 0.346, indicative that 
a reasonable solution has been achieved. A more definite test of solution quality is 
investigation of the resulting electron density map. Good solutions to the phase 
problem should give rise to regions of continuous electron density, with clear solvent 
channel through the crystal. The resulting experimental map for NRC1 NBARC 
domain shows both clear solvent channels and interpretable electron density 
(Figure 5.2.14).  
x
y
z
A.
B.
D. E.
C.
 
Figure 5.2.14 Density-modified electron density map generated by experimental phasing 
 
A. AB face of NRC1 NBARC unit cell solved by experimental phasing. Blue regions 
indicate electron density (2.5σ), separated by clear solvent channels. B. Electron density 
(1.5σ) consistent with β-strands. C. Interpretation of density in (B.) Spheres correspond 
to Cα atoms joined by peptide bonds. D. Distinct density at 1.5σ corresponding to an α-
helix. E. Placement of protein backbone into density of D.  
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The clear and interpretable electron density generated by experimental phasing 
strongly suggests that a valid solution for phases has been calculated. Interestingly 
we were able to identify a continuous region of electron density in the putative 
ligand binding pocket that was distinct from protein backbone in this region. 
Preliminary analysis indicated that this density was consistent with ADP (Figure 
5.2.15). 
A. B.
 
Figure 5.2.15 Identification of distinct non-main chain electron density and fitting of ADP 
 
ADP was not added during purification nor was it present in crystallisation 
conditions, and therefore the bound ADP identified in the electron density must have 
co-purified with the protein. This suggests a high affinity for the ligand, as 
purification was performed over two days and included two rounds of preparative-
scale gel filtration. Co-purification of nucleotides has been observed for the NBARC 
domains of Apaf-1 and CED-4, as well as the full-length NLRC4 protein, indicating 
high nucleotide affinity as a common feature of NBARC domains.  
Having determined that we have been able to obtain a valid solution to generate 
electron density of the crystal structure of NRC1, with clear electron density around 
the ligand binding site and ARC2 subdomain, we performed several rounds of 
manual model building and refinement. Although refinement typically leads to a 
comprehensive structural model that adequately describes experimental data, 
refinement can introduce biases into electron density maps and should be 
considered when investigating structures with poor associated statistics. 
 
A. Building protein backbone (blue cylinders) into experimentally derived electron density 
at 1.75σ shows a region of electron density that cannot be explained by protein main 
chain or side-chains. B. Placement of a ball-and-stick representation of ADP into this 
region of electron density shows a good fit to existing density. Red spheres indicate 
oxygen atoms, phosphate atoms are orange, carbons green and nitrogen atoms blue.     
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5.2.10 Investigation of preliminary refined structure and maps 
  
As part of the PHENIX AutoSol pipeline, a preliminary model interpreting the 
electron density was produced by PHENIX AutoBuild. This preliminary model did 
not fully explain the existing electron density, and was unable to assign amino-acid 
identities to many residues. Model improvement was performed in COOT by 
building Cα traces in obvious regions of density. Identified heavy atom sites were 
used to assign identities to many residues, and were of particular use around the 
putative ligand binding site, where strong electron density made interpretation more 
difficult. After manual building phase refinement was performed using Refmac5. The 
output from this refinement was then used to identify regions with negative electron 
density in the 2Fo-Fc map and Cα traces extended where appropriate. Several 
rounds of refinement were performed in this manner, comparing refined maps 
against the original density-modified maps from PHENIX AutoSol to ensure that 
refined maps did not significantly diverge from the experimentally-derived electron 
density map. 
5.2.10.1 Electron density interpretation results in a structure closely resembling 
Apaf-1 
Although model building remains incomplete due to regions of missing or poorly 
resolved electron density (Section 5.2.11), it has been possible to interpret large 
regions of the protein to give an idea of the general domain arrangement (Figure 
5.2.16). 
A. B.
 
Figure 5.2.16 Comparison of the partial structure of NRC1 NBARC domain (A.) and the 
crystal structure of Apaf-1 NBARC domain (B.). 
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This preliminary structure shows four β-strands corresponding to the Rossmann fold 
found in multiple NTPases, an α-helical “bundle” of the ARC1 subdomain and the 
winged-helix fold of the ARC2 subdomain. Comparison with Apaf-1 NBARC shows 
high similarity in domain composition and organisation. Given the preliminary nature 
of the NRC1 NBARC crystal structure, and the observation that electron density 
outside of the ligand binding site and ARC2 domains is less well defined, detailed 
comparisons of these regions may not be appropriate. In general terms however, 
the overall fold of these two domains is broadly very similar, in agreement with 
predictions from homology modelling.   
Electron density in the refined maps is weakest in peripheral regions of the protein, 
particularly the ARC1 domain and α-helices around the NB domain, however given 
the quality of electron density around the ligand binding pocket, and positioning of 
SeMet residues we have been able to confidently interpret this region and draw 
some preliminary conclusions.  
5.2.10.2 Identification of ligand-interacting residues 
 
By interpreting the experimental electron density map, aided by the positioning of 
selenomethionine residues, we were able to identify key residues interacting with 
the bound ADP (Figure 5.2.17). 
 
 
Figure 5.2.17 Identification of residues interacting with bound ADP 
A. Preliminary crystal structure of NRC1 NBARC domain. B. Crystal structure of Apaf-1 
NRC1 NBARC domain. NB domain coloured in blue, ARC1 in green and ARC2 
subdomain in purple. Structures can be superimposed in CCP4MG with an rms of 2.11 
over 213 residues.  
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Given the incomplete nature of the structure presented here, and the statistics 
associated with model accuracy, inferences from such incomplete representations 
should be made with caution. Despite this the preliminary structure shows good 
electron density in certain regions, notably in the ligand-binding and ARC2 domain, 
and structural features give us greater confidence in our interpretation of the 
electron density. These structural features relate to three known functional motifs: 
the Walker-A motif, Walker-B motif and MHD motif. 
5.2.10.3 Positioning of the Walker-A lysine  
 
The conserved lysine in the Walker-A motif of plant NBARC domains is known to be 
essential for function in planta. Furthermore, work with various NTPases highlights 
the role of this residue in nucleotide binding. Mutations to this residue frequently 
result in a loss of binding, with structural examples demonstrating the direct role for 
this residue in protein-ligand interactions. The crystal structure of NRC1 shows this 
lysine positioned in close proximity to the β-phosphate of bound ADP, forming 
charge-charge interactions (Figure 5.2.18).  
 
 
Figure 5.2.18 Interactions between Walker-A lysine and ADP 
 
ADP is involved in multiple interactions between both side-chain and main-chain atoms 
of NRC1 NBARC domain. All three subdomains (NB, ARC1 and ARC2) contribute a 
number of potential interacting partners 
Lysine 191 of the conserved Walker-A motif is positioned within the ligand binding site, 
<3.3Å from the β-phosphate of ADP, allowing bond formation between both ADP and 
ATP. 
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The positioning of this lysine within the ligand-binding pocket, and its proximity to 
the bound ligand is in line with our expectations on the basis of prior knowledge 
regarding NTPase-ligand interactions. 
5.2.10.4 Conserved aspartate residues face the ligand-binding pocket  
 
The NBARC domain of two R-proteins have been demonstrated to catalyse the 
hydrolysis of ATP. This activity is normally attributed to the conserved Walker-B 
motif, which contains a catalytic aspartate residue. This residue directly or indirectly 
stabilises divalent cations (normally Mg2+), which are required for bond cleavage. 
The putatively catalytic aspartate of NRC1 is shown in Figure 5.2.19 
 
 
Figure 5.2.19 Location of conserved Walker-B residues 
 
As we would expect for functional ATPases, the conserved and putatively catalytic 
aspartate of NRC1 NBARC is located within the ligand-binding pocket, facing the β-
phosphate of bound ADP, and presumably any potential ATP β-γ phosphate bonds. 
Interestingly the second conserved aspartate in this Walker-B motif also faces the 
ligand-binding site, which may explain residual activity seen in Section 6.2.7.  
5.2.10.5 Involvement of the MHD motif in ligand interactions 
 
We were particularly interested to find the MHD motif located in very close proximity 
to the bound ligand. The high conservation of this motif, and the invariability of the 
central histidine in particular suggested that this motif is functionally important. 
Both the predicted catalytic aspartate residue D268 and neighbouring D267 of the 
Walker-B motif face into the ligand-binding pocket of NRC1, in proximity to β-phosphate 
of bound ADP and predicted β-γ bond of hypothetic ATP molecules. 
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Mutations in this motif lead to autoactivation, suggesting a role in regulation, and 
experiments linking this autoactivation to changes in ligand occupancy point to 
potential changes in protein-ligand interactions. In this crystal structure we see the 
central histidine <4Å from the β-phosphate of ADP, and therefore close enough to 
form salt bridges with the ligand (Figure 5.2.20).  
A. B.
 
Figure 5.2.20 Proximity of conserved "MHD" motif to bound ADP 
 
This proximity also suggests that an alternative conformation is required when the 
protein is bound to ATP, as the conformation presented here would lead to 
significant steric clashes between the histidine and γ-phosphate. This interaction 
may also play a role in preventing spontaneous activation, which is discussed later 
(Section 7.4). 
 
5.2.10.6 Global view of MHD and ADP 
 
Using this partial structure and the well-resolved data around the ligand-binding site 
of NRC1 NBARC we are able to hypothesise about the role of the MHD motif in 
protein regulation. Our data indicates that this “closed” conformation in the presence 
of ADP is unfeasible in the presence of ATP, given the positioning of the histidine 
central to the MHD motif.  Looking at this interaction in the context of the full domain 
can allow us to infer the potential for ATP binding to alter NBARC conformation 
(Figure 5.2.21). 
A. Electron density around the “MHD” (in this case VHD) motif of NRC1 NBARC 
domain and ADP at 1.5σ shows good fit for these two regions. Density for C-
terminal aspartate is present, although not as well defined. 
B. Atomic distances of 3.11Å between histidine and ADP β-phosphate is within the 
limits for salt-bridge formation (<4.0Å). 
 Page 168 of 232 
 
 
Figure 5.2.21 Histidine-ligand interaction in context of NBARC subdomains 
 
From this view we hypothesise that in the presence of the γ-phosphate of ATP, the 
NBARC domain will take on a more open conformation, with the ARC2 domain 
swinging away from the NB/ARC1 domains. This change is likely to be facilitated by 
the loop region connecting the first two helices in the ARC2 domain (lilac), giving the 
potential for flexible rearrangements between these regions.  
5.2.11 Uninterpretable electron density prevents completion of NRC1 
NBARC structure 
 
This crystal structure of NRC1 NBARC bound to ADP remains incomplete, despite 
significant efforts to improve model quality and electron density maps. There are 
two major regions of poor electron density that prevent model completion- the 
region corresponding to the ARC1 domain, and the regions expected to form 
connecting helices between the β-strands of the Rossmann fold (Figure 5.2.22). 
Cartoon representation of NRC1 NBARC domain (blue) with the side chain of the 
conserved histidine of the MHD motif and bound ADP represented as cylinders. Dashed 
line indicates potential salt bridge over a distance of 3.1Å. 
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A. C.
B. D.
.
 
Figure 5.2.22 Problematic regions of electron density preventing model completion 
Electron density can often be poorly resolved in highly-mobile protein regions, such 
as in loops or mobile domains. For the NBARC domain of R-proteins, no regions are 
predicted to be inherently flexible. The ARC1 domain has been suggested to act as 
a hinge region, and it may be that in an ADP-bound conformation, or in the absence 
of the CC/LRR domains, two helices are more flexible than the others and thus 
unresolvable. However the ADP bound structure of Apaf-1 gives no indications of 
this issue, and characterisation of the protein by SAXS suggests that the protein is 
rigid in solution. The Rossmann fold is not predicted to be flexible, and has been 
well resolved in other crystal structures. Given the large spatial separation of these 
two regions, and the well-resolved density of the ARC2 domain, which we 
hypothesise should be able to take on different respective conformations, it is 
unlikely that these pathologies are due to biological properties of the protein.  
Electron density and ribbon interpretation of problematic regions of the NRC1 NBARC 
crystal structure. A. and B. show the same region in the ARC1 domain at 1.5σ and 1.0σ 
respectively. This region is predicted to consist of a 4-helix bundle, however discontinuity 
of electron density prevents building of coherent structures. C and D show the same 
region at the top of the Rossmann fold β-strands at 1.5σ and 1.0σ respectively. 
Predictions based on other NTPases would indicate that each strand should lead into an 
α-helix, however density in this region is patchy at best.  
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An alternative explanation is that the data we have collected have an explicit 
pathology that manifests as disorder, for example the data may be twinned. 
Twinning tests performed by XTRIAGE do not clearly indicate twinning for the native 
or SeMet data sets, although some tests do give ambiguous results.  
We have screened multiple crystals from E. coli-derived protein to collect datasets 
without this potential pathology. SeMet-derived phases have been extended to 
several crystals from E. coli produced protein (resolutions ranging from 2.9-3.3Å), 
from both similar crystallisation conditions, and from conditions at significantly 
higher pH. Despite these screens the electron density from these datasets 
demonstrated the same issues in these regions of the protein.  
Native datasets from insect cell-derived protein crystals were collected (Table 5.2.5) 
and phases solved by molecular replacement using the most complete structure of 
NRC1 NBARC from the process described in Section 5.2.10. The resulting electron 
density maps showed little improvement in quality at problematic regions. 
  
NRC1 NBARC 
 WTIC 
Data collection   
Instrumentation DLS-i03 
Wavelength (Å) 0.9795 
Resolution range (Å) 55.4 - 2.88 
Space group P64 
Unit cell parameters 
a = b = 110.81Å 
 c = 53.39Å 
 
α = β = 90° γ = 120° 
Completeness (%) 100 (100) 
Unique reflections 8660 
Redundancy 19.9 (20.8) 
Anomalous redundancy - 
Rmerge 0.051 (0.785) 
CC half 0.999 (0.552) 
I/σ(I) 22.1 (2.1) 
Number SAD sites* - 
 
Table 5.2.5 Data collection for NRC1 NBARC crystals from Insect cell expression 
 
Data collections looking for changes in crystal packing, or improvements in derived 
electron density maps by using an alternate protein source. Although able to produce 
reasonable electron density maps following MR with the incomplete model of NRC1 
NBARC domain, overall electron density is not improved in problematic regions. Data 
were analysed automatically by the xia2 pipeline at Diamond Light Source 
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5.2.12 Using the preliminary structure of NRC1 NBARC  
 
The mechanistic basis for R-protein regulation has yet to be fully characterised 
structurally and biochemically. Despite the limitations in the structure described 
above we have been able to design a series of mutants to allow us to probe the 
biochemistry of NRC1 NBARC domain (Table 5.2.6). 
Mutation 
Expected biochemical 
effect 
Potential physiological 
effect 
K191A Loss of nucleotide binding Inactive R-protein 
 
D481V 
Unknown- potential 
increased ATP affinity or 
deficient ATPase activity 
 
Highly auto-active 
 
H480A 
Unknown- potential 
increased ligand 
exchange, or impaired 
ligand discrimination 
 
Mild auto-activation or 
constitutively inactive 
protein 
 
H480F 
Potential increased ligand 
exchange 
Autoactivation, mimicking 
active (ATP-bound) state 
 
D268N 
Significant reduction/loss 
of ATPase activity 
 
Auto-activation 
 
D267N 
Potential reduced ATPase 
activity 
 
None/mild autoactivation 
 
D268N_D267N 
Abolition of ATPase 
activity 
 
Autoactivation 
Table 5.2.6 Structure-guided mutants of NRC1 NBARC 
 
Specifically targeting residues that we see involved in different ligand interactions 
should allow us to better characterise how ligand binding, discrimination and 
hydrolysis influence the structure and activity of plant NBARC domains. By linking 
knowledge of the roles of motifs conserved in other proteins (such as the Walker-B 
motif), and phenotypes seen in in planta experiments we are able to suggest the 
resulting effect of different mutations on the biochemistry and in planta activity of 
NRC1 NBARC domain. Where these predictions are shown to be wrong will allow 
Mutants were selected for either their known effect on R-protein biochemistry and 
regulation in planta or to investigate the mechanistic basis for R-protein regulation. The 
crystal structure of NRC1 NBARC domain reveals an aspartate residue (D267) in close 
proximity to the predicted catalytic aspartate of the Walker-B motif (D268). To account 
for potential misjudgements in assigning residue identities in this region, and to prevent 
compensatory effects in response to either of these residues a double mutant 
(D268N_D267N) was included. 
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us to better assess the predictive capabilities of general models for R-protein 
regulation. 
5.3 Discussion 
We have used a range of structural techniques to investigate the physical properties 
of NRC1 NBARC domain and generate tools that will allow us to more fully explore 
the structural and biochemical basis for NRC1 regulation. Our data are consistent 
with a number of predictions, such as the structural similarity between Apaf-1 and 
NRC1 NBARC domains, and can partially validate hypotheses about R-protein 
structure-function relationships generated from indirect methods. Ambiguity 
regarding certain aspects of NRC1 NBARC behaviour in solution suggest that 
further experiments are required for full characterisation of this protein domain.  
5.3.1 Heterologous expression of NRC1 NBARC in E. coli results in 
well-folded protein 
We aimed to use a range of physical techniques to understand and characterise the 
basis of R-protein activation by investigating the NBARC domain of NRC1. At the 
time of writing there are no examples of the purification of solubly-expressed plant 
NBARC domains in the literature, and so the purification of soluble NBARC domain 
from NRC1 gives us a unique opportunity to explore the behaviour of this regulatory 
domain. The first notable aspect of this protein’s behaviour is that it does not appear 
to exist as a simple monomer in solution. This contrasts with our prediction that the 
NBARC domain would exist as a monomer in the inactive state, with the potential to 
oligomerise in response to activation as seen in the apoptosomes formed by APAF-
1 and CED-4. Ambiguity in analytical gel filtration data over the precise molecular 
mass of this species in solution could be resolved using additional experiments such 
as size-exclusion chromatography with multi-angle light-scattering (SEC-MALS), or 
analytical ultracentrifugation, which is not liable to artefacts from protein-matrix 
interactions.  
Furthermore the design of a solubly-expressing R3a coiled-coil construct was used 
to inform construct design to screen expression of multiple R-proteins and their 
domains in E. coli and insect cells (Section 3.5.1). This method allowed us to 
identify a further three coiled-coil domains that could be expressed solubly in E. coli. 
Our characterisation here of a well-behaving, solubly expressed R-protein NBARC 
domain may be used by future researchers to expand our repertoire of 
biochemically characterised R-proteins in a similar manner. 
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SAXS can be a very useful tool to complement many physical and biochemical 
techniques. Although X-ray crystallography is the gold standard for producing 
atomic details about protein structure, the need to crystallise proteins may lead to 
artefacts in conformation or oligomeric state. SAXS in contrast is unable to produce 
the high-resolution data of X-ray crystallography. The major benefit of SAXS is that 
the data are collected from experiments performed in solution. This can allow 
comparison of crystallographic conformations and solution envelopes to validate 
crystallographic structures. Beyond this SAXS can also be used to investigate 
specific protein properties. Calculations of Rg values and Porod volumes can give 
an idea of oligomeric state in the absence of high-resolution envelopes, and 
investigation of derived plots such as the normalised-Kratky plot can give 
information regarding the symmetry of a protein in solution. Of particular interest 
here is the ability to determine the flexibility of a protein by generating Porod-Debye 
plots. Having established these plots for wild-type protein, presumably in an ADP-
bound state, future work can build on this to compare the effects of ligand binding, 
or the effects of mutation on protein symmetry, size and flexibility.     
 
5.3.2 Preliminary crystal structure of NRC1 reveals co-purification with 
ADP and highlights central role for conserved Histidine 
 
We undertook a series of experiments to determine the crystal structure of NRC1 
NBARC domain with the view to better understand the structural basis for its 
conserved switch mechanism. We have solved the crystal structure of NRC1 
NBARC domain to 2.5Å, revealing that the protein co-purifies with ADP, and the 
molecular basis for this binding. Furthermore, we identified interactions between the 
β-phosphate of ADP and a histidine that we believe plays a pivotal role in ligand 
discrimination, determining the conformation of the active and inactive states. This 
histidine forms the centre of the widely conserved MHD motif, and its role in 
interacting with ADP, and potentially stabilising the ARC2 domain, may explain the 
high level of conservation of this motif across a wide range of R-proteins.  
Complete structural characterisation of this domain has been unsuccessful due to 
limitations in resolving and interpreting regions of electron density in our 
experimentally-derived maps. Despite this, the electron density maps, and use of 
identified SeMet sites, allowed sequence placement and gives us confidence in our 
interpretation of the ligand binding site and surrounding areas. Refinement of 
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phases has allowed us to identify the amino acid side-chains involved in co-
ordinating protein-nucleotide interactions, and has allowed us to design a series of 
structure-guided mutants to probe different aspects of ligand discrimination and 
auto-inhibition.  
5.3.3 Designing structure-based mutants to investigate ligand-
dependent regulation 
 
With experimentally derived structural information about the interactions between 
NRC1 NBARC and ADP we have been able to design a number of point mutants to 
explore regulation of the protein. Some of these mutants have been explored in 
similar proteins, such as the Walker-A mutation leading to loss-of-binding in multiple 
NTPases, however the effect these changes have on R-protein dynamics in solution 
has yet to be explored. We have been able to rationalise the phenotype of 
previously generated mutations that have no experimentally determined basis, such 
as the commonly used MHD->V mutation to cause autoactivation. Furthermore as we 
were able to express the NBARC domain of NRC1 solubly in E. coli we had hoped 
to use these mutants to provide detailed analysis of the mechanisms of ligand 
discrimination and regulation through investigations into the biochemistry and 
dynamics of mutations to the conserved MHD motif in isolation. The biochemistry of 
both wild-type and point-mutants are explored in Chapter 6 “Functional 
characterisation of NRC1 NBARC domain”. 
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6.1 Introduction 
Models for R-protein regulation have been typically derived from experiments 
performed either in planta or using refolded protein. Such models allow us to 
hypothesise about the behaviour of the N-terminal domains of NRC1 in isolation and 
conversely allows us to test and validate such generalised models. For example 
signalling repression is suggested to occur by stable interactions between the 
NBARC and coiled-coil domains1, 153, 165. These in planta experiments are 
qualitatively very useful, however due to the complex environments in which they 
are performed it is not possible to derive quantitative data regarding binding 
affinities and stability. Additionally the complex cellular environment means that 
such interactions may be indirect, mediated by additional host proteins, or may 
require post-translational modification of the domains to facilitate such interactions. 
Purification of proteins allows the removal of potentially confounding host proteins, 
and allows the use of sensitive techniques to generate quantitative data regarding 
their biochemical properties. 
Biochemical investigations into refolded N-terminal R-protein domains suggest that 
these proteins are catalytically active102, 103, however the rates of activity appear to 
be very low. Indeed some researchers questioned whether the domains were true 
nucleotide binding sites with bona fide enzymatic activity166. Soluble expression of 
these domains from homologous R-proteins should allow comparison to these 
previously published data, and exploration of whether this low activity may be due to 
the effects of refolding, or whether slow ATP hydrolysis is an intrinsic property of 
these proteins. Better understanding of rates of ATP hydrolysis may have 
implications for maintaining active states in planta, and the tolerance these proteins 
will have to mutations that may inadvertently affect protein-nucleotide interactions. 
Here we test three key putative functions of R-protein NBARC domains that are 
believed to influence the regulation of R-proteins in planta. We investigate the 
possibility of signal repression by CC/NBARC interactions, the ability to revert from 
“on” to “off” states by ATP hydrolysis, and the possibility of the NBARC domain to 
interact with DNA.  
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6.2 Results 
Note: DNA fluorescence anisotropy assays were performed with the Cann group (Durham 
University). SPR was performed by Clare Stevenson (JIC). 
6.2.1 Purification of NRC1 N-terminal domains for in vitro assays 
Both NRC1 NBARC domain and coiled-coil domains were expressed using 
conditions identified in Section 3.5.2. 6L of pOPIN-S3C:NRC1CC in BL21 Lemo were 
grown in PB media and induced at an OD600 of 0.6 by the addition of 1mM IPTG 
after cultures had been rapidly cooled on ice. Cells were pelleted by centrifugation 
and lysed by sonication. Cell debris was removed by centrifugation and clarified 
lysate loaded onto a pre-equilibrated 5mL Ni2+-NTA column. Bound protein was 
eluted by single step addition of 500mM imidazole and loaded onto a superdex 
sepharose S75 column. Given the low predicted absorption of light at 280nm by the 
protein, all fractions were collected from the column as the protein was unlikely to 
produce a significant peak (Figure 6.2.1). 
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Figure 6.2.1 Purification of SUMO-tagged NRC1 coiled-coil 
 
SUMO-tagged NRC1CC was found to elute at both 150mL and ~110mL (void-volume 
of the column), indicating that a fraction of the protein is either misfolded or forming 
large complexes. Coomassie staining of SDS-PAGE separated proteins show very 
few contaminants in the void volume (Figure 6.2.1, Right, first three lanes), making 
self-association or aggregation a likely explanation for this elution peak. The lower 
Soluble E. coli extract expressing SUMO-tagged NRC1 coiled-coil domain loaded onto a 
sepharose S75 superdex column following nickel-affinity IMAC. Left. Gel filtration trace of 
eluting proteins. Major peak at approximately 110mL is indicative of the presence of 
proteins larger than ~70kDa eluting from the IMAC column. Right. SDS-PAGE of 
fractions eluting from the SEC column indicates that protein consistent with the mass of 
SUMO-tagged NRC1CC elutes in both the void-volume (first 3 lanes) of the column and at 
approximately 150mL with few contaminants. 
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molecular-weight bands seen in the coomassie stained SDS-PAGE gels could be 
either contamination or degradation products. As our intention was to purify soluble, 
well-folded protein only fractions containing the SUMO-tagged protein that eluted 
away from the column void-volume were used for further purification. Selected 
fractions were pooled and concentrated to <20mL prior to the addition of 3C 
protease and incubated overnight at 4°C. Residual tagged protein and protease 
were removed by subtractive IMAC. Flow-through and washes were collected and 
concentrated to <5mL and loaded onto a superdex sepharose S75 column for final 
purification and buffer exchange (6.2.2).   
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Figure 6.2.2 Final purification of the NRC1 coiled-coil domain 
We were able to detect NRC1CC eluting in both the void-volume of the column, and 
at ~170mL. This was surprising as only SUMO-tagged protein eluting away from the 
void volume, indicative of well-folded protein, was used for tag removal. The 
presence of NRC1CC in the void-volume of this second purification may be indicative 
of either instability of the protein in solution leading to aggregation, or an equilibrium 
between monomeric and multimeric coiled-coil domain. SDS-PAGE and coomassie 
staining shows that purified protein contains no visible high molecular-mass 
contaminants, however the presence of lower molecular-mass bands indicates 
some protein degradation. This was confirmed by the observation that the protein 
was unstable in solution, with significant degradation apparent after ~3 days. 
Purification of NRC1CC following SUMO-tag removal and subtractive IMAC shows two 
well-defined peaks eluting from a superdex S75 SEC column (Left). The first peak is 
consistent with the void-volume of the column suggesting a species of >70kDa. The 
second peak shows clear separation from the void-volume indicating well folded protein. 
Right. SDS-PAGE and coomassie staining of fractions from the second elution peak. 
Migration of the protein is consistent with the expected size of the coiled-coil domain, 
however multiple bands may suggest degradation of the protein.   
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Protein eluting away from the void-volume was pooled and concentrated for 
downstream experiments, with fresh protein produced for each use. 
NRC1 NBARC domain was typically purified from 4L of PB induced at OD600 = 0.6 
with 1mM IPTG after rapid chilling of cultures on ice. Protein expression was 
performed at 18°C for 16h with constant shaking. Purification of soluble protein was 
performed as described in Section 5.2.1 to obtain untagged, soluble NRC1 NBARC 
domain.  
6.2.2 Assessment of point mutant protein folding by circular dichroism 
The introduction of point mutations may lead to global changes in protein fold, 
significantly affecting structure and therefore function. To test that the point mutants 
we were able to generate did not have significant changes in folding we performed 
circular dichroism experiments using wild-type NRC1 NBARC domain from both E. 
coli and insect cells, and used these spectra to investigate the effects of D268N and 
D481V mutations on the secondary structure of purified NBARC domain. Proteins 
were diluted >20 fold to a final concentration of 0.1mg/mL in phosphate buffer and 
spectra recorded from 180-260nm in 1nm steps at 25°C (Figure 6.2.3).  
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Figure 6.2.3 Circular dichroism spectra of wild-type NRC1 NBARC and generated point 
mutants 
 Page 180 of 232 
 
 
Comparison of CD spectra shows no apparent change in secondary structure 
between heterologous expression system, and indicates that the introduction of 
point mutations of aspartate at position 481 and 268 to valine and asparagine 
respectively do not lead to significant changes in secondary structure. We were 
therefore confident that changes in biochemical activity of these proteins is not likely 
to be due to substantial changes in protein folding.  
 
6.2.3 NRC1 coiled-coil and NBARC domains do not form a stable 
complex in vitro 
A potential explanation for signal repression in the absence of a pathogen is that the 
CC domain is sequestered by the NBARC domain bound to ADP, and thus unable 
to interact with downstream signalling components. In this model displacement of 
ADP for ATP results in a conformational change in the NBARC domain, which 
releases the CC domain, allowing it to interact with essential signal transduction 
factors.  We tested whether this was a feasible method for regulation of NRC1 
activity by investigating whether the CC and NBARC domains were able to interact 
in the absence of any additional factors.  
Analytical gel filtration was performed with the coiled-coil domain and NBARC 
domains to determine their individual elution volumes. The two domains were then 
mixed and incubated on ice for 2-6 hours or 4°C overnight and the protein mixture 
elution volumes measured by analytical gel filtration. Gel filtration separates proteins 
based on their size and conformation; larger proteins elute in a smaller volume than 
proteins with a lower molecular mass. We therefore focussed on the formation of a 
new A280 peak in an elution volume smaller than that seen for NRC1 NBARC 
domain of circa 10.3mL (Figure 6.2.4).  
A. Wild-type NBARC domain purified from E. coli. B. Wild-type NBARC domain 
purified from insect cells. C. NRC1 NBARCD481V purified from E. coli. D. NRC1 
NBARCD268N purified from insect cells.  
Purified proteins were diluted >20 fold into phosphate buffer to minimise buffer 
interference. Spectra were recorded at 25°C in 1nm steps, with three readings 
recorded per wavelength. Plots represent averaged, buffer subtracted spectra. 
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Figure 6.2.4 Analytical gel filtration of NRC1 coiled-coil and NBARC domains 
 
NBARC and CC domains were mixed at 1:1, 1:2 and 1:4 molar ratios, using three 
separate protein preparations for the NBARC domain and two independent 
purifications of the CC domain. No signs of complex formation were seen during 
analytical gel filtration even with high molar excess of CC domain. This may indicate 
that the proteins require either additional host proteins or the LRR domain of the 
protein to stabilise weak interactions, or require post-translational modifications in 
order to form a stable complex in planta. 
A. Elution of NRC1 coiled-coil domain shows a single major peak at approximately 
12.1mL. 
B. NRC1 NBARC domain elutes as a single peak at approximately 10.4mL 
C. Incubation of these two domains at a 4:1 molar ratio (coiled-coil to NBARC) 
shows no significant change in elution volume and no formation of additional 
higher-molecular mass species. NRC1CC has very low absorption at 280nm and 
so produces a much smaller elution peak than the NBARC domain despite the 
high molar excess 
D. SDS-PAGE and coomassie staining of fractions eluting from C. The lack of both 
proteins present in the same fractions confirms the results from C.   
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6.2.4 Yeast 2-hybrid is unable to identify interactions between N-
terminal NRC1 domains 
Although heterologous protein expression in E. coli allows high yields of highly 
purified proteins, the simple prokaryotic environment may not be able to recreate 
the folds and modifications of proteins expressed in eukaryotic cells. We used a 
eukaryotic-based in vivo assay to confirm two key in vitro results regarding NRC1 
NBARC interactions- the inability of the coiled-coil domain to form a complex with 
the NBARC domain, and the observation that the NBARC domain appears to purify 
as a homodimer. We used a yeast 2-hybrid (Y2H) system to test for interactions for 
two reasons. Firstly the eukaryotic environment may produce NRC1 domains that 
better reflect the state of the protein in planta, and secondly Y2H can be more 
sensitive to transient interactions than exclusion chromatography and 
immunoprecipitation experiments.   
ProQuest yeast 2-hybrid system uses the separation of the GAL4 transcription 
factor into separate DNA binding (DBD) and activation domains (AD) to test whether 
two proteins interact when fused independently to the DBD and AD domains. If the 
two proteins interact, the DBD and AD come into proximity and are able to drive 
transcription of a target gene. Reconstitution of the transcription factor drives 
expression of HIS3, which is required for growth of the yeast strain MaV203 on 
media lacking histidine. Once yeast cells have been co-transformed with vectors 
carrying the genes of interest fused N-terminally to the activation and binding 
domains, they are spotted out onto histidine-deficient media, and only if the two 
proteins interact are the cells able to survive and form colonies. In order to fine-tune 
this selection and reduce false-positives by leaky expression of HIS3, the media is 
also supplemented with a repressor of this gene expression, 3-amino-1,2,4-triazole 
(3AT). 
DNA encoding the coiled-coil domain of NRC1 was cloned into the pDEST32 vector 
as described in Section 2.2.2. The region encoding the NBARC domain was cloned 
into both pDEST22 and pDEST32 vectors to allow testing for dimerization. Yeast 
were co-transformed with plasmids encoding pDEST22:NRC1CC, 
pDEST32:NRC1NBARC, pDEST22:NRC1NBARC, pDEST22:empty vector, or 
pDEST32:empty vector to test for interactions and baseline activity. Empty vector 
controls are required to determine whether fusion of the vector to the gene of 
interest leads to spontaneous activation and gene expression- particularly important 
for investigations into the activity of R-protein NBARC domains in light of recent 
publications highlighting the potential for DNA binding167(Section 6.2.8). Following 
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transformation yeast were plated on media lacking leucine and tryptophan (SC-LW 
media) to select for co-transformants, as only cells carrying both pDEST22 and 
pDEST32 vectors are able to grow in the absence of these two amino acids. After 
four days at 28°C growth individual colonies were selected, re-suspended in water 
and spotted on to media lacking leucine, tryptophan and histidine (SC-LTH). Plates 
were incubated at 28°C and imaged every day for four days (Figure 6.2.5). 
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A CB
Interaction 
controls
 
Figure 6.2.5 Yeast 2-Hybrid for NBARC dimerisation and coiled-coil interactions 
 
Although there appears to be moderate growth for yeast cells expressing both the 
coiled-coil and NBARC domain of NRC1, this growth is comparable to yeast 
carrying the individual domains and empty vector controls (pDEST22:EV with 
pDEST32:NRC1CC, and pDEST22:NRC1NBARC with pDEST32:EV). Growing yeast in 
lower concentrations of the inhibitor 3AT (7.5mM and 5mM) affected all co-
MaV203 yeast, auxotrophic for leu, trp and his, co-transformed with pDEST22 and 
pDEST32 vectors encoding NRC1CC and NRC1NBARC domains. Image shows colonies 
after four days growth at 28°C on SC-LYH media, supplemented with 10mM 3-AT. Three 
transformants from two independent transformations were selected and spotted out with 
representative colonies shown above. All colonies show intermediate phenotypes 
between the “weak interaction” control C, and the “moderate interaction control” B. 
Colony growth when individual constructs are co-transformed with empty vectors 
indicates mild auto-activation, with experimental colonies not growing significantly more 
than these negative controls. 
 Page 184 of 232 
 
transformants equally, and so did not lead to a difference in growth phenotype 
between experimental and negative control transformants.  
Contrary to in vitro data, there are no indications of strong NBARC-NBARC 
interactions in this system. One of the first indications that the protein may be 
forming oligomers was the observation that removal of the ~13kDa N-terminal 
SUMO tag lead to a decrease in elution volume from a preparative gel filtration 
column (Section 5.2.1). This may suggest that the N-terminal tag prevents normal 
protein-protein interactions, which can only occur after cleavage. In this yeast 2-
hybrid system cloning into both the bait and prey vectors leads to an N-terminal 
protein fusion. It is possible that fusion to the DBD and AD acts analogously to the 
presence of the N-terminal SUMO tag in preventing NBARC dimerization. 
6.2.5 NRC1 NBARC domain is a functional ATPase 
Given the presence of conserved Walker-A and Walker-B motifs in NRC1 NBARC 
domain, we hypothesised that this protein should be functional ATPase, as is the 
case for I-2 and Mi-1. In the model described in Section 1.7, ATPase activity may be 
an important characteristic of R-proteins, allowing them to reset after activation by 
hydrolysing ATP to ADP with associated conformational changes. In this model 
ATPase activity and nucleotide exchange are intrinsic functions of NBARC domains, 
requiring no external activation as is the case for many GTPases, but instead 
require the removal of the inhibitory LRR domain. 
Purified NRC1 NBARC domain should therefore be able to facilitate the turnover of 
ATP in the absence of the LRR domain. We took two approaches to test this- one 
assay measuring the release of ADP as it is displaced by ATP, the second 
measuring the release of free phosphate (Pi). 
ADP release was measured using a linked enzymatic assay. ADP is used as a 
phosphate acceptor in the conversion of phosphoenolpyruvate to pyruvate by 
pyruvate kinase (PK). Pyruvate is then used by lactic dehydrogenase (LDH) to 
produce lactate in a reaction that results in the oxidation of NADH. NADH absorbs 
light at 340nm to a much greater extent than NAD+ and so the conversion of NADH 
to NAD+ can be measured spectroscopically as a decrease in A340, allowing indirect 
measurement of the amount of ADP released by an ATPase (Figure 6.2.6). 
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Figure 6.2.6 Schematic of linked ATPase assay 
 
The ATPase activity of NRC1 NBARC domain was assessed using this linked 
PK/LDH assay, with the rate of decrease in A340 being proportional to the rate of 
ADP release. Initial measurements were made in the absence of NRC1 NBARC 
domain every minute for 10 minutes to assess the background change in A340 and 
readings taken every minute after the addition of NRC1 NBARC domain (or BSA as 
a negative control) to measure the average rate of A340 decrease. Also included 
were samples that contained NRC1 NBARC domain, but no ATP. Structural studies 
indicate that the protein co-purifies with ADP and so this control was used to 
distinguish between ATP hydrolysis and subsequent ADP release, and stochastic 
dissociation of ADP from the protein (Figure 6.2.7).  
 
This linked pyruvate kinase (PK) lactate dehydrogenase (LDH) assay allows indirect 
measurement of ADP and thus ATP hydrolysis performed by a putative ATPase. ADP is 
used by PK to produce pyruvate from phosphoenolpyruvate (PEP). This pyruvate is then 
a substrate for the NADH-dependent formation of lactate by LDH. The assay measures 
the oxidation of NADH, which absorbs light at 340nm strongly, to NAD+ which does not. 
By using an excess of PEP and NADH in reaction conditions, and the high Kcat of both 
PK and LDH it is possible to measure the rate of ATP hydrolysis by a putative ATPase by 
observing change in A340 over time. 
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Figure 6.2.7 PK/LDH linked ATPase assay of NRC1 NBARC domain 
 
In these assays we are able to see a clear difference between NRC1 NBARC and 
the BSA control, indicating that the NRC1 NBARC generates ADP for use in the 
linked assay. Additionally the difference between NRC1 NBARC domain in full 
assays and assay conditions lacking ATP suggests that this ADP is not the result of 
stochastic dissociation of the co-purifying ADP. It is possible that the ADP measured 
is not newly formed by the hydrolysis of ATP, but rather the presence of ATP 
displaces pre-existing ADP. Continuing these assays for a longer time period, say 
until the depletion of PEP would demonstrate the bona fide ATP turnover. 
Alternatively the use of a second, independent ATPase assay can be used to 
demonstrate ATPase activity. 
The second method we used to test the ATPase activity of NRC1 NBARC measures 
the release of free phosphate (Pi) using malachite green125, 168. This method 
A. Plot showing three technical replicates for sample absorbance at 340nm over 
time prior to the addition of NRC1 NBARC domain. 
B. The same samples as in A. following addition of 50µM NRC1 NBARC domain.  
C. Comparison of rate of A340 decrease between samples before and after addition 
of protein. Positive values indicate an increase in rate of NADH oxidation and 
therefore more ADP available for linked reactions. No ATP control indicates the 
rate of ADP release from WT NBARC domain in the absence of ATP. Columns 
indicate median values, with error bars showing SE. Data from three repeats 
were analysed using Sigma plot. Shapiro-Wilk test indicates that data are not 
normally distributed and so analysis was performed as pairwise one-way 
ANOVA on ranks. Significance was determined using Dunn’s method. For WT 
NBARC domain n=8, for BSA and no ATP controls n=9. 
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requires fewer additional inputs, and is preferable to the linked assay as free 
phosphate is unlikely to co-purify with the protein, a complication for the linked 
assays. In this method Pi forms a complex with molybdenum which absorbs light at 
630nm. The reactions were performed using 2mM MgCl2 and 1mM ATP in HEPES 
pH7.5. Reactions were stopped by quenching with malachite green reagent and 
quenched reactions left for 20 minutes at room temperature to stabilise before 
readings were taken. As the solution continues to increase in A630 over time, BSA 
was included as an internal control in all runs, allowing background subtraction 
(Figure 6.2.8).  
 
Figure 6.2.8 Malachite green assay comparing BSA and NRC1 NBARC-mediated phosphate 
release 
 
6.2.6 Investigating ligand-dependent oligomeric changes in NRC1 
NBARC domain   
A number of NBARC domain containing proteins are known to undergo changes in 
oligomeric state when activated- Apaf-1, Ced-4 and DARK all form large 
apoptosomes when activated, with interactions mediated by their NBARC domains. 
We therefore wanted to investigate whether the NBARC domain of NRC1 showed 
changes in oligomeric state in response to activation- either by the binding of a non-
hydrolyzable ATP analogue (ATP-γ-S), or the introduction of autoactivating 
mutations. 
To monitor the ability of ATP-γ-S to bind to NRC1 NBARC domain we used the 
linked PK/LDH assay, as described in Section 6.2.5. Full ATPase assays were set 
ATPase assays performed with either BSA (light blue) or WT NRC1 NBARC domain 
purified from E. coli. OD630 increases with phosphate concentration. Bars represent 
mean OD values with error bars showing SD. Reactions performed in triplicate. Data 
presented here are from a full assay shown in Figure 6.2.13. 
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up, and the rate of ADP release/ ATP hydrolysis measured for 10 minutes. After this 
time period, 5mM ATP-γ-S was added to the reactions and change in A340 decrease 
measured (Figure 6.2.9). 
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Figure 6.2.9 Spiking linked PK/LDH assay with non-hydrolysable ATP analogue 
 
From this preliminary experiment it appears that complete binding of ATP-γ-S to the 
NBARC domain is achieved approximately 20-30 minutes after addition of the 
substrate analogue. We used this to establish a minimum incubation period for 
NRC1 NBARC and ATP-γ-S before performing additional experiments. 
In Section 5.2.4  we demonstrated that the elution volume of NRC1 NBARC domain 
from a superdex 10/300 GE column is approximately 10.3mL. As the NBARC 
domain was found to co-purify with ADP (Section5.2.8), we believed that this would 
represent this domain in the “off” state, and so activation via nucleotide exchange 
could result in either higher order oligomers as is the case for Apaf-1, or could result 
in dissociation of the complex leaving monomeric protein. Preliminary experiments 
were performed by DLS (dynamic light scattering) using 1mg/mL NRC1 NBARC 
domain incubated with either ADP or ATP-γ-S overnight at 4°C (Table 6.2.1). 
 
Averaged A340 for three technical replicates of linked PK/LDH assay with 50µM WT 
NRC1 NBARC acting as a source of ADP. Arrow indicates time point for addition of 5mM 
ATP-γ-S, ADP-NP or A4 buffer for the two negative controls. Dotted line is linear 
extrapolation from original rate of reaction for ATP-γ-S to show expected behaviour of 
NRC1 NBARC in the absence of non-hydrolysable analogue. A340 shows a sharp 
decrease following addition of ATP-γ-S, indicating rapid release of ADP. Plateau at ~40 
minutes suggests that NRC1 NBARC is no longer able to bind to hydrolysable ATP and 
is thus fully occupied by the non-hydrolysable analogue.  
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R (nm) %Pd MW-R (kDa) %Mass 
ADP treated 3.6 13 67 97.8 
ATP-γ-S treated 3.2 19.5 51 97.4 
 
Table 6.2.1 Estimated NRC1 NBARC particle size in response to treatment with either ADP 
or ATP-γ-S by DLS 
 
This preliminary result suggests a change in particle dimension in response to 
treatment with an ATP analogue. To confirm this result, and get more accurate data 
regarding protein mass, we performed analytical gel filtration with fresh protein that 
was incubated with either ADP or ATP-γ-S. Protein was incubated for 6-16 hours at 
4°C, with one set incubated for 4 hours at 4°C followed by 1 hour at room 
temperature, before being loaded onto a superdex™ S75 10/300 GL column. Figure 
6.2.10 shows the resulting elution traces of the NBARC domain in the presence of 
these two ligands.  
NRC1 NBARC domain incubated with either 1mM ADP or 1mM ATP-y-S overnight at 
4C. Ten readings were taken at 25°C per sample and data interpreted using 
DYNAMICS® v6 software (Wyatt technology) assuming particles as rayleigh spheres. R 
(nm) denotes calculated particle radius, %Pd denotes polydispersity of samples, MW-R 
indicates the calculated molecular weight of particles based on radial measurements. 
Addition of the non-hydrolsable ATP analogue ATP-γ-S appears to result in a decrease 
in particle mass of approximately 16kDa.  
 Page 190 of 232 
 
 
Figure 6.2.10 Analytical gel filtration of NRC1 NBARC domain incubated with either ADP or 
ATP-γ -S 
 
The elution profiles we see for NRC1 NBARC domain incubated with either ADP or 
ATP-γ-S shows no significant changes in response to the different ligands. Although 
we were unable to characterise the bound ligand prior to these assays, the linked 
enzymatic assay demonstrating ADP release suggests that nucleotide exchange 
should occur during this time frame, and given the excess of ATP-γ-S we should 
expect at least partial occupancy with this ligand. However as the substrate trapping 
experiment (Figure 6.2.9) was performed only once, it may be that this rate of 
nucleotide exchange is not representative of the behaviour of NRC1 NBARC in 
solution, and so it is possible that when incubated at 4°C the protein has undergone 
Analytical gel filtration of NRC1 NBARC domain purified from E. coli incubated with either 
1mM ADP (A.) or 1mM ATP-γ-S (B.). Elution profiles were consistently similar over 
multiple experiments, indicating that the size of NRC1 NBARC complexes does not 
change in the presence of these two ligands under these conditions. 
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little nucleotide exchange. This would mean that the gel filtration traces in Figure 
6.2.10 are representative only of ADP-bound protein. To overcome this issue we 
tested the oligomeric state of the NRC1 NBARC Walker-B mutant, which we 
predicted would have impaired ATPase activity and therefore be more likely to co-
purify with ATP (Figure 6.2.11). 
 
Figure 6.2.11 Analytical gel filtration of NRC1 Walker-B mutant and wild-type protein derived 
from insect cell expression 
Mutation to the conserved aspartate in the Walker-B motif of NRC1 NBARC domain 
does not result in a dramatic change in oligomeric state when measured by 
analytical gel filtration. We predicted that this protein should be more likely to co-
purify with ATP due to deficient ATPase activity, and that this trace would therefore 
A. Analytical gel filtration of NRC1 NBARCD268N mutant predicted to be deficient in 
ATPase activity purified from insect cells. Protein shows a single, well-defined peak at 
approximately 10.2mL. 
B. Analytical gel filtration of wild-type NRC1 NBARC domain purified from insect cells. 
Protein elutes identically to NRC1 NBARCD268N, and consistent with the major elution 
peak of E. coli-derived protein. 
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represent the oligomeric state of the protein bound to ATP. As we see in Section 
6.2.7, this Walker-B mutation does not lead to complete abolition of ATPase activity 
and so further work is required to characterise the bound ligand to determine 
whether this trace is representative of ATP-bound protein. 
Finally we tested whether MHD->V mutations cause activation by altering protein 
oligomeric state, potentially mimicking activated or ATP-bound protein. As shown in 
Figure 6.2.12, the introduction of this mutation in NRC1 NBARC domain did not 
result in changes in oligomeric state. Analytical gel filtration of this protein shows 
additional minor elution peaks. The elution volume of each peak and corresponding 
calculated molecular mass is summarised in Table 6.2.2 , with values for E. coli-
derived wild-type protein elution peaks for comparison. 
 
Figure 6.2.12 Analytical gel filtration of NRC1 NBARCD481V 
 
 
Peak 
Elution volume 
(mL) 
MW 
(kDa) 
NRC1 1 7.73 171.88 
NRC1 NBARCD481V mutant elutes with a predominant peak at 10.2mL, consistent with the 
behaviour of wild-type protein, presumably indicative of this domain in its inactive state. 
Additional peaks eluting at smaller volumes is indicative of multiple oligomeric states or 
conformations. 
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NBARCD481V 2 9.044 94.99 
3 10.22 56.06 
WT NRC1 
NBARC 
1 9.55 75.79 
2 10.35 52.90 
 
Table 6.2.2 Summary of NRC1 elution peaks and corresponding molecular weights 
 
Analytical gel filtration of NRC1 NBARCD481V shows that the majority of the protein 
elutes in the same way as wild-type protein. We are able to identify two minor 
elution peaks and have calculated their approximate molecular masses, which 
appear to be distinct from wild-type elution. This gel filtration has been performed 
with a single protein purification and so we cannot confidently state that these peaks 
will be a consistent feature of this purified protein.  
6.2.7 Aspartate to Valine mutation in NRC1’s conserved ‘MHD’ motif 
leads to increased ATPase activity 
As we were unable to attribute autoactivation by the MHD->V substitution to 
constitutive changes in oligomeric state, we decided to explore other aspects of 
predicted NBARC biochemistry to explain this dysregulation. The observation that 
this substitution results in preferential binding of ATP over ADP in the flax disease 
resistance protein M led authors to suggest that this mutation either leads to a 
greater affinity of ATP in these mutants, or that these proteins are deficient in 
ATPase activity. 
We investigated whether the MHD->V mutation in NRC1 NBARC domain resulted in 
decreased ATPase activity of NRC1 NBARCD481V. Malachite green assays were 
performed as described in Section 2.17.2 with the results summarised in Figure 
6.2.13 Phosphate releasing activity of NRC1 NBARC mutants in malachite green 
ATPase assay . 
Summary of the peaks identified for analytical gel filtration of NRC1 NBARCD481V and 
their corresponding molecular mass. The peaks seen for WT NRC1 NBARC is included 
to give a comparison of potential oligomeric states. 
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Figure 6.2.13 Phosphate releasing activity of NRC1 NBARC mutants in malachite green 
ATPase assay 
 
The preliminary results from this assay indicate that rather than a decrease in 
ATPase activity, this mutation results in a significant increase in ATPase activity, 
however given the low signal in these assays replicates would increase the 
statistical robustness of these experiments and our confidence in this interpretation.  
6.2.8 NRC1 NBARC does not interact strongly with DNA 
The difficulties to date in positively identifying the signalling components of many R-
proteins has led some researchers to suggest that this indicates a very short 
signalling cascade, making it less likely to be disrupted by random mutagenesis 
screens. Recently the Cann group at Durham University have published evidence 
A. Mean OD630 after 1 hour incubation of ATP reaction buffer with 50μM protein followed by 
quenching for 20 minutes with malachite green reagent. Error bars indicate standard 
deviation of the mean. Malachite green ATPase assays were performed twice for NRC1 
NBARCD481V samples and three times for all other treatments. 
B. As in A. but with average BSA reading subtracted for each run. A630 decreases over time 
and so subtraction of BSA background readings allows better comparison between 
assays. Data were analysed in Sigma Plot. Significance was determined using holm-sidak 
method for pairwise comparisons of the mean values. Mean phosphate release is 
approximately 12.11µM for E. coli-derived wild-type protein, 5.85uM for insect-cell derived 
wild-type protein, 0.519µM for NBARCD268N (insect-cell) and 29.89µM for NBARCD481V (E. 
coli). 
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suggesting that NBARC domain of Rx interacts non-specifically with DNA167, and 
that this activity may be conserved for the NBARC domains of multiple R-proteins. 
The source of protein for these experiments included the coiled-coil domain as well 
as the NBARC domain, and required the liberation of protein from inclusion bodies. 
We decided to test whether solubly expressed NRC1 NBARC domain also showed 
an ability to interact non-specifically with DNA. We initially used surface plasmon 
resonance (SPR) to look for non-specific NBARC-DNA interactions.  
SPR can be used to detect a wide range of macromolecular interactions. One 
interacting partner (bait) is attached to a metal chip and a laser aimed at an angle at 
the other side of the chip. A detector measures the intensity of reflected light, which 
is sensitive to the properties of the interface between the chip and the medium (in 
this case a buffer solution). Potential interacting partners can be washed over the 
surface of the chip, where they can bind to the bait. Binding changes the refractive 
index of the chip and results in a decrease in intensity of reflected light, measured in 
response units (RU) (Figure 6.2.14). 
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Figure 6.2.14 Schematic of an SPR experiment 
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Standard SPR setup can be modified to allow easy testing of protein interactions 
against multiple DNA sequences. ReDCaT (Re-usable DNA capture technique) 
uses a short, generic DNA oligo conjugated to biotin169. This DNA oligo is then be 
bound to a streptavidin-coated SPR chip. Target DNA sequences can then be used 
in SPR experiments by including a short section of DNA that is complementary to 
the immobilised sequence, allowing these two sections to anneal. Once the test 
DNA has annealed to the generic DNA oligo adaptor the target protein can be 
injected into the flow cell and the response measured. Once an experiment is 
complete the cell can be washed in high-salt conditions to remove the bound protein 
and annealed DNA, leaving only the biotin-conjugated adaptor sequence. 
Using this method we tested the ability of NRC1 NBARC domain to interact with five 
randomly selected double-stranded oligonucleoutides. Protein was tested at 50, 
100, 500 and 1000µM.The sensogram (Figure 6.2.15) shows no signs of interaction 
between NRC1 NBARC domain and this selection of oligonucleotides. 
A. Typical SPR set up. A flow cell containing a gold chip to which one protein-interacting 
partner is adhered to has buffer passed over it. A laser is shone at the other side of the 
chip at angles that allows total internal reflection. Using these conditions an evanescent 
wave is produced, which can be absorbed by free electrons to generate surface 
plasmons, resulting in decreased intensity of the reflected light at a specific angle. The 
intensity of reflected light is measured by a detector and the angle of minimum reflection 
can be recorded.  
B. Addition of a species capable of binding to the anchored interacting partner changes 
the refractive index of the chip, affecting the angle at which light is maximally absorbed 
by the production of surface plasmons. This change in maximum absorbance is 
measured by the detector, which records a new angle of minimum reflection. This shift in 
angle of minimum light intensity is recorded in response units (RU). 
C. A typical SPR sensogram.1. Loading of a potential interacting partner onto a chip 
leads to an increase in response units. 2. Flowing over a species capable of binding to 
this interacting partner gives a large increase in response units. 3. Removal of the 
binding species, for example by high-salt washes. 4. Stripping the chip of the affixed 
interacting partner to allow re-use of a single chip. 
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Figure 6.2.15 SPR of NRC1 NBARC interaction with double-stranded DNA 
 
It is possible to calculate Rmax, the maximum expected increase in response units for 
saturation binding for the DNA oligos used to give a sense of scale expected for interactions 
between this protein and DNA. For the shortest DNA oligo against monomeric NRC1 
NBARC is approximately 3300RU, and for the longest oligo 1600RU. Even factoring the 
potential for sub-optimal concentrations of NRC1 NBARC the lack of any signs of response 
strongly suggests that this protein does not interact with DNA as even partial occupancy 
should be registered in this system. 
As we were unable to detect interactions by SPR we established a collaboration 
with Martin Cann’s group at Durham University to test NRC1 NBARC domain using 
techniques they have employed to investigate Rx-DNA interactions. To investigate 
NRC1 NBARC interactions with DNA we used fluorescence anisotropy with a 
fluorescently labelled DNA oligo demonstrated to interact with Rx. Fluorescence 
anisotropy is based on the ability of fluorophores in solution to depolarize light. 
Highly mobile fluorophores are able to re-orientate rapidly in solution and so when 
subjected to polarized lights, the light emitted is relatively depolarised. Larger, less 
mobile fluorophores such as those attached to large proteins are less free to tumble 
in solution and so when these are subjected to polarized light, fewer are able to re-
Introduction of NRC1 NBARC to flow cells containing affixed dsDNA does not lead to an 
increase in response units. Five separate DNA sequences ranging from 20 to 40 
nucleotides in length were tested against 50, 100 and 500nM NRC1 NBARC domain. 
After initial binding of DNA to the SPR chip (an increase of ~500 RU) traces remain 
unresponsive to both the addition of protein and wash steps, indicating no binding events 
occur.  
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orientate prior to photon emission and thus emit light polarized parallel to the 
excitation light (Figure 6.2.16).  
Depolarised 
light
Light polarised 
parallel to 
incoming beam
A. B. C.
D. E. F.
 
Figure 6.2.16 Schematic of fluorescence anisotropy experiments 
We used untagged, purified NRC1 NBARC domain to investigate its ability to 
prevent the depolarization of light emitted from a fluorescently labelled 
oligonucleotide. Initial tests indicated that NRC1 NBARC was able to reduce 
depolarization of emitted light significantly more than BSA (Figure 6.2.17), with no 
dramatic difference between interactions with single-stranded and double-stranded 
DNA (data not shown). 
A. Incoming light (black arrow) with specified polarisation (red arrow) is absorbed by 
fluorophores in solution (green ovals). B. Light is emitted from fluorophore after time tau 
(fluorescence lifetime. If rotational lifetime of the molecule (theta) is less than that of the 
fluorescence lifetime the molecule will emit light with a new polarisation. C. Measurement 
of polarisation of light emitted parallel and perpendicular to excitation beam determines 
whether depolarisation has occurred. D. Incoming light is absorbed by a fluorophore 
conjugated to a large macromolecule. E. Larger complexes have a longer rotational 
lifetime and so are less likely to re-orientate prior to photon emission. F. Detected light is 
recorded as being primarily parallel to the excitation beam and so emitted light is 
described as anisotropic.   
 
If an additional protein is added to D that is capable of binding the conjugated 
macromolecule, rotational lifetime will increase, resulting in less depolarisation of light. If 
the added protein is unable to interact with the conjugated macromolecule, no change in 
anisotropy is recorded. 
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Figure 6.2.17 Fluorescence anisotropy of labelled single-stranded DNA in response to BSA 
and NRC1 NBARC 
 
 
In order to try to determine the binding affinity of this protein for DNA we produced a 
binding curve using increasing concentrations of NRC1 NBARC against single-
stranded DNA oligonucleotide (Figure 6.2.18).  
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Single-stranded fluorescently labelled DNA treated with 10uM BSA or NRC1 NBARC. 
After 20 minutes incubation at room temperature in a 96-well plate samples were 
subjected to polarized excitation light and the polarization of the emitted light recorded. 
Increased anisotropy in the presence of NRC1 NBARC suggests binding to the DNA to 
increase rotational lifetime. Graph shows mean values and SD. 
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Figure 6.2.18 Binding curve for NRC1 NBARC and single-stranded DNA 
 
In this experiment we were able to see greater anisotropy in the presence of NRC1 
NBARC than BSA, indicating that NRC1 NBARC may be interacting with the single-
stranded DNA in this system. Subtraction of BSA signal produces a binding curve 
that does not reach saturation point, but shows a dose-dependency. Although it is 
possible to derive a logarithmic curve, the lack of saturation means that we cannot 
be confident that a linear interpolation may not better represent binding interactions. 
As the binding curve did not reach saturation we were not confident in the derived 
Kd for this interaction. In order to saturate the system we increased the 
concentration of NRC1 NBARC to 160µM. As there appeared to be negligible 
binding at the lowest concentrations used, we increased the starting concentration 
of NRC1 NBARC to 0.3μM (Figure 6.2.19). 
A. Raw data showing changes in fluorescence anisotropy of fluorescently labelled 
DNA in response to increasing concentrations of NRC1 NBARC or BSA. Protein 
concentrations range from 0.03µM to 60µM with each concentration tested with 
triplicate technical replicates.  
B. Averaged and BSA-subtracted fluorescence anisotropy of NRC1 NBARC 
interacting with single-stranded DNA from A. 
C. Binding curve calculated using SigmaPlot global curve analysis, selecting for 
single-site binding kinetics. Derived curve gives a Kd = 33.54 +/- 8.22, and R2 
0.9886.  
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Figure 6.2.19 Saturated binding curve for NRC1 NBARC double-stranded DNA interactions 
 
The ability to fit a hyperbolic binding curve suggests that NRC1 NBARC binds to 
DNA in a single-site interaction, and we can derive a Kd of approximately 6µM in 
this instance. The nature of these experiments was exploratory, and so the above 
figures represent single experiments with technical replicates. In order to make 
more definitive judgements regarding binding affinities and significance of the data 
more replicates are required, particularly given the low signal from these 
experiments.  
Disparity between the apparent Kd from the two binding curves makes interpretation 
of a likely Kd problematic. Interestingly the apparent maximum response from our 
saturated binding curve is approximately 0.06, which is surpassed in our previous 
curve without signs of plateauing- the significance of which cannot be determined 
without further experiments. 
 
 
 
Averaged and BSA-subtracted fluorescence anisotropy in response to increasing NRC1 
NBARC concentrations. Protein concentration ranges from 0.3uM to 160uM. Curve was 
fitted using SigmaPlot global curve analysis to give a Kd = 5.9692 +/- 3.70, with R2 
0.7271  
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6.3 Discussion 
6.3.1 NRC1 exhibits ATPase activity consistent with predictions. An 
autoactive mutant displays higher rates of ATP hydrolysis, 
contrary to expectations  
We have used two independent methods to investigate the ability of NRC1 NBARC 
domain in isolation to facilitate ATP hydrolysis. Although turnover is significantly 
higher than BSA controls, the slow rate of hydrolysis or exchange raises the 
question of biological relevance. R-proteins are known to respond very rapidly to the 
presence of effectors, and so how likely is it that the ability to hydrolyse ATP to ADP 
over the course of hours acts as a bona fide regulatory mechanism? Despite low 
enzymatic activity relative to proteins like catalase, in planta investigations indicate 
that R-proteins require the ability to hydrolyse ATP: mutating residues in the R-
protein I-2 that result in decreased rates of ATPase activity causes effector-
independent cell-death105. This suggests that ATP hydrolysis, even with very low 
turnover rates, is required for R-protein regulation. Analysis of the data from linked 
PK/LDH assays suggests that the data are not normally distributed and so post-hoc 
analysis was performed to account for this non-normal distribution. Although this 
analysis stated that wild-type protein displays significantly enhances activity relative 
to negative controls, this non-normal distribution, variability in the data and low 
signal make a compelling case for increased replicates to improve confidence in this 
result.   
Low ATPase activities are not entirely unexpected. I-2 and Mi-1 also display low 
levels of ATP turnover, as does the animal homologue Apaf-1102, 170. When the full-
length resistance protein M was purified from yeast, bound ligand could be 
quantified, but the authors were unable to confidently detect ATPase activity130. 
There are multiple potential reasons for this low ATPase activity: these reactions are 
performed isolated from other host proteins, and so it may be that additional 
proteins may be required to stimulate ATPase activity, similar to GTPase regulation. 
Alternatively it may be that in the absence of the CC or LRR domains, ATPase 
activity is reduced- for example the LRR domain may facilitate nucleotide exchange. 
Or it may be that these proteins require ATPase activity, but in order to balance 
inhibition in the absence of a pathogen, with rapid responses to invasion, this 
activity must be low (further discussed in Section 7.2). 
When investigating the basis for autoactivity in the flax resistance protein M, the 
authors suggest that the higher occupancy of ATP relative to ADP may be due to 
either increased affinity for this ligand, or a deficiency in ATPase activity. The idea 
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that MHD->V mutations may reduce the ability of R-proteins to hydrolyse ATP is 
consistent with the observation that functional Walker-B motifs are required to 
prevent autoactivation. However two observations may indicate a different role for 
the MHD motif in R-protein regulation: protein modelling typically places the MHD 
motif distal from the Walker-B motif, with numerous examples of ATPases that do 
not possess MHD-like motifs, and in planta assays of R-protein responses to 
mutations indicate that MHD mutations result in far more dramatic auto-activation 
than Walker-B mutations alone, however this does not rule out multiple roles for the 
MHD motif.  
We have demonstrated that the isolated NBARC domain of NRC1D481V displays 
higher rates of ATP hydrolysis than wild-type protein. This result was unexpected, 
and may be the result of two main factors. Firstly it is possible that the R-protein 
NRC1 behaves, and is regulated differently to the resistance protein M found in flax. 
NRC1 appears to be a downstream signalling component rather than a canonical R-
protein, and so there may be differences in the way that this protein is kept in a 
signalling-competent “off” state. The high conservation of the MHD motif in R-
proteins, particularly in the domain showing the highest level of conservation argues 
against this point, as presumably the motif is conserved on the basis of conserved 
function. A second possibility is that the observation of this autoactive mutant’s 
ability to hydrolyse ATP comes from an isolated domain, whereas experiments into 
the occupancy of the flax-rust protein M comes from full-length protein. In the 
context of full-length protein it is possible that mutating this aspartate to valine 
results in changes in domain orientation or affinity. Increased ATP occupancy could 
be due to increase nucleotide release- the observation that the NBARC domain co-
purifies with ADP suggests a high affinity, or very slow ligand release, and the 
increase in ATPase activity, although significantly greater than wild-type, leads to 
less than a 2-fold increase. If the rate of ADP release in MHD->V mutants is increased 
more than the rate of ATPase activity then we would expect to see a greater 
proportion of R-protein bound to ATP than wild-type, with this disparity decreasing 
over time. 
6.3.2 Mechanistic basis for increased ATPase activity in NRC1 
NBARCD481V 
There are multiple ways in which changing the aspartate residue near the ligand 
binding pocket may affect the rate of ATP hydrolysis. One potential explanation is 
that this mutation leads to destabilisation of the NBARC●ADP complex, resulting in 
more rapid nucleotide exchange. Similarly, the replacement of the hydrophilic 
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aspartate with a hydrophobic valine may destabilise the interactions between the 
ARC2 and NB domain, resulting in a more open conformation of the ligand binding 
pocket, again facilitating nucleotide exchange. Alternatively the MHD->V mutation 
may cause an increase in ATPase activity indirectly, by its effect on the 
neighbouring histidine. From the preliminary crystal structure of NRC1 NBARC we 
hypothesise that the histidine of the MHD motif is likely to play two main roles in 
regulating NBARC activity. Firstly, its size and proximity to the β-phosphate of ADP 
suggest that this conformation is unfeasible in the presence of ATP due to steric 
clashes, and so one role of this histidine may be in ligand discrimination, and driving 
conformational changes of the protein. Secondly both the size of the residue and its 
charge suggests it may be required to act as a locking mechanism. If the difference 
between “on” state NBARC domain and “off” state is the positioning of the ARC2 
domain relative to the ARC1/NB domain, then it may be that the charge-charge 
interactions between the histidine and β-phosphate of ADP are required to prevent 
the stochastic movements of the ARC2 domain, which may mimic the presence of 
bound ATP.  
The absolute conservation of this central histidine supports the idea of a locking 
mechanism, as ligand discrimination by steric clashes could equally be achieved by 
the side chain of phenylalanine. If this is the case, then the role of the negatively 
charged aspartate may be to keep histidine positioned in a way that allows the 
histidine-B-phosphate interaction to occur- for example by stabilising a dis-favoured 
rotamer by charge-charge interactions. Investigations by van Ooijen et al suggest 
that the role of this aspartate may be to stabilise the helix on which the central 
histidine sits, therefore facilitating the histidine-beta-phosphate interactions110, which 
may be the case for NRC1. Homology modelling of I-2 NBARC domain on Apaf-1 in 
this paper positions the MHD aspartate sidechain away from the central histidine, 
where it is unlikely to interact directly with the side chain of Histidine. The 
preliminary crystal structure of NRC1 NBARC suggests that these two side-chains 
may be positioned more closely, supporting a more direct role for this residue, 
however we cannot rule out the effect that this substitution may have on secondary 
structure elements in this region.   
6.3.3 NRC1 signalling repression cannot be explained simply by 
NBARC sequestration of the coiled-coil domain 
The simplest explanation to explain repression of R-protein signalling in the 
absence of a pathogen is the idea that the signalling component (the coiled-coil 
domain) is normally held in a conformation that does not allow interaction with the 
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necessary components to trigger a response. In the model that we have been 
exploring this is performed by a complex forming between the coiled-coil and 
NBARC domains. Investigations using purified protein in the absence of an 
additional factors indicate that the CC and NBARC domains or NRC1 do not form a 
stable interaction, leading to a few potential explanations. Firstly it is possible that 
complex formation requires the LRR of the protein. As we were unable to produce 
soluble LRR in this study, we cannot explore whether the addition of the LRR would 
lead to complex formation. From an evolutionary perspective it should be possible to 
test this theory, if enough NRC1 homologs can be found. Complex formation 
requires compatible protein-protein interactions, and for these interactions to remain 
stable there should be indications of either stabilising selection in specific regions, 
or co-evolution between the three domain interaction interfaces. Early indications of 
the feasibility of this interaction arrangement could come in the form of experiments 
into the presence of transient interactions between the CC and NBARC domains 
using sensitive methods such as SPR or isothermal calorimetry. 
It is possible that these two domains do form a complex in planta without requiring 
stabilisation by the LRR, but requiring an additional bridging factor. We have yet to 
test this hypothesis- expression of the two domains in planta followed by co-IP and 
mass spectrometry may be able to identify such a bridging element. Common false-
positive results from co-IP experiments include molecular chaperones, particularly if 
expression is driven by a high-expression constitutive promoter such as the CaMV 
35S promoter. However, it is entirely feasible that such a chaperone may be the 
required stabilising factor- thus discriminating between expression artefact and 
legitimate interactor may be difficult.   
Sequestration of the CC domain of NRC1 may not be required to repress the 
signalling activities of NRC1. Work by Sueldo et al indicates that overexpression of 
the NBARC domain, not the coiled-coil domain, of NRC1 leads to cell death. This is 
similar to Rx, where it was found that the NBARC domain also causes cell death 
when expressed alone. Therefore it may be that in the case of NRC1 there is no 
requirement to form a CC-NBARC complex to prevent CC interactions with 
downstream signalling components.  
6.3.4 NBARC-DNA interactions 
Recent publication by Fenyik et al describing the DNA-binding capabilities of Rx led 
us to speculate whether such activity could be observed in the solubly expressed 
NBARC domain of NRC1. Initial experiments using SPR was unable to detect any 
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signs of binding, despite the high sensitivity of this method and range of 
oligonucleotides used. This lack of apparent interaction could be due to multiple 
experimental factors, and so we worked with the Cann group using their established 
protocols to explore whether NRC1 NBARC interacts with DNA in their system. 
Our preliminary data suggest that NRC1 NBARC is able to bind to single-stranded 
DNA (ssDNA) as measured by the changes in the ability for this labelled DNA to 
depolarise light when excited by a linearly polarised source. We were able to derive 
two apparent Kd values for single stranded DNA from an unsaturated and saturated 
binding curve, with approximately five-fold difference between these two values. If 
the interaction between NRC1 and DNA is as weak as suggested by our first 
binding curve it may explain why we were unable to see an interaction with SPR. 
Although SPR is a very sensitive method to detect interactions the best results are 
typically obtained using a protein concertation range 0.1 to 10 fold higher than the 
predicted Kd. As this would mean using purified protein at a concentration 
approaching 300µM, or approximately 6000 fold more than was used, it may not be 
surprising that we were unable to detect significant signal. Despite this, the large 
increase in RU predicted from NRC1 binding would suggest that weak interactions 
should be detectable. Future experiments using this system should therefore use 
increased NBARC concentrations for optimal data collection. Using such high 
concentrations of protein for SPR may lead to non-specific interactions between 
protein and the chip, and so non-specific binding must first be tested to determine 
the validity of such an experiment.  
Although our fluorescence anisotropy experiments suggest NBARC-DNA 
interactions the sensitivity of this technique to factors in addition to bone fide 
interactions means that validation with complimentary techniques is advised. For 
example increasing protein concentration can affect the turbidity of solution, which 
will slow the rate of molecular tumbling and increase anisotropy. This factor can be 
compensated for by the use of appropriate controls, such as our use of BSA, which 
also showed increasing responses with concentration. Our subsequent 
investigations into the oligomeric state of NRC1 NBARC suggests that such 
experiments may require additional controls to improve confidence in interpretation. 
Changes in fluorescence anisotropy are affected by the molecular mass of the 
interacting partner, with the binding of larger macromolecules having a greater 
effect on anisotropy than smaller molecules. At the time of these experiments we 
believed NRC1 NBARC to act as a monomer in solution, giving it a molecular mass 
of approximately 40kDa. In this case the use of BSA (MW 66kDa) would give a 
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conservative binding affinity once this control was subtracted from experimental 
signal. If NRC1 NBARC is acting as a dimer in solution then the subtraction of non-
specific BSA control of 66kDa may overestimate the effect of specific binding of an 
80kDa dimer. Ideally such experiments should be performed with point mutants that 
are defective in DNA binding. As protein-DNA interfaces can be extensive, a simple 
single point mutation may not suffice, and so considerable work would be required 
to identify the smallest number of mutations abolishing DNA interactions without 
affecting protein stability. Such an extensive screen is beyond the scope of this 
project, yet may be essential to fully characterise NBARC-DNA interactions to 
supplement existing data regarding this novel R-protein activity.     
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7 
General discussion 
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The rapid increase in confirmed or putative R-genes in plant genomes, facilitated by 
cheaper, faster sequencing, and tools such as RenSeq171, is providing us with new 
resources to tackle virulent phytopathogens. As these new R-genes are cloned and 
sequenced they also allow us to evaluate our models for R-protein behaviour, and 
open avenues for crop improvement. For example identification of non-canonical 
NB-LRRs has let us explore the role of decoy modules, potentially raising the 
possibility for “plug and play” R-proteins with directed specificity. Likewise, by 
studying the function of individual domains in the context of R-protein biology we 
can expand our models for R-protein behaviour to inform deployment in the field 
and rational improvements to individual proteins.   
Models from in planta and genetic investigations allow us to explore many aspects 
of R-protein biology. However, complementing these investigations with biochemical 
studies in vitro can give us a more detailed view of the mechanistic basis for 
regulation and signalling of these agriculturally important proteins.  
This project aimed to increase our understanding of some of the biochemical and 
structural properties of solanaceous CNL R-proteins, however given the limited 
published resources for such studies a key focus was development of tools to allow 
such experiments to be performed. 
7.1 Development of tools for future experiments 
At the time of writing there were very few examples of R-proteins or their domains 
suitable for biochemical investigations. Difficulties in expressing protein domains, 
either solubly or refolded from inclusion bodies, combined with the difficulties in 
detecting enzymatic activity has resulted in our understanding of the biochemistry of 
these proteins resting on very few examples, from a diverse family. Furthermore 
commonly used assays, such as filter-binding assays that are required to monitor 
very low levels of activity are susceptible to influences of poorly folded or unstable 
proteins, and thus need to be complemented with additional biochemical 
techniques. 
7.1.1 Purification of soluble R-protein domains 
Central to this project was the development of material to allow further 
characterisation of R-proteins and their subdomains in vitro. Biochemical 
investigations of R-proteins, from oligomeric state to enzymatic activities, and 
putative interactions have been limited by the difficulties of obtaining sufficient yields 
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of suitable protein for these types of experiment. We pursued extensive screening 
efforts to obtain suitable material from E. coli and eukaryotic expression systems. 
We utilised both advanced methods to screen constructs that would not necessarily 
be included in traditional screening methods, and traditional construct design with 
medium-throughput screens of expression conditions, both in house and with the 
Oxford Protein Production Facility (OPPF).  
We have not been able to rationalise some of our successful expression screens, 
for example why specific constructs seem to have an absolute expression strain 
requirement, distinct from similar constructs. Thus researchers wishing to express 
new R-protein domains in E. coli will most likely need to carry out similar expression 
screens. However we have been able to increase the number of solubly expressing 
R-protein domains, which may aid future construct design.  
To date our ideas regarding the structure and behaviour of R-protein CC domains in 
vitro rely on two examples- MLA10 and Rx. To these published proteins we have 
been able to add four new examples of solanaceous CC domains for future work: 
R3a, I-2, NRC1-like and NRC1.  
More significantly we have been able to demonstrate the soluble expression of the 
NBARC domain of the plant CNL NRC1. This provides a unique tool for 
investigating the behaviour of this domain in isolation. Just as we hope that by 
increasing the number of coiled-coils that can be expressed in E. coli may aid future 
research, this new construct may help inform design of additional R-protein NBARC 
constructs to allow characterisation of a diverse range of these regulatory domains. 
The ability to produce wild-type and specific point mutants in this protein can allow 
future investigations into different aspects of R-protein behaviour and regulation.  
7.1.2 Generation of R3a-detecting antibodies 
One of the more frustrating aspect of this project has been the inability to confidently 
immunoprecipitate untagged R3a from plant material. We had hoped that the 
production of specific antibodies would allow us to probe proteins interacting with 
signalling-competent R3a to help elucidate important host proteins involved in R-
protein activation and signalling. However this has not been possible with the 
techniques used here, in spite of a series of screens designed to improve 
experimental conditions. 
Despite this we have demonstrated that these antibodies can detect the coiled-coil 
domain of R3a when expressed as part of the full-length protein in planta, and when 
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purified as a single domain from E. coli. These antibodies have further been used to 
show mutant stability and accumulation for the homologous protein I-2, 
demonstrating that the use of these antibodies is not restricted to 
immunoprecipitation experiments. 
As the R3a-AVR3a pathosystem is an area of ongoing interest we hope that these 
antibodies can be of use to researchers in this field as a tool to further elucidate the 
regulation of R3a-dependent HR signalling, through techniques such as native-
PAGE, far-western blotting, or to identify co-purification of native R3a with tagged 
putative interactors. 
7.2 Preliminary structural characterisation of NRC1 NBARC 
domain 
Understanding the mechanistic basis for R-protein regulation and the effect of 
mutations to conserved motifs in the NBARC domain has typically relied on 
homology modelling from animal homologues, which may demonstrate difference in 
regulatory mechanisms- for example NBARC-mediated apoptosomes formation 
seen in many animal NBARC proteins has yet to be demonstrated as a feature of 
the NBARC domains of R-proteins.  
Despite these potential differences the preliminary structure of NRC1 NBARC 
domain presented here indicates significant structural similarity to the ADP-bound 
form of Apaf-1 NBARC domain, as opposed to His-Asp phosphotransferases166 thus 
validating the assumptions made in prior papers about this structural conservation 
for example109, 110, 134, 172. If a complete structure of this NBARC domain can be 
produced in future it can form a more reliable template for future R-protein 
homology models, particularly those for which experimental support is not available. 
I-2 and Mi-1 both have experimentally determined ATPase activity, and thus 
functional conservation can be used to supplement low sequence conservation. 
This activity has not been validated outside these two examples, and so it is 
possible that there exist subfamilies of NBARC proteins resembling and behaving 
like CED-4, which does not have demonstrated ATPase activity, and those acting 
like Apaf-1. Due to the higher sequence identity between plant NBARC domains, a 
completed structure may increase the accuracy of models of these domains, 
particularly those that deviate from characterised examples77, 110. Even if this 
preliminary ADP-bound structure remains incomplete it can be used to identify gross 
conformational changes if researchers are able to solve the structure of an ATP-
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bound or active plant NBARC domain, to better understand the switch mechanism 
of these proteins. 
Of more direct importance is the identification co-purifying ADP, and the NBARC 
residues involved in this interaction. Co-purification of this ligand indicates a high 
affinity of plant NBARC domains for adenosine nucleotides, as has been 
demonstrated for animal homologs and full-length R-proteins98, 130, 173, 174. Such a 
high affinity suggests that the low hydrolysis rate of ATP in vitro may not be the 
result of a long-lived active structure (ATP-bound NBARC), but due to low ligand 
turnover, however further experiments are required to validate this hypothesis. If 
true this may explain the apparent positive role of the LRR in HR-signalling- if the 
LRR forms interactions with the ARC2 subdomain as has been suggested, then 
activation may result in dissociation of the LRR from this domain, not simply to 
passively allow nucleotide exchange, but to actively “pull” the ARC2 subdomain 
away from the ligand binding site. This would then allow ATP binding, which could 
stabilise the resulting “on” conformation. 
Alternatively it may be that slow ATP hydrolysis is a result of low enzymatic activity, 
and not limited by nucleotide exchange. ATPase activity has been demonstrated to 
be required for proper regulation, as reduced ATPase activity has been linked to 
autoactivity in planta. There are two possible reasons why this activity is required, 
and required to be slow. Firstly as the protein is being synthesised it is likely to bind 
to ATP, given the high ATP to ADP ratio in cells, although data regarding relative 
affinities is necessary for greater confidence in this interpretation. This would result 
in R-proteins synthesised in an “on” conformation, which would require conversion 
to an “off” state to prevent aberrant cell death. Secondly little is known about the 
protein dynamics involved in cell-death, though these processes are often depicted 
as single-molecule events. If cell-death initiation requires multiple copies of an R-
protein to be in an “on” state (analogous to the requirements for apoptosomes 
formation in animals), then rapid hydrolysis of ATP may reduce the likelihood of this 
minimum activation concentration being reached when required. This may explain 
dose-dependent effects seen with the overexpression of certain R-proteins. Under a 
constitutively active promoter such as the CaMV35S protein synthesis occurs more 
quickly, and so if ATP hydrolysis is low, as suggested here, then enough nascent R-
proteins are formed bound to ATP before hydrolysis can re-set the proteins, leading 
to cell death. 
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7.3 Putative roles for the MHD motif 
Work with the flax rust resistance protein M expressed in yeast indicated that 
introduction of MHD->V mutations in this protein leads to higher occupancy of ATP 
relative to ADP when compared with wild-type protein130. In this work the authors 
suggest two explanations for this: either this mutation results in decreased ATPase 
activity, or an increased affinity for ATP, however this question remains unsolved 
due to issues demonstrating ATPase activity.  Preliminary data we present here 
suggests that rather than decreasing ATPase activity, mutations to the aspartate of 
the MHD motif of NRC1 may result in increased ATP hydrolysis. 
We hypothesise that this increase in ATPase activity is not due to increased ATP 
hydrolysis, but is due to disruption of the interactions between the conserved 
histidine and the β-phosphate of ADP. This could prevent the “locking” of the ARC2 
domain in place, and allow increased nucleotide exchange. Indirect evidence 
supports the idea that the MHD motif is not directly involved in hydrolysis. Firstly, 
double mutants with reduced ATP hydrolysis and MHD mutations do not see an 
additive effect175. Secondly the crystal structure of NRC1 suggests that this 
aspartate is unlikely to be close enough to interfere with the Walker-B motif, known 
to be required for ATP hydrolysis. Finally many ATPases exist without this MHD 
motif, suggesting that this motif is dispensable for ATP hydrolysis in STAND 
proteins.  In reference to the work performed with the TNL protein M, increased 
nucleotide exchange could result in greater ATP occupancy if the increased rate of 
exchange is greater than the rate of ATP hydrolysis, particularly if a higher affinity 
for ATP over ADP can be demonstrated, as has been suggested for Apaf-1176.  
 
7.4 Models for R-protein regulation 
Together the functional and structural studies we have performed favour the 
interpretation put forward by Chattopadhyaya et al109 and van Ooijen et al175 
amongst others, that the NBARC domain in the off state is bound to ADP and 
resembles ADP-bound Apaf-1. The positioning of the β-phosphate and MHD motif 
supports the interpretation that in the “on” state the ARC2 domain is pushed away 
from the NB-ARC1 domains, forming a more elongated structure. 
The crystal structure of NRC1 NBARC domain also supports bioinformatic 
analayses suggesting that the invariant histidine is the most important residue in the 
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MHD motif, given its direct interactions with the ligand. Furthermore we suggest that 
this histidine has two functions in R-protein regulation- both as a ligand sensor 
based on steric constraints, and as a locking mechanism as a simple sensor activity 
indicated by the crystal structure of NRC1 could be performed by uncharged 
species such as phenylalanine. 
We do not see evidence for sequestration of the CC by the NBARC as a general 
mechanism for signal repression. It is possible that the methods we employed are 
not sensitive enough to detect interactions, and could be tested by more sensitive 
isothermal calorimetry or SPR experiments. However such transient interactions are 
unlikely to be sufficient to prevent aberrant cell death. It may be that additional 
factors are required to form a stable complex, such as the LRR domain, or some 
other interacting partner, however we have not been able to generate the materials 
required to test this.  
Alternative activities for the CC domain have been proposed- for example the CC of 
NRC1 may be involved in controlling localisation, as has been shown for a number 
of CC domains90 rather than activating signalling, and so does not require 
intramolecular interactions to repress cell death. This is supported by work from 
Sueldo et al suggesting that NRC1 may function in a similar way to Rx, with the NB 
domain and not the CC domain responsible for signalling cell death177. For NRC1 an 
alternative model whereby the CC controls localisation, either through post-
translational modification or interactions with host proteins may be more 
appropriate. In this model activation may result in re-localisation, and recognition of 
the NBARC in an open conformation, stabilised by ATP by downstream signalling 
components may explain the behaviours we see. 
Whether a lack of direct CC-NBARC interactions is a general feature in multiple R-
protein or is specific to NRC1 is not known. It may be that this alternative model 
reflects the behaviour of separate classes of R-protein (those using the N-terminus 
for signalling and those using the N-terminus for localisation or regulation), or may 
be a feature unique to NRC1-like proteins. NRC1 does not act as a traditional R-
protein, but as a downstream signal protein, and so may undergo fundamentally 
different regulation. The activity of NRC1 downstream of other immune receptors 
does not preclude the activities identified here from being generally applicable to 
“true” R-proteins. NRC1 shares the same domain architecture as canonical CNLs 
with the same conserved motifs identified in bona fide R-proteins, and so is unlikely 
to behave in a completely unrelated way. 
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7.5 Future perspectives 
There are many fundamental questions regarding the structure and behaviour of 
CNLs that remain unanswered. The role of the CC domain in controlling oligomeric 
state remains contentious as the two published examples give contradictory results, 
with Rx CC acting as a monomer and MLA10 CC forming a dimer in solution86, 92. 
The materials we have produced may give insight into whether CC monomers or 
dimers are more common for solanaceous R-proteins. Furthermore structural 
characterisation of these domains could help elucidate whether there is a typical CC 
fold, and the role of known motifs in CC activity.  
From our medium-throughput screens we were able to solubly express three of five 
solanaceous CC domains, when based on a construct known to express solubly in 
E. coli. Using a similar approach the construct boundaries from NRC1 NBARC 
expression may likewise improve the ability to produce solubly-expressing NBARC 
domains from other R-proteins, allowing investigations into the variability of R-
protein behaviour in vitro such as rates of ATP hydrolysis, and potential protein-
protein interactions.   
The ability to produce the NRC1 NBARC MHD->V mutant has led to an unexpected 
finding, which should be further characterised. Replication of existing assays is 
required to determine if the observed increase in ATPase activity is significant. The 
role of this motif in controlling enzymatic activity, ligand binding and protein 
conformation has yet to be elucidated. A combination of biochemical assays and 
spectroscopic methods, such as SAXS to compare protein flexibility, should allow 
discrimination between changes in nucleotide exchange and ATP hydrolysis.  
Although we have not been able to comprehensively describe the NBARC domain 
of NRC1, or the full behaviour of CNL CC domains in vitro, this project has yielded 
valuable resources that can directly or indirectly improve our understanding of these 
important and robustly regulated proteins. 
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Appendix Figure 1 Western blot of R3a IP experiment 
Full blot from Figure 4.2.5 A. I- input, U- unbound, E-elution. 
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Appendix Figure 2 Intact MS for R3aCC domain 
Intact MALDI mass spectroscopy spectrum for R3aCC purified in Section 3.4. Performed by 
Gerhard Saalbach 
  
 
 
Appendix Table  1 
List of primers used in this project. 
 
 
